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Abstract 
X-ray fluorescence techniques have proven beneficial for identifying and quantifying 
trace elements in biological tissues. A novel approach has been developed that employs 
x-ray fluorescence with an aim to locate the presence of nanoparticles, such as gold, 
which are embedded into tissues. The nanoparticles can be functionalised to act as 
markers for tumour characteristics to map the disease state, and then imaged to inform 
cancer therapy regimes. The uptake of nanoparticles by cancer cells could also enable 
detection of small clusters of infiltrating cancer cells which are currently missed by 
commonly used imaging modalities. The novel system, consisting of an energy 
resolving silicon drift detector with high spectral resolution, and a synchrotron source, 
showed potential in both quantification of and sensitivity to nanoparticle concentrations 
typically found in tumours. A linear relationship between fluorescence intensity and 
nanoparticle concentration was found down to 0.001 mgAu/ml, the detection limit of 
the system. A successful translation using a more clinically available bench-top x-ray 
tube was demonstrated, and found not to degrade the linearity or detection limit. The 
achieved system sensitivity suggests clinical usefulness in measuring tumour uptake in 
vivo. A set of bio-phantoms consisting of collagen type 1 gel, populated with colorectal 
cancer cells (HT29) and healthy murine fibroblast cells (3T3) that have been incubated 
with gold nanoparticles (GNPs), were created. The bio-samples were successfully used 
to (i) demonstrate GNP uptake in cells, and (ii) demonstrate the use of the novel bench-
top system in measuring GNP uptake in cells. Translation to a 2D imaging technique 
was undertaken, using polycapillary optic technology to acquire positional information 
of gold XRF emissions, and energy resolving single channel and pixellated detectors. 
The GNP-imaging capabilities of the XRF technique were demonstrated using Perspex 
phantoms incorporating different GNP concentrations. Details of phantoms with 
concentrations as low as 0.025 mgAu/ml have been successfully imaged, with potential 
to image lower concentrations. It can be inferred from feasibility data collected that the 
x-ray fluorescence technique can be combined with x-ray diffraction methods to form a 
novel multi-modality system that is sensitive to GNP distribution and can discriminate 
biological tissue. Future work will develop this combined system to locate tumours and 
provide information on tumour characteristics.   
 6 
 
Table of Contents 
Abstract ............................................................................................................. 5 
List of figures .................................................................................................. 14 
List of tables .................................................................................................... 20 
List of abbreviations ........................................................................................ 21 
Outputs ............................................................................................................ 23 
 
1 Introduction ................................................................................................. 25 
1.1 The clinical problem .............................................................................. 25 
1.1.1 Biology of the tumour microenvironment ..................................... 26 
1.1.2 Hypoxia: a case study in radiotherapy........................................... 27 
1.1.3 Current hypoxia measurement techniques .................................... 29 
1.2 Requirements of an imaging technique to answer the clinical problem 32 
1.3 Aims ...................................................................................................... 33 
1.4 Technical objectives .............................................................................. 34 
1.5 Justification of technical objectives....................................................... 35 
1.5.1 Use of GNPs as a contrast agent for radiotherapy ......................... 35 
1.5.2 Current techniques used to image GNPs ....................................... 37 
1.5.3 Requirements for GNP imaging .................................................... 38 
1.5.4 X-ray fluorescence techniques ...................................................... 39 
1.5.5 Introduction to x-ray diffraction .................................................... 42 
1.5.6 Justification of bio-phantom production ....................................... 43 
 7 
 
1.6 Novelty of this work .............................................................................. 44 
1.7 My contribution to this work ................................................................. 45 
1.8 Structure of this thesis ........................................................................... 48 
2 Quantitative measurement of gold nanoparticle concentration ............. 50 
2.1 X-ray fluorescence: Introduction ........................................................... 50 
2.2 Nanoparticle samples ............................................................................ 52 
2.3 Synchrotron fluorescence system: L-fluorescence ................................ 54 
2.3.1 System design ................................................................................ 54 
2.3.2 X-ray source .................................................................................. 55 
2.3.3 X-ray detector system .................................................................... 55 
2.3.4 Detector Collimator ....................................................................... 56 
2.3.5 Measurement procedure ................................................................ 57 
2.4 Translation to a bench-top fluorescence system: L-fluorescence ......... 57 
2.4.1 Difficulties involved in translating from a synchrotron source to a 
clinical x-ray tube .................................................................................................... 58 
2.4.2 System design ................................................................................ 60 
2.4.3 Bench-top x-ray source ................................................................. 60 
2.4.4 Beam collimator ............................................................................ 61 
2.4.5 X-ray detector system .................................................................... 61 
2.4.6 Measurement procedure ................................................................ 61 
2.5 Translation to a bench-top fluorescence system: K-XRF ..................... 61 
2.5.1 Difficulties involved in translating to a K-XRF system ................ 62 
2.5.2 System considerations ................................................................... 63 
 8 
 
2.5.3 System design ................................................................................ 64 
2.5.4 X-ray source .................................................................................. 65 
2.5.5 X-ray filtration ............................................................................... 65 
2.5.6 HPGe detector ............................................................................... 68 
2.5.7 Measurement procedure ................................................................ 69 
2.6 Data analysis procedure ......................................................................... 69 
2.6.1 Isolation of the gold L-XRF signal ................................................ 69 
2.6.2 Isolation of the gold K-XRF signal ............................................... 73 
2.6.3 Absorption correction technique ................................................... 74 
2.6.4 Detection limit ............................................................................... 76 
2.6.5 Sensitivity ...................................................................................... 76 
2.6.6 Linearity and accuracy .................................................................. 77 
2.7 Results ................................................................................................... 78 
2.7.1 Measured spectra ........................................................................... 78 
2.7.2 Absorption correction techniques .................................................. 78 
2.7.3 Linearity of calibration line and accuracy of concentration 
measurement  ....................................................................................................... 81 
2.7.4 Detection limit ............................................................................... 83 
2.7.5 Sensitivity ...................................................................................... 83 
2.7.6 XRF measurements at depth .......................................................... 84 
2.7.7 Summary of results ........................................................................ 89 
2.8 Discussion ............................................................................................. 89 
2.8.1 Sensitivity ...................................................................................... 89 
 9 
 
2.8.2 Detection limit ............................................................................... 94 
2.8.3 Uncertainty in quantitative analysis .............................................. 95 
2.9 Summary of key points learned ............................................................. 96 
2.9.1 Effect of detector choice ................................................................ 96 
2.9.2 Effect of exciting source ................................................................ 97 
2.9.3 Effect of signal (K- vs. L-XRF) .................................................... 98 
2.10 Alternative method of quantitative measurement of GNP 
concentration: X-ray edge subtraction ........................................................................ 98 
2.10.1 Background ................................................................................... 98 
2.10.2 Method ........................................................................................... 99 
2.10.3 Results ......................................................................................... 101 
2.10.4 Discussion ................................................................................... 103 
2.11 Conclusions ...................................................................................... 105 
3 Development of tissue engineered bio-samples ...................................... 107 
3.1 Aims and objectives ............................................................................ 107 
3.2 Introduction to tissue culture and engineering .................................... 108 
3.3 Considerations involved in development of a 3D cellular model with 
nanoparticle inclusions .............................................................................................. 111 
3.3.1 Internalisation of GNPs into cells ............................................... 111 
3.3.2 Engineering of a 3D scaffold ....................................................... 116 
3.4 Development of bio-phantom construction protocol ........................... 117 
3.4.1 Aims of production of bio-phantoms .......................................... 117 
3.4.2 Design criteria for a useful bio-phantom for XRF analysis ........ 118 
 10 
 
3.4.3 Chronological steps towards a bio-phantom protocol ................. 119 
3.4.4 Cell Maintenance ......................................................................... 120 
3.4.5 Incubation of cells with gold nanoparticles ................................. 123 
3.4.6 Cell counting ............................................................................... 125 
3.4.7 Preparation of a 3D collagen model ............................................ 126 
3.4.8 Fixation of samples ..................................................................... 127 
3.4.9 TEM imaging protocol ................................................................ 128 
3.4.10 Development of a novel 3D artificial cancer mass with GNP 
inclusions  ..................................................................................................... 129 
3.4.11 Discussion ................................................................................... 132 
3.5 GNP cell uptake of two different GNP sizes ....................................... 133 
3.5.1 Aim of investigation .................................................................... 133 
3.5.2 Method ......................................................................................... 133 
3.5.3 Results ......................................................................................... 133 
3.5.4 Discussion ................................................................................... 140 
3.6 Selection of GNP incubation time ....................................................... 144 
3.6.1 Aim of investigation .................................................................... 144 
3.6.2 Method ......................................................................................... 144 
3.6.3 Results ......................................................................................... 145 
3.6.4 Discussion ................................................................................... 147 
3.7 GNP dose uptake measurement ........................................................... 148 
3.7.1 Aim of investigation .................................................................... 148 
3.7.2 Production of samples ................................................................. 149 
 11 
 
3.7.3 X-ray fluorescence analysis of samples ...................................... 150 
3.7.4 TEM analysis of samples ............................................................ 156 
3.7.5 Discussion ................................................................................... 159 
3.8 Conclusions ......................................................................................... 161 
4 Towards a real system .............................................................................. 163 
4.1 Requirements for biomarker imaging .................................................. 164 
4.1.1 Sensitivity to NP concentration ................................................... 164 
4.1.2 Spatial resolution ......................................................................... 165 
4.1.3 Partial volume effect ................................................................... 166 
4.2 Development of nanoparticle imaging phantoms ................................ 167 
4.2.1 Sensitivity .................................................................................... 167 
4.2.2 Contrast resolution ...................................................................... 169 
4.3 Imaging system 1: SDD step and scan with mechanical collimator ... 170 
4.3.1 Experimental arrangement .......................................................... 170 
4.3.2 X-ray source ................................................................................ 171 
4.3.3 Nanoparticle phantom ................................................................. 171 
4.3.4 X-ray detector .............................................................................. 172 
4.3.5 Collimation .................................................................................. 172 
4.3.6 Measurement volume .................................................................. 172 
4.3.7 Imaging procedure ....................................................................... 172 
4.3.8 Results of 1D scan of sensitivity phantom .................................. 173 
4.3.9 Discussion ................................................................................... 175 
 12 
 
4.4 Imaging system 2: SDD step and scan with a focussing polycapillary 
optic  ............................................................................................................. 175 
4.4.1 Translating from a mechanical collimator to focussing 
polycapillary optic ................................................................................................. 176 
4.4.2 Experimental arrangement .......................................................... 177 
4.4.3 X-ray source ................................................................................ 177 
4.4.4 Nanoparticle phantom ................................................................. 177 
4.4.5 Polycapillary x-ray optics ............................................................ 178 
4.4.6 Gold nanoparticle imaging procedure ......................................... 179 
4.4.7 Image reconstruction ................................................................... 179 
4.4.8 Results ......................................................................................... 180 
4.4.9 Discussion ................................................................................... 181 
4.5 Imaging system 3: Use of an energy resolving pixellated detector ..... 182 
4.5.1 Controlled drift detector .............................................................. 183 
 
4.5.3 Selection of detector collimator................................................... 184 
4.5.4 Demonstration of angular acceptance of parallel polycapillary 
optics 185 
4.5.5 Experimental arrangement .......................................................... 188 
4.5.6 X-ray source ................................................................................ 189 
4.5.7 Nanoparticle phantom ................................................................. 189 
4.5.8 Detector collimator ...................................................................... 190 
4.5.9 X-ray detector .............................................................................. 190 
4.5.10 Gold nanoparticle imaging procedure ......................................... 190 
 13 
 
4.5.11 Image reconstruction ................................................................... 190 
4.5.12 Results ......................................................................................... 191 
4.5.13 Discussion ................................................................................... 191 
4.6 Summary of key results of XRF imaging of GNPs ............................. 192 
4.7 Development of a combined XRF/XRD system ................................. 193 
4.7.1 X-ray diffraction techniques ........................................................ 194 
4.7.2 The role of x-ray diffraction in tissue discrimination .................. 196 
4.7.3 The role of x-ray diffraction in distinguishing bio-phantom tissue
 198 
4.7.4 XRD measurement of GNP samples ........................................... 202 
4.7.5 Towards the design of a combined XRF/XRD system ............... 205 
4.7.6 Summary of key ideas ................................................................. 217 
4.8 Conclusions ......................................................................................... 218 
 
5 Conclusions ................................................................................................ 219 
6 Bibliography .............................................................................................. 222 
 
 
 
 
 
 14 
 
List of figures 
Figure 1 The tumour and its environment. ...................................................................... 26 
Figure 2 Illustration of x-ray fluorescence process. ........................................................ 40 
Figure 3 Transitions that give rise to the various emission lines . .................................. 40  
Figure 4 Theoretical Lα and Lβ gold x-ray emissions. ................................................... 51 
Figure 5 GNP samples produced over different concentrations ranging from 0.001 – 8 
mgAu/ml. ........................................................................................................................ 52 
Figure 6 Experimental set-up of XRF measurement system. ......................................... 55 
Figure 7 Experimental arrangement of sample, detector collimator and SDD. .............. 57 
Figure 8 Concept of a collimating polycapillary optic.................................................... 59 
Figure 9 Experimental arrangement of bench-top L-XRF system. ................................. 60 
Figure 10 Experimental set-up of K-XRF measurement system. ................................... 65 
Figure 11 Simulated spectral shape of x-ray beam at tube voltage 120kV with 1.5mmPb 
filter and without Pb filtration. ........................................................................................ 66 
Figure 12 Measured effect of Pb filter thickness on (a) x-ray intensity corrected by 
incident intensity measured using an ion chamber, and (b) spectral width (expressed as 
FWHM). .......................................................................................................................... 67 
Figure 13 (top) Synchrotron measured spectra of two different GNP concentrations. ... 70 
Figure 14 Data surrounding the gold Lα and Lβ peaks. A background fit (solid line) 
gives the background beneath each gold fluorescence peak. .......................................... 71 
Figure 15 Gaussian fits to Lα (top) and Lβ (bottom) peak.. ........................................... 72 
Figure 16 Measured x-ray fluorescence spectrum of an 8 mgAu/ml GNP sample. ....... 73 
Figure 17 Data surrounding the gold K-α peaks. A background fit (solid line) gives the 
background beneath each gold fluorescence peak.. ........................................................ 74 
Figure 18 Illustration describing determination of accuracy of GNP concentration 
measurement. .................................................................................................................. 77 
 15 
 
Figure 19 Weighted least squares linear fit (solid line) of XRF signal over a range of 
measured GNP concentrations using the L-XRF synchrotron source, without and with a 
scatter correction. ............................................................................................................ 79 
Figure 20 Weighted least squares linear fit (solid line) of XRF signal over a range of 
measured GNP concentrations using the L-XRF bench-top source, without and with a 
scatter correction ............................................................................................................. 80 
Figure 21 Weighted least squares linear fit of XRF signal over a range of measured 
GNP concentrations using the synchrotron source, L-XRF bench-top source  and K-
XRF bench-top source .................................................................................................... 82 
Figure 22 Depth measurement of 8 mgAu/ml GNP sample; a range of Perspex 
thicknesses were added above the sample to test the effect of depth of measurement on 
the L-XRF method. ......................................................................................................... 85 
Figure 23 Measured XRF spectra of an 8 mgAu/ml sample acquired with a range of 
Perspex thicknesses above the sample. ........................................................................... 86 
Figure 24 Effect of Perspex thickness above an 8 mgAu/ml sample on measured L-XRF 
signal. .............................................................................................................................. 86 
Figure 25 Measured XRF spectra of an 8 mgAu/ml GNP sample surrounded by a range 
of Perspex thicknesses..................................................................................................... 87 
Figure 26 Effect of Perspex thickness surrounding 8 mgAu/ml sample on measured K-
XRF signal. ..................................................................................................................... 88 
Figure 27 Incident spectra of molybdenum bench-top source with 50 μm molybdenum 
filtration and without filtration. ............................................................. 92_Toc312020471 
Figure 28 Attenuation coefficients of gold and water illustrating the achievable contrast.
 ......................................................................................................................................... 99 
Figure 29 Schematic of the x-ray edge subtraction system. ........................................... 99 
Figure 30 Transmission image of GNP sample at 12.07 keV, 11.77 keV and XRES 
image of same GNP sample . ........................................................................................ 101 
Figure 31 Profile plots across the XRES image and transmission image taken at 12.07 
keV ................................................................................................................................ 101 
Figure 32 Log-subtracted and high energy transmission MPV over central ROI. ........ 103 
Figure 33 Model of endocytotic mechanisms and intracellular transport  .................... 112 
 16 
 
Figure 34 Optical microscope images of (a) HT29 and (b) 3T3 cells .......................... 121 
Figure 35 Cell culture flasks containing HT29 cells being incubated with GNPs  and 
without GNPs  ............................................................................................................... 123  
Figure 36 Photograph of cell pellet formed after centrifuging a cell suspension.. ....... 125 
Figure 37 Hemocytometer with glass coverslip being viewed with an optical 
microscope. ................................................................................................................... 125 
Figure 38 A range of 3T3-embedded collagen samples over a range of initial GNP 
concentrations. .............................................................................................................. 127 
Figure 39 Illustration of the novel 3D tumour model with GNP inclusions. ................ 130 
Figure 40 Mould and compression load used to compress the gel to form an ACM. ... 131 
Figure 41 (a) Cuboidal ACM once removed from mould, (b) ACM components to be 
inserted into a low density collagen gel seeded with 3T3 cells . .................................. 132 
Figure 42 TEM image of a 3T3 cell incubated with 1.9 nm GNPs. ............................. 134 
Figure 43 TEM image of a 3T3 cell incubated with 15 nm GNPs. .............................. 135 
Figure 44 TEM image of HT29 cells incubated with 1.9 nm GNPs. ............................ 136 
Figure 45 TEM image of a HT29 cell incubated with 15 nm GNPs............................. 137 
Figure 46. High magnification TEM images of 3T3 cells incubated with (a) 1.9 nm. 
Images (b) and (c) both show 3T3 incubation with 15 nm NPs.. ................................. 138 
Figure 47. High magnification TEM images of HT29 cells incubated with (a) and (b) 
1.9 nm and (c) and (d) 15 nm.. ...................................................................................... 139 
Figure 48  TEM image of cell membrane surface of HT29 cell incubated with 1.9 nm 
GNPs. The image has captured each step of endocytosis ............................................. 142 
Figure 49 TEM images of HT29 cells exposed to 1.9 nm GNPs over a range of 
incubation times: (a) 4 h, (b) 10 h, (c) 24 h and (d) 48 h. ............................................. 146 
Figure 50 X-ray spectra measured in XRF mode of a 0.04 mgAu/ml calibration sample 
using a range of molybdenum filter thicknesses (0, 20, 40 and 70 μm thickness ......... 152 
 17 
 
Figure 51 Measured spectra of 4 mgAu/ml GNP incubation dose sample and 0 
mgAu/ml (control sample) acquired over 2400 s. ......................................................... 153 
Figure 52 Calibration curve relating scatter-normalised XRF signal to GNP 
concentration. ................................................................................................................ 154 
Figure 53 Measured GNP concentrations found in 3T3 and HT29 samples over a range 
of four and three initial incubation doses respectively.................................................. 155 
Figure 54 TEM images of HT29 cells incubated with three different GNP doses: (a) 4 
mgAu/ml, (b) 2 mgAu/ml, (c) 1 mgAu/ml. An image (d) is displayed of 3T3 cells 
incubated with 2 mgAu/ml as a comparison to (b). ...................................................... 157 
Figure 55 TEM images of GNP-filled vesicles within HT29 cells incubated over a range 
of GNP concentrations: (a) 4 mgAu/ml, (b) 2 mgAu/ml and (c) 1 mgAu/ml. Image (d) 
displays that vesicles within one cell are filled at different densities. .......................... 158 
Figure 56 An optical fluorescence image of murine carcinoma, labeled with hypoxia 
marker pimonidazole (green). ....................................................................................... 166 
Figure 57 Illustration of the partial volume effect ........................................................ 167 
Figure 58 Sensitivity phantom consisting of 9 mm holes drilled into a 10 mm thick 
Perspex slab. .................................................................................................................. 168 
Figure 59 Contrast phantom; 9 mm hole including a straw located centrally to provide a 
barrier between two different GNP concentration solutions. ........................................ 169 
Figure 60 High contrast phantom filled with GNP solutions 4 mgAu/ml (central) and 
0.2 mgAu/ml (outer ring) .............................................................................................. 170 
Figure 61 Experimental set-up of scanning imager ...................................................... 171 
Figure 62 Illustration of 1D profile scan procedure.. .................................................... 173 
Figure 63 Recorded spectra as a function of the x scanning coordinate in the case of the 
highest probed concentration hole (8mg/ml). ............................................................... 173 
Figure 64 Gold XRF signal vs. scan coordinate. .......................................................... 174 
Figure 65 Experimental set-up for 2D scanning system. .............................................. 177 
Figure 66  84MLS11 polycapillary optic lens (Institute for Scientific Instruments 
GmbH, Berlin, Germany) in its vacuum tight case. ...................................................... 178 
 18 
 
Figure 67 Designed vacuum tight detection module with the polycapillary lens  ........ 178  
Figure 68 Sample energy spectra collected in two different points of the scan. (Top) in 
pure Perspex. (bottom) within the hole filled with the GNP‘s solution with a 
concentration of 4 mg/ml. ............................................................................................. 180 
Figure 69 2D gold XRF images in log scale of GNP contrast phantoms acquired using 
an SDD coupled to a focusing polycapillary optic........................................................ 181 
Figure 70 Relationship between critical acceptance angle of the polycapillary optic and 
x-ray energy. ................................................................................................................. 185 
Figure 71 Position of maximum intensity measured across the face of the beam. ....... 187 
Figure 72 Energy and angular dependence of x-ray acceptance of polycapillary optic 188 
Figure 73 Experimental set up of CDD XRF imaging system. .................................... 189 
Figure 74 XRF images (log scale) of GNP contrast resolution phantom using the CDD – 
polycapillary optic XRF system. . ................................................................................. 191 
Figure 75 EDXRD and ADXRD experimental set-up using a high purity Germanium 
detector and Active Pixel Sensor respectively . ............................................................ 195 
Figure 76 Comparison of the scatter signatures for the ‗pure‘ carcinoma sample with 
that of both normal breast tissue (50:50 fat/fibrous mixture) and a pure fibroglandular 
sample  .......................................................................................................................... 196 
Figure 77 Measured diffraction signatures of the collagen I hydrogel, with and without 
3T3 presence, and a water sample................................................................................. 199 
Figure 78 Measured diffraction signatures of biological phantoms composed of HT29 
and 3T3 cells imbedded in a collagen matrix................................................................ 201 
Figure 79 Measured diffraction signature of an 8 mgAu/ml GNP sample and water... 203 
Figure 80 XRD spectra for four different GNP sizes: (a) 20.2 nm, (b) 6.8 nm, (c) 3.0 nm 
and (d) 1.6 nm.. ............................................................................................................. 204 
Figure 81 Schematic diagram of a multi-hole mechanical collimator. ......................... 206 
Figure 82 Voxel size of image produced by polycapillary optic system. . ................... 207 
Figure 83 Schematic of general XRD system, used to calculate the momentum transfer 
resolution components . ................................................................................................ 209 
 19 
 
Figure 84 Effect of collimator width (d1 and d2), angle of divergence, L1 and L2 on 
angular resolution. ......................................................................................................... 211 
Figure 85 Top: Calculated values of constant momentum transfer for healthy breast 
(x=1.1 nm
-1
) and breast carcinoma (x =1.6 nm
-1
). Bottom left: Calculated scatter angle 
difference between healthy breast and carcinoma over a range of energies. Bottom right: 
Calculated energy difference of healthy breast and carcinoma coherent scatter peaks 
over a range of scatter angles. ....................................................................................... 215 
Figure 86 Emitted x-ray spectra of an 8 mgAu/ml sample measured in two different 
geometries: (i) in optimum XRF geometry (90º with no optic), and (ii) in a typical XRD 
geometry (11º with a parallel optic).. ............................................................................ 216 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
List of tables 
Table 1 pO2 values below which outcome of therapy is impaired and proteome and 
genome changes are apparent.......................................................................................... 29 
Table 2 Summary of advantages and disadvantages of current hypoxia imaging 
techniques. ....................................................................................................................... 32 
Table 3 Quantification results from microCT measurements of mice intravenously 
injected with Herceptin-GNPs.. ...................................................................................... 37 
Table 4 Theoretical energies and yields of the gold K- and L-fluorescence emissions. . 51 
Table 5 Fluorescence characteristics of lead and tungsten  ............................................ 63 
Table 6 Measured minimum energy of filtered x-ray spectrum at different Pb filter 
thicknesses. ..................................................................................................................... 68 
Table 7 Detection limits of L-XRF systems (synchrotron and bench-top) and K-XRF 
bench-top system at a 95% confidence level. ................................................................. 83 
Table 8 Measured sensitivity to XRF signal of GNPs for each measurement system .... 84 
Table 9 Summary of key results in order to compare the performance of each XRF 
system. ............................................................................................................................. 89 
Table 10  Characteristics of each source for gold XRF measurement ............................ 93 
Table 11 Quantities of GNP-PBS suspension and cell medium required for nanoparticle 
incubation of cells. ........................................................................................................ 124 
Table 12 Number of HT29 and 3T3 cells embedded into collagen scaffold for each 
sample. .......................................................................................................................... 149 
Table 13 SNR of a range of molybdenum filter thicknesses of XRF spectra. .............. 152 
Table 14 Geometrical parameters of the 84MLS11 x-ray polycapillary optic lens . .... 179 
Table 15 Characteristics of the SDD and CDD systems for use in XRF imaging.. ...... 184
 21 
 
List of abbreviations 
 
3T3   Mouse embryonic fibroblast cell line  
ACM  Artificial cancer mass 
ATSM  Diacetyl-bis(N
4
-methylthiosemicarbazone) 
BOLD-MRI Blood oxygenation level dependent 
CCD   Charge-coupled device 
CDD   Controlled Drift Detector 
CMOS  Complementary metal-oxide-semiconductor 
CTAB  Cetyltrimethylammonium bromide 
dHb   De-oxyhaemoglobin  
DIW   De-ionised water  
DL   Detection limit 
DMEM  Dulbecco‘s Modified Eagle Medium  
ECM   Extra cellular matrix  
EDTA  Ethylenediaminetetraacetic acid 
EPR   Enhanced permeability and retention effect 
FCS   Foetal Calf Serum  
FMISO  Fluoromisonidazole 
FWHM  Full width at half maximum  
GNPs   Gold nanoparticles  
GNRs   Gold nano-rods  
HA   Hyaluronic acid  
Her2   Human epidermal growth factor receptor 2 
HIF-1  Hypoxia inducible factor 1  
HPGe   High purity germanium detector 
HT29  Human colon adenocarcinoma cell line  
ICP-AES  Inductively coupled plasma atomic emission spectroscopy  
IMRT  Intensity modulated radiotherapy  
K-XRF  X-ray fluorescence resulting from electron transitions to the K-shells 
L-XRF  X-ray fluorescence resulting from electron transitions to the L-shells 
MCS   Multicellular spheroids  
 22 
 
MEM   Minimum Essential Medium  
MPV   Mean pixel value  
OHb   Oxyhaemoglobin  
PBS   Phosphate buffered saline  
PEG   Polyethylene glycol  
RME   Receptor mediated endocytosis  
SDD   Silicon drift detector  
SERS   Surface-enhanced Raman spectroscopy  
SNR   Signal to noise ratio  
TEM   Transmission electron microscopy  
TER   Total external reflection  
VEGF  Vascular endothelial growth factor 
XFCT  X-ray fluorescence computed tomography  
XRD   X-ray diffraction  
XRES  X-ray edge subtraction  
XRF   X-ray fluorescence 
 23 
 
Outputs 
Journal publications 
Ricketts, K., Castoldi, A., Guazzoni, C., Ozkan, C., Christodoulou, C., Gibson, A., 
Royle, G. (2011) A quantitative x-ray imaging system for gold nanoparticle 
tumour biomarkers. Physics in medicine and biology – in print. 
Ricketts, K., Loizidou, M., Cheema, U., Nyga, A., Castoldi, A., Guazzoni, C., Gibson, 
A., Royle G. (2011) 3D biological phantom production of cells with nanoparticle 
inclusions -in preparation. 
Castoldi, A., Guazzoni, C., Ricketts, K., Ozkan, C., Gibson, A., Royle, G. (2012) 
Application of silicon drift detectors in x-ray fluorescence imaging of gold 
nanoparticles Nuclear Instruments and Methods in Physics Research – in 
preparation. 
 
Conference publications 
Castoldi, A., Guazzoni, C., Ricketts, K., Gibson, A., Griffiths, J., Royle, G., & 
Bjeoumikhov, A. (2011) 2-D energy-resolved imaging of gold nanoparticle 
distribution at concentrations relevant for in-vitro studies. IEEE Transactions on 
Nuclear Science. 
Ricketts, K., Christodoulou, C., Guazzoni, C., Castoldi, A., Ozkan, C., Sodini, N., 
Griffiths, J. A., Gibson, A., Royle, G. (2010) A system for x-ray diffraction and 
fluorescence imaging of nanoparticle biomarkers. IEEE Transactions on Nuclear 
Science. 
Ricketts, K., Ozkan, C., Christodoulou, C., Dreossi, D., Castoldi, A., Guazzoni, C., 
Gibson, A., Royle, G. (2011) X-ray edge subtraction imaging of gold nanoparticle 
concentrations for biological imaging. IEEE Transactions on Nuclear Science. 
 
 
 
 
 
 24 
 
Prizes 
First prize: UCL Medical Physics & Bioengineering Poster Prize 2011 (Final year PhD 
students), Quantitative biological imaging of tumour properties using nanoparticles  
First prize: UCL Medical Physics & Bioengineering Poster Prize 2010 (First and 
Second year PhD students), Diffraction applications in radiotherapy – imaging hypoxia 
 
Grants 
Beamtime at Diamond Light Source, Oxford, UK (December 2011) 
Beamtime at Elettra Synchrotron Source, Trieste, Italy (June 2011) 
Beamtime at Diamond Light Source, Oxford, UK (February 2011) 
Beamtime at Elettra Synchrotron Source, Trieste, Italy (October 2010) 
 
UCL Graduate School travel grant to enable experiments at Politecnico di 
Milano, Italy 
 
 
 1. Introduction 
 
 
25 
 
 
 
 
Chapter One 
1 Introduction 
 
1.1 The clinical problem 
Current radiotherapy techniques prescribe a homogeneous dose to the target 
volume. However, tumours are heterogeneous tissues that encompass a variety of cell 
types of differing radiosensitivities. The distribution of cells is also heterogeneous 
throughout the tumour volume, with infiltrating cancer cells lying on the periphery of 
the bulk tumour. Such infiltrating cells may lie outside the treatment volume and 
survive therapy, thereby reducing treatment efficacy. The microenvironment of the 
tumour also dictates treatment success (for example, cells under hypoxic conditions will 
be less radiosensitive than their normoxic counterparts).  
Modern intensity modulated radiotherapy (IMRT) techniques can be used to 
deliver heterogeneous dose distributions across the tumour, boosting the dose to less 
radiosensitive regions. In order to make use of this technology, there is now a clinical 
need for a functional imaging technique sensitive to tumour characteristics that gives 
radiosensitivity information (such as oxygen concentration, proliferative ability and 
angiogenesis [1]). An equally important need is the development of a technique with 
high enough tumour specificity and sensitivity to detect the presence of peripheral 
infiltrating cancer cells.  
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In order to fully understand the clinical problem in radiotherapy, an 
understanding of the biology of the tumour microenvironment is required. 
1.1.1 Biology of the tumour microenvironment 
The tumour microenvironment consists of the following: (i) cancer cells; (ii) 
non-cancer cells (including endothelial cells that line the inner surface of blood vessels, 
and immune system cells e.g. lymphocytes and macrophages); (iii) secreted soluble 
factors (growth factors and cytokines which are signalling molecules used in cellular 
communication); and (iv) non-cellular solid material e.g. extra cellular matrix (ECM) 
consisting of collagen which provides structural support. The tumour and its stroma (the 
layer of tissue surrounding it) are multi-regional as illustrated in Figure 1.   
 
Figure 1 The tumour and its environment (the hypoxic component is spatially and temporally 
heterogeneous throughout the tumour). 
 
The tumour stroma environment may be hypoxic, with low pH and low glucose 
levels. As a result normal cells surrounding the tumour exhibit altered characteristics 
compared with cells in normal conditions. They can develop mutations in response to 
soluble products released by the tumour altering genes, and tissue and vasculature 
structure becomes more disorganised [2]. There may therefore be a need to target both 
cancer cells and stromal components to be more effective. Radiotherapy treatment 
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volumes aim to target the bulk tumour and region of microscopic extension with the aim 
of killing the proliferative cancerous cells.  
Tumour characteristics play a role in determining radiotherapy treatment 
success. For example, cell density should be considered when prescribing dose; a 
greater number of cells per unit volume will require a greater dose to achieve tumour 
control. Also, the effect of other concurrent treatments will impact on the treatment 
outcome of radiotherapy, e.g. a good tumour blood supply is required for chemotherapy 
agents to reach cancer cells. The heterogeneity of the tumour and its environment will 
impact on the radiosensitivity of the cells within the cancer mass. Hypoxia will be used 
as a case study to demonstrate how cell biology affects radiosensitivity.          
1.1.2 Hypoxia: a case study in radiotherapy 
Nearly 50% of locally advanced breast cancers exhibit hypoxic and/or anoxic 
tissue areas within the tumour mass [2]. Hypoxia has three main causes: (i) 
abnormalities in the structure and function of tumour microvessels result in perfusion 
related (acute) hypoxia which is transient and affects cells up to the vessel wall; (ii) 
increased diffusion distances between blood vessels and an expanding tumour cell mass 
competing for oxygen results in diffusion related (chronic) hypoxia, which affects 
cells greater than 70-100 μm from the nearest capillary (the maximum oxygen diffusion 
distance); (iii) anaemic hypoxia due to the reduced oxygen carrying capacity of blood 
as a result of disease or treatment related anaemia [2], [3].  
O2 has a role as the terminal electron acceptor in oxidative phosphorylation; the 
electron transferral releases energy which is used to form ATP, the energy source of 
cells. When O2 is absent the hypoxia inducible factor 1 (HIF-1), a transcription factor, 
promotes hypoxic cells to up-regulate more than 100 proteins that promote survival and 
increase aggressiveness of hypoxic tumour cells [4]. The functions of the proteins 
include stimulating angiogenesis, switching the mitochondria to glycolysis (a source of 
energy that does not require O2), and inhibiting apoptosis by inducing mutations in the 
p53 gene (the gene that controls apoptosis) [5]. Metastatic spread is also promoted by 
upgrading enzymes that degrade the ECM, allowing cells to break away from the 
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primary tumour [6], and producing molecules that down-regulate the immune 
surveillance system [7].  
As a result of the proteome (complete set of proteins in a cell at a given time) 
changes, the effectiveness of certain cancer therapies becomes impaired below the 
values of oxygen tensions (pO2) displayed in Table 1. Loss of apoptosis and chaotic 
angiogenesis results in decreased blood flow which in turn results in decreased delivery 
of chemotherapy drugs. It is the aim of radiotherapy to kill cancer cells, but poor 
oxygen availability results in a lower radiation cell kill. Ionising radiation produces free 
radicals that cause DNA double strand breaks which act to cause cell death; if the 
primary free radical reacts with oxygen to form a secondary radical, damage to the 
DNA is permanent. However, if the primary radical reacts with smaller molecules such 
as thiols the damage is repairable [1]. The radiosensitivity of cells is dependent on the 
phase of the cell cycle, with cells in the G1 phase being more radiosensitive than cells in 
the S-phase [3]. Cells exposed to hypoxia are generally arrested at the G1/S-phase 
boundary of the cell cycle [8]. This results in a decreased rate of proliferation, and so 
cells have reduced radiosensitivity resulting in reduced cell kill.          
Sustained hypoxia also plays an important role in malignant progression of solid 
tumours by increasing the genomic instability and number of genetic variants. New 
variants that can survive the hypoxic conditions are selected through clonal expansion, 
leading to the emergence of more aggressive clones that are resistant to therapy, able to 
overcome nutrient deprivation and able to escape the hostile environment resulting in 
metastases [2], [8].     
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Table 1 pO2 values below which outcome of therapy is impaired and proteome and genome changes are 
apparent [8]. Oxygen tensions measured in head and neck cancers revealed a median range pO2 of 10 - 
30 mmHg compared with a median range value of pO2 of 24 - 66 mmHg in normal tissue [9]. 
Effect pO2 range (mmHg) 
Effectiveness of immunotherapy becomes impaired ≤ 30 – 35 
Cell death with photodynamic therapy ≤ 15 – 35 
Cell death on exposure to radiation ≤ 25 – 30 
Binding of hypoxia markers ≤ 10 – 20 
Proteome changes ≤ 1 – 15 
Genome changes ≤ 0.2 – 1 
 
Hypoxia imaging will assist the selection of patients requiring more aggressive 
treatment or individualised therapy. Hypoxia should be used as a biometric parameter to 
assist dose prescription in radiotherapy, and can also be used as an independent 
prognostic factor for overall and disease-free survival, resulting from the association of 
tumour hypoxia with treatment failure and malignant progression [2], [5].  
A hypoxia imaging technique is necessary as hypoxia is difficult to predict or 
model; hypoxia is not static and changes in response to irradiation and chemotherapy 
[2], [9].  
1.1.3 Current hypoxia measurement techniques 
An ideal hypoxia imaging technique would: (i) reflect cellular instead of 
vascular pO2; (ii) be sensitive to pO2 levels relevant to tumour therapy (<25 – 30 
mmHg); (iii) be simple to perform, non-toxic, and allow repeated measurements; and 
(iv) have the ability to be performed during treatment once the patient has been 
positioned for treatment [3]. For particular use as a radiotherapy imaging technique, the 
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following points must be considered: (i) hypoxia is not static; levels of oxygenation 
change in response to irradiation and chemotherapy; and (ii) it is important to know 
when and if re-oxygenation occurs after fractions as this changes the distribution of 
hypoxic regions [1]. The extent and rapidity of re-oxygenation is difficult to predict for 
individual tumours, and so it may be useful to map perfusion as well as hypoxia. These 
factors highlight the need for repeated imaging throughout the treatment course.  
A variety of methods have been used to measure cellular oxygenation in 
tumours, including invasive intra-tumoural measurement with pO2 electrodes. Technical 
limitations of this direct measurement have encouraged the use of alternate markers for 
tumour hypoxia [10]. Ex vivo techniques include immunohistochemical detection of 
endogenous proteins overexpressed as a result of the cells‘ hypoxic condition (such as 
HIF-1α) and exogenous injected drugs that are bound intracellularly only in areas of 
hypoxia. Clinically used exogenous markers are the 2-nitroimidazoles and pimonidazole 
which are injected intravenously prior to a tumour biopsy. Clinical studies have reported 
that such markers become detectable at a pO2 below 10 mmHg [11], whereas 
radiotherapy becomes impaired at higher pO2 values (Table 1). Necrotic cells do not 
metabolise the marker and so do not stain positive for hypoxia. Staining is also mainly 
observed at a distance greater than 100 µm from the nearest perfused vessel, suggesting 
that these exogenous markers indicate chronic, diffusion limited hypoxia [12]. 
Histology studies may only be performed on thin slices due to the low penetration of 
radiation wavelengths used in optical imaging techniques, rendering it not useful as an 
in vivo technique.            
A number of biological parameters may be used to image hypoxia. De-
oxyhaemoglobin (dHb) concentrations can be directly measured by blood oxygenation 
level dependent (BOLD) MRI techniques. dHb in red blood cells is paramagnetic 
whereas oxyhaemoglobin (OHb) is not paramagnetic. dHb increases the MR transverse 
relaxation time (R2*) of water in blood and surrounding tissues; thus T2* weighted 
imaging reveals changes in vascular oxygenation [5]. BOLD-MRI is sensitive to pO2 
within and in tissues adjacent to perfused vessels [3]. BOLD-MRI images are more 
likely to reflect perfusion related hypoxia rather than chronic diffusion related hypoxia; 
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red blood cells in vessels are too distant from chronically hypoxic regions. Also, for 
BOLD-MRI to measure tissue oxygenation status, red blood cells must be delivered to 
the tissue of interest, and so good blood flow is a requirement. Furthermore, it is 
sensitive to changes in Hb concentration, which may result from vascular volume and 
flow alterations. BOLD-MRI can therefore only provide qualitative rather than 
quantitative measurement of oxygenation change [5].   
Nuclear medicine techniques make use of the change in chemistry at low oxygen 
tensions enabling the reduction and retention of certain radiopharmaceuticals at hypoxic 
sites. 
18
F-fluoromisonidazole [1-(2-nitroimidazolyl)-2-hydroxy-3-fluoropropane; 
18
F-
FMISO] is the most widely used PET agent for mapping regional hypoxia. Estimated 
total body absorbed dose for a 70 kg man injected with 3.7 MBq/kg is 0.013 mSv/MBq; 
for a woman it is 0.014 mSv/MBq. The limitations of FMISO include the dependency 
of early tumour uptake on blood flow to the region, making late phase imaging 
preferable [13]. Whole body clearance of 
18
F-FMISO is slow resulting in a poor contrast 
in raw images [5]. An alternative PET imaging technique for hypoxia is based on a 
metal complex of radioactive copper with ATSM, diacetyl-bis(N
4
-
methylthiosemicarbazone). Cu-ATSM uptake is more rapid than 18F-FMISO uptake, 
and the reported hypoxic-to-normoxic ratio is greater. However the early uptake and 
washout of Cu-ATSM may be influenced by regional blood flow [5].    
The degree of angiogenesis can also be determined using microCT techniques. 
However measurement of angiogenesis does not directly determine oxygenation levels 
as it does not consider the possible presence of acutely hypoxic regions resulting from 
random temporary occlusions of the blood vessels [3]. 
The presence of lactate/lipids in the tumour region is linked to hypoxia; they are 
the result of cell membrane breakdown caused by the hypoxia induced proteome 
changes. Lactate/lipid levels can be detected using optical techniques [14]. 
1
H MRI can 
also be used to image lactate [5].    
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The advantages and disadvantages of current hypoxia measurement techniques 
are summarised in Table 2. 
Table 2 Summary of advantages and disadvantages of current hypoxia imaging techniques. 
Modality  Advantages Disadvantages 
BOLD-MRI 
(Paramagnetic dHb 
increases transverse 
relaxation rate R2*)  
Monitors changes in pO2 
Also measures cell 
density  
Requires good blood flow 
Takes long time 
Not available during treatment 
Not quantitative method 
   
PET  
1. 18F-MISO 
2. Cu-ATSM  
Can see metastases of 1° 
cancer 
Requires injection 
Does not monitor changes in pO2 
Not available during treatment 
   Optical Imaging  Quantitative information 
on OHb and dHb 
concentration  
Current availability in clinic  
   
Micro-CT 
(Images angiogenesis)  
Angiogenesis:  perfusion 
info  
Indirect measure of hypoxia (does 
not account for acute hypoxia)  
 
1.2 Requirements of an imaging technique to answer the clinical 
problem 
In order to improve treatment response to radiotherapy, and inform dose 
prescription by considering radiosensitivity of the tumour, a technique is required that 
has the following capabilities: 
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1. A technique that provides a metric of the biology of the target volume is 
required. Bio-parameters that affect radiosensitivity (such as the case study 
of hypoxia presented in this thesis) should be identified.  
2. A technique that can measure the distribution of such bio-parameters will 
provide a map of radiosensitivity.  
3. It would be advantageous if more than one bio-parameter could be imaged 
concurrently (such as hypoxia and proliferative ability), as radiosensitivity is 
not only attributed to just one bio-parameter. Also, some bio-parameters are 
related such as hypoxia and perfusion, and gaining information on both 
parameters would increase the sensitivity of the technique.  
4. A quantitative technique rather than a qualitative imaging method is needed 
to better inform radiotherapy dose prescription. 
5. A system that is sensitive to low numbers of infiltrating cells on the tumour 
periphery. Current techniques do not provide the required sensitivity. 
6. A technique that could image the distribution of bio-parameters in vivo or in 
thick ex vivo tissue samples as opposed to currently available ex vivo 
histopathology techniques would have a big impact on cancer treatment. 
Current histopathology techniques are limited to thin slices due to the poor 
penetrating power of optical fluorescence light that produces the images.   
 
1.3 Aims 
The overarching aim of this project is to develop a technique for guiding the 
planning and maximising the treatment objectives of radiotherapy. In order to strive 
towards this grand aim, the following specific aims were set for this work: 
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1. Identification of a suitable contrast agent that can be used to image bio-
parameters in cancer. This work proposes the use of gold nanoparticles 
(GNPs) to image bio-parameters in tumours. 
2. To design, build and evaluate a new system for quantitative x-ray detection 
of GNPs in vivo or in thick ex vivo tissue / research samples, taking 
advantage of the penetration of x-rays at depth. 
3. Assessment of feasibility and collection of proof of principle data on x-ray 
based diagnostic imaging of GNP distribution. 
4. Establishment of novel 3D in vitro cancer models with GNP inclusions in 
order to test the x-ray based system, and demonstrate GNP uptake in cells. 
    
1.4 Technical objectives 
To achieve these aims, the following technical objectives are required: 
1. Development of a quantitative technique based on x-ray fluorescence (XRF) 
that is sensitive to GNP concentrations typically delivered to tumours.  
2. Feasibility measurements for assessment of a quantitative imaging 
technique. This system will be capable of high resolution (better than 1 mm), 
high sensitivity to GNP concentration (provided by XRF techniques), and 
with the ability to discriminate tissue type (through use of x-ray diffraction 
(XRD) techniques) within a bulk 3D volume.     
3. Development of a procedure to produce 3D tumour models with GNP 
inclusions, in order to facilitate system testing. This objective is broken 
down into the following: 
a. Procedural development to achieve GNP uptake in cell lines. 
b. Production of 3D cellular models with GNP inclusions. 
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c. Development of methods to reliably distribute GNP uptake within the 
cellular models.    
 
1.5 Justification of technical objectives 
It is believed that the technical objectives outlined above work towards 
providing a solution to the clinical need for imaging bio-parameters to better inform 
radiotherapy. Each suggested component to the proposed project will be discussed in 
turn in order to provide evidence for its use and role in solving the clinical problem.  
1.5.1 Use of GNPs as a contrast agent for radiotherapy 
GNPs are increasingly used in in vivo cancer models to act as a contrast agent 
for x-ray based imaging techniques [15]. Nanoparticles (NPs) can target tumours 
passively or actively. Passive targeting relies on the unique characteristics of the tumour 
microenvironment, mainly: (i) leaky tumour vasculature; the size of nanoparticles (1-
100 nm) is smaller than the tumour vasculature pores (up to 400 nm) and so may be 
leaked into the tumour interstitium via surrounding blood vessels [16], and (ii) a 
dysfunctional lymphatic drainage system which increases retention of particles in the 
tumour tissue. This is referred to as the enhanced permeability and retention (EPR) 
effect. Tumour specificity may be further increased through active targeting; antibodies 
attached to the nanoparticle can be taken up by specific cellular receptors, thus acting as 
markers for bio-parameters that provide information about cell radiosensitivity. Linking 
to cancer specific antibodies to enhance targeting and detection has been reported in in 
vivo models [17]. The uptake of nanoparticles by cancer cells could also enable 
detection of small clusters of infiltrating cancer cells which are currently missed by 
commonly used imaging modalities.  
GNPs present a realistic potential for clinical use; they are biocompatible (gold 
is biologically inert and stable), and have readily modifiable surfaces to increase 
solubility (in order to travel through the bloodstream) and enhance cell-specific uptake 
[18]. GNP coating with polyethylene glycol (PEG), sodium citrate or heparin lowers 
 1. Introduction 
 
 
36 
 
acute toxicity and sufficiently evades both host immune reactions and irreversible 
binding to circulating serum proteins [19].   
GNPs are an ideal contrast medium for use in x-ray imaging techniques. GNPs 
are more effective than previous iodinated contrast techniques as gold has a higher 
atomic number (Au:79 compared to I:53) and therefore is more absorptive, providing 
better contrast with lower dose. Molecular imaging is also possible due to the greater 
number of atoms delivered to the receptor site (~250 Au atoms per 1.9 nm nanoparticle 
compared with 3 (monomer) or 6 (dimer) I atoms per molecule when using iodinated 
contrast agents [15]), thereby increasing the signal per cell  
 A great advantage of using GNPs as an imaging contrast agent for radiotherapy 
is that GNPs have been shown to enhance local dose deposition for both x-ray 
radiotherapy [20], [21], [22] and proton radiotherapy [23]. Their high Z leads to 
increased photoelectric absorption and production of secondary ionising species. 
Therefore, as well as a novel approach to defining sub-clinical tumour infiltration, 
GNPs may also allow tumour-specific local dose enhancement if they can be located 
and retained in tumour cells. This relies on ionisation occurring close enough to DNA; 
this can be achieved either through targeting the NP to the cell nucleus, or inducing an 
energetic ionising species that can reach DNA from elsewhere in the cell.   
The literature was searched for typical GNP concentrations found in tumours. 
Hainfeld et al studied the uptake of 15 nm GNPs coated with PEG and covalently 
coupled to Herceptin using a mouse model [24]. Herceptin is a humanised monoclonal 
antibody currently used to treat human breast cancers with upregulated Her2 (human 
epidermal growth factor receptor 2) expression, namely Her2+ tumours. The resulting 
GNP concentrations found in the whole tumour, periphery and muscle for a 15 nm GNP 
injection of 1.1 gAu / kg mouse are displayed in Table 3. 
Coupling the GNPs to Herceptin demonstrated the ability to functionalise GNP 
uptake; an increased uptake of the GNPs in Her2+ tumours compared with Her2- 
tumours was found. A high dose of GNPs (1.1 mgAu/g) was injected into the mouse, 
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but other studies presented in the literature administer a much lower dose of typically 
0.01 mgAu/g [25]. Our system was therefore designed to be sensitive to concentrations 
100 times lower than those reported in Table 3. The tumour/muscle contrast values were 
also used in the development of imaging phantoms in Section 4.2. 
Table 3 Quantification results from microCT measurements of mice intravenously injected with 
Herceptin-GNPs. The Her2+/Her2- ratio is the Her2+ % injected dose/g divided by the corresponding 
Her2- % injected dose/g. Muscle value is from atomic absorption measurements [24]. 
 GNP 
concentration 
(mgAu/ml)* 
Her2+/Her2- Tumour/muscle 
Her2+ (whole tumour) 1.82 1.3 (whole tumour)  11.4 
Her2- (whole tumour) 1.36  8.5 
Her2+ (periphery) 3.48 1.6 (periphery) 21.8 
Her2- (periphery) 2.22  13.9 
Her2+ (centre) 0.34 2.2 (centre) 2.1 
Her2- (centre) 0.16  1.0 
Muscle 0.16 1.0 (muscle)  
*Calculated for a 20 g mouse injected with 1.1 mgAu/g (i.e. a 22 mgAu injection) from 
percentage uptake of initial GNP dose values presented in [24]. 
 
1.5.2 Current techniques used to image GNPs 
Non invasive in vivo techniques are being developed. Hainfeld et al are the first 
group to image gold nanoparticles (GNPs) in vivo in mice using microCT; the mice 
were injected intravenously with 1.9 nm GNPs at a concentration of 2.7 mgAu/g [15]. 
Deliberately high amounts of gold were used to investigate x-ray contrast given by the 
NPs. No signs of toxicity resulting from the gold were found, with low retention in the 
liver and spleen, and elimination by the kidneys. Another group have demonstrated that 
 1. Introduction 
 
 
38 
 
good contrast to noise CT images can be obtained at gold concentrations of 0.1 
mgAu/ml [26]. A more recent study by Hainfeld et al reports that microCT enables 
quantification of GNPs within various regions of a murine tumour; a calibrated 
relationship between radiodensity and gold concentration was demonstrated down to 
0.05 mgAu/ml [24].  
Techniques based on optical spectroscopy were found to be satisfactory for the 
quantification of GNP concentration in vivo [27], [28]; it has been demonstrated that a 
diffuse optical spectroscopy technique can measure down to 15.4 x 10
8
 gold 
nanoshells/ml to within 12.6% of the known concentration. The literature also reports 
photoacoustic imaging techniques that use GNPs as a contrast agent [29]. Photoacoustic 
imaging involves delivering non-ionising laser pulses to tissue; some of the delivered 
energy is absorbed and converted to heat, leading to transient thermoelastic expansion 
followed by ultrasonic emission which is detected to form high spatial resolution 
images. GNPs have unique optical absorption properties and are therefore useful in this 
field. Surface-enhanced Raman spectroscopy (SERS) techniques have also been used to 
image GNPs; GNPs consisting of a gold core, a Raman-active molecular layer (a 
fluorescence dye) and a silica coating were used for Raman imaging in vivo [30]. 
However, the aforementioned optical techniques are limited to shallow sites (~ 5 mm 
deep)     
There is currently a need for an in vivo system sensitive to even lower GNP 
concentrations than the techniques presented in the literature in order to meet the aims 
of this project. 
1.5.3 Requirements for GNP imaging 
There is a clinical need for imaging GNP distribution, particularly for GNPs 
located (i) in vivo, and (ii) in ex vivo samples or in vitro research samples. 
In vivo imaging will require a high energy radiation technique (such as x-rays) in 
order to penetrate through thicknesses of tissue, and will require a high intensity source 
in order to keep acquisition time to a minimum to avoid motion artefacts and increase 
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patient throughput. The system will have to be optimised to keep absorbed dose to a 
minimum. The scope of this project is to assess the feasibility of a novel GNP imaging 
technique, and dose considerations have not been considered at this stage.  
The imaging of in vitro research samples or ex vivo tissue poses a different set of 
requirements. Lower energy x-rays are sufficient to penetrate the lower thicknesses 
involved, and acquisition time is not an issue as the sample is not moving (although an 
optimum system is preferred to keep sample throughput times at a minimum). Dose is 
not an issue for fixed research samples or ex vivo tissue; however, if the project is 
developed to include live 3D cultures, sample dose must be considered. 
1.5.4 X-ray fluorescence techniques 
Current imaging technologies for GNPs lack the ability to measure sufficiently 
low concentrations (the lowest measurable concentration was 0.05 mgAu/ml using 
microCT [24]). Mentioned techniques are also incapable of mapping two or more 
biomarkers simultaneously (refer to Section 1.2 for details of why this capability is 
useful).  
This project proposes the use of XRF as a technique that can be used to improve 
on sensitivity and multi-biomarker capability lacking in current systems. XRF employs 
x-rays to generate a fluorescence signal from the GNPs that can be detected and mapped 
to provide quantitative information about the sample. Figure 2 illustrates the XRF 
process. The energy of the emitted XRF x-ray is determined by the energy transition 
made by the electron lowering in energy which is characteristic to the element that was 
fluoresced.      
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Figure 2 Illustration of x-ray fluorescence process. 
 
A range of transitions are possible, resulting in a range of possible XRF 
emission energies. The energy level transitions corresponding to each of the 
fluorescence lines are illustrated in Figure 3. K-XRF and L-XRF correspond to energy 
transitions involving electrons falling down to K and L shells respectively.  
 
Figure 3 Transitions that give rise to the various emission lines [31]. 
 
XRF is a technique that can be used to provide concentration information; the 
energy of the fluorescence x-ray gives information about the element present, and the 
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magnitude of the XRF signal is proportional to the concentration of that element. XRF 
is now a well established technique for the detection and quantification of trace amounts 
of heavy metals in vivo. The technique has been used to measure metals in organs near 
the skin surface such as lead in bone, first reported in 1976 [32]. K-XRF has been 
successfully used to determine low levels of gold in the kidney following chrysotherapy 
[33], [34]. In vivo XRF in cancer and rheumatology patients has helped to understand 
how platinum and gold are retained in the target sites (tumour and bone joints for 
platinum and gold respectively) and other organs (with particular attention to the 
kidneys) [35]. Techniques using a number of different sources and geometries have 
been reviewed, including systems that excite both L-XRF and K-XRF [36].  
The benefit of this approach in comparison with conventional optical 
biofluorescent markers is that the XRF signal can penetrate centimetres of tissue and is 
therefore appropriate to bulk tissue volumes and potentially in vivo studies. XRF also 
has the benefit that two or more biomarkers can be imaged simultaneously; different 
molecular targeting biomarkers can be tagged to different element NPs each of which 
will give a different energy signal.  
A feasibility study of an x-ray fluorescence computed tomography (XFCT) 
system using an x-ray tube that can produce quasi-monochromatic x-rays for in vivo 
measurement of high Z contrast media was undertaken [37]. Drawing from simulations 
and experiment of K-XRF production from gadolinium contrast medium (Z = 64), the 
study concluded that neither fan- nor pencil-beam XFCT is practical for in vivo use in 
terms of spatial resolution, minimum detectable concentration and scanning time.     
XFCT imaging of GNP-loaded phantoms has been successfully performed using 
K-XRF in gold (67 and 68.8 keV) [38]. Relatively high GNP concentrations were tested 
by the system, the lowest being 5 mgAu/ml (greater than that expected in vivo). Also, 
this technique requires a pencil beam and therefore its speed will limit its clinical use.  
This project hypothesises that an XRF system could achieve greater sensitivity 
and spatial resolution than XRF systems presented in the literature, and could be used 
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for quantitative measurement of GNP concentration. In order to determine the 
capabilities of XRF, the performance of three different XRF systems will be compared; 
(i) a synchrotron based L-XRF system, (ii) a bench-top L-XRF system, and (iii) a 
bench-top K-XRF technique.   
1.5.5 Introduction to x-ray diffraction 
Whilst XRF relies on NP markers, x-ray diffraction (XRD) can discriminate 
between tissue types based upon differences in their elemental composition. Section 
4.7.2 in Chapter Four will discuss the role of XRD in tissue discrimination. The 
diffraction signal stems from coherent interactions. Coherent (or Rayleigh) scatter 
occurs when an incident photon interacts with tightly bound atomic electrons, causing 
them to oscillate and emit radiation of the same wavelength as the incident photon.  The 
probability of an x-ray coherently scattering from a single free electron into solid angle 
dΩ is written as the Thomson coefficient 
      Equation 1 
where dσ0 is the classical scattering coefficient per electron, θ the scattering 
angle and ro is the classical electron radius. The linear differential scattering cross 
section is given by  
    22
2
0 ),(cos1
2
ZxF
r
d
d coh 



     Equation 2 
where Fm(x,Z) is the molecular form factor and Z is the atomic number. Fm(x,Z) 
accounts for the interference effects by radiation scattered by electrons in the material, 
and is the Fourier transform of the electron charge distribution in the scattering atoms; it 
is therefore a property of the material only [39]. Fm(x,Z) is presented in terms of 
momentum transferred to the photon (x) which accounts for  the dependence of scatter 
distribution on scatter angle and energy: 
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2
sin

hc
E
x 
        
Equation 3 
Photons coherently scattered by electrons in the same atom, molecule or 
neighbouring molecule can interfere with each other [40]. The condition for 
constructive interference is described by the Bragg law; the difference in path length 
must be equal to an integer number of wavelengths:  
 sin2dn          Equation 4 
where n is the order of diffraction, λ is the photon wavelength, d is the spacing 
between the scattering planes and θ is the photon scatter angle. 
It has been demonstrated that tissue discrimination is possible using XRD 
techniques [41], [42], [43], [44]. The extent to which the XRD signal will be of use in 
combination with XRF measurement will be assessed in this project. A further 
discussion of the role of XRD will be undertaken in Chapter Four.   
1.5.6 Justification of bio-phantom production 
In order to test and demonstrate the use of the novel developed x-ray imaging 
technique, a range of bio-phantoms will be made. The aim of this section of the project 
will be to demonstrate GNP-uptake in both healthy and cancer cells, and to attain GNP 
concentrations similar to that expected in literature (refer to Section 1.5.1 for typical 
concentration values).   
It is important to use a range of phantoms that resemble in vivo tumour 
conditions; in vivo cancers incorporate densely packed cancer cells surrounded by ECM 
and other non-cancerous cells. Tissue engineering work will be carried out to develop 
artificial cancer masses (ACMs) to closely mimic these components. Novel ACMs will 
be constructed that incorporate different concentrations and distributions of GNPs. The 
ACM phantoms will act as challenging 3D imaging test phantoms for the XRF imaging 
technique. 
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Tissue engineering techniques are currently available that can control collagen 
density in scaffolds; these techniques are fully discussed in Chapter Three, Section 
3.4.10. We will further develop these techniques to embed GNP-loaded cells within a 
collagen matrix to provide samples appropriate for measurement with the novel XRF 
system, and to demonstrate the ability of the XRF system in quantitative measurement 
of GNP uptake in cells.    
 
1.6 Novelty of this work 
A novel solution is required to meet the clinical need for a quantitative technique 
to map bio-markers in vivo, as a complete solution does not currently exist in the 
literature. The following facets of the project were novel: 
 The overall concept developed in this project to use GNPs as a contrast agent to 
map radiosensitivity in order to inform radiotherapy dose prescription (and 
additionally act as a dose enhancer) is novel.  
 The use of the spectrometer developed by Politecnico di Milano for GNP 
concentration measurement is novel; the spectrometer had previously been used 
for XRD techniques [45], [46] and also to measure proton induced x-ray 
emissions [47]. The spectrometer was optimised for use to measure GNPs (in 
terms of source used).  
 An XRF system was developed that has the highest sensitivity to GNP 
concentration found in literature (sensitive down to 0.005 mgAu/ml, and further 
improved to a detection limit of 0.001 mgAu/ml). The closest technique for 
quantitative measurement of GNP concentration was an order of magnitude less 
sensitive [24]. 
 A K-XRF imaging system was previously reported in the literature; however, 
fundamental limitations of interaction cross sections involved in K-XRF (refer 
to Section 2.5.1.1) means that an L-XRF technique would provide greater 
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sensitivity. To the author‘s knowledge, our system is the first quantitative L-
XRF GNP measurement system. 
 Previous work in tissue engineering enabled production of 3D cellular 
phantoms, and also artificial cancer masses (refer to Section 3.4.10). I extended 
the established technique to make novel XRF imaging test phantoms, and also to 
produce cellular phantoms to demonstrate the capability of the quantitative XRF 
system in measuring GNP uptake in cells. The novel technique incorporated 
GNP inclusions in the cells in a known distribution; to the author‘s knowledge 
this is the first time that such GNP-included cellular phantoms have been made. 
 The idea to combine XRF/XRD as an imaging system to measure GNP 
concentration and distribution and to identify tissue type for radiotherapy 
applications is novel. The system design put forward in this project is novel, and 
open to further development in the future.              
 
1.7 My contribution to this work 
An interdisciplinary approach was required to meet the aims of this project, and 
as such this was a collaborative effort. The following departments were involved in this 
collaboration, and I spent time in each department to draw the research lines together: 
 Radiation Physics Section, Department of Medical Physics and 
Bioengineering, UCL, London 
 Division of Surgery and Interventional Science, UCL, London 
 Tissue Repair and Engineering Centre, UCL, London 
 Department of Electrical Engineering, Politecnico di Milano, Milan 
The project required the convergence of different research areas. The areas are 
listed below, along with my particular contribution to each aspect of the project: 
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1. Understanding and identification of clinical needs in radiotherapy:  
I was well placed to identify clinical needs in radiotherapy as I previously 
worked as a hospital physicist in a radiotherapy department. I identified gaps 
in the capabilities of current radiotherapy techniques through a focussed 
literature search. Also, attendance at the Mayneord Philips Summer School, 
2009, which was focussed on modern radiotherapy techniques, broadened 
my awareness of the field. Discussion with clinicians from the UCL Cancer 
Institute, research physicists at the Royal Marsden Hospital, Surrey, and 
academic staff in the Radiation Physics Department, UCL (in particular my 
supervisors) led to the selection of this particular project.       
2. Tissue engineering and tissue culture:  
I worked at the Division of Surgery and Interventional Science, UCL, 
London to learn tissue culture techniques. I performed all cell maintenance 
involved in the cellular studies. I developed a protocol to achieve GNP 
uptake in cells, and verified this procedure through assistance with the 
Electron Microscopy Service at the Royal Free Hospital, Hampstead. I spent 
time at the Royal National Orthopaedic Hospital, Stanmore, to learn existing 
tissue engineering techniques. I extended this standardised technique to 
produce novel 3D cultures of cells with GNP inclusions. I designed and 
constructed a range of 3D bio-phantoms that were appropriate to be 
measured by the developed XRF system. Building upon previously 
developed tissue engineering techniques, I extended existing procedures in 
making ACMs through novel addition of GNP inclusions. The 3D phantoms 
had optimum design for use in XRF imaging systems.    
3. Handling of nanoparticles:  
I followed the recommended procedure to re-suspend the NPs in a water 
solution, and provided a range of GNP concentration solutions in order to 
test the system. I designed a range of GNP imaging phantoms to include 
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concentrations and contrasts found in vivo. All but one set of samples were 
made by me (a collaborator made the set of samples taken to the Elettra 
Synchrotron source for the synchrotron L-XRF study).  
4. X-ray detector development:  
The silicon drift detector and controlled drift detector were designed and 
made by our collaborators from the Department of Electrical Engineering, 
Politecnico di Milano, Milan. The high purity germanium detector was 
manufactured by EG&G, Ortec. I was involved in selecting the optimum 
settings of each detector, such as pulse shaping time, amplification etc. 
appropriate for use in gold XRF measurement.     
5. Implementation of x-ray techniques in the development of a quantitative 
system sensitive to GNPs:  
I designed and optimised the K-XRF system to induce gold XRF. The design 
of the L-XRF already existed and had been previously used to measure 
proton induced x-ray emissions [47]; however I optimised it for use to 
induce L-XRF in gold, including selection of a source (in terms of target, 
energy, filtration), detector collimation and geometry. Along with 
collaborators (who assisted with detector operation) I performed the 
measurement and comparison of the different XRF systems.  
I was successful in a proposal for a grant to gain synchrotron access for the 
series of measurements (both at the Diamond Light Source, UK and at the 
Elettra Synchrotron Source, Trieste). I planned the necessary experiments for 
each synchrotron trip, and provided samples for this measurement campaign 
(biological and non-biological). I was part of a team consisting of members 
from UCL and Politecnico di Milano which operated in shift work to collect 
all the XRF and XRD data. 
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6. Feasibility study of XRF imaging of GNPs, and work towards a combined 
XRF/XRD imaging technique: 
I designed and made a set of Perspex phantoms with GNP inclusions to 
mimic concentrations found in vivo in order to test the performance of XRF 
imaging systems. I also extended an existing protocol to make cellular 3D 
bio-phantoms with GNP inclusions to test the imaging capabilities of the 
XRF technique.   
I devised a set of measurements necessary to direct future work in the 
development of a combined XRF/XRD imaging system, and performed the 
data acquisition of all of the investigations. I have also referred to literature 
to support my proposal of measurements previously undertaken. I drew 
conclusions as to the appropriateness of the combined modality system.  
7. Data analysis of GNP measurements:  
I developed Matlab code to perform all data analysis of the measurements 
reported in this thesis, with the exception of the 2D image reconstruction, 
which was performed by colleagues at the Politecnico di Milano.  
 
1.8 Structure of this thesis 
This thesis has already outlined the clinical problem, and put forward a novel 
technique that meets the listed requirements. The novel system makes use of GNPs as a 
contrast agent combined with an XRF technique to measure tumour properties in vivo. 
Chapter Two will demonstrate the sensitivity of XRF techniques to make quantitative 
measurements of a range of GNP concentrations expected to be found in vivo. The 
performance of three alternative XRF systems will be compared, and conclusions made 
as to the suitability of the XRF technique in meeting the requirements to solve the 
clinical problem. Chapter Three will present the procedure that has been developed for 
making novel 3D GNP-loaded cellular phantoms. It will also demonstrate that GNP 
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uptake in cells has been achieved, and will report the measured passive GNP uptake in 
two different cell lines (cancer and non-cancer lines were considered). A demonstration 
of the novel XRF technique‘s ability to measure GNP uptake in cells is presented. 
Transmission electron microscopy was used to confirm and further understand the GNP 
uptake process in cells. Chapter Four presents XRF images collected of different GNP 
phantoms constructed to test the system imaging capabilities. These images act as a 
proof of concept for the envisaged XRF imaging technique. A preliminary set of 
measurements is finally presented to assess the feasibility of a combined XRF/XRD 
imaging system, and conclusions are made as to the viability of such a technique in 
radiotherapy.     
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Chapter Two 
 
2 Quantitative measurement of gold nanoparticle 
concentration 
 
2.1 X-ray fluorescence: Introduction 
X-ray fluorescence (XRF) can be used to provide quantitative information about 
elements present in a sample, and the magnitude of the XRF signal is proportional to the 
concentration of that element (Section 1.5.4). This project proposes to measure GNP 
concentration using XRF measurement techniques. XRF involves high energy radiation 
and so can be a useful technique in measuring GNP distribution in vivo. XFCT imaging 
of a GNP-loaded PMMA phantom has been successfully demonstrated [38]; however 
this technique requires a pencil beam and therefore its speed will limit its clinical use. 
Relatively high GNP concentrations were tested by the system, the lowest being 5 
mgAu/ml. However it is expected that much lower concentrations will typically be 
taken up by cells, with concentrations of the order of 0.01 mgAu/ml expected in 
tumours [24], [25]; refer to Section 1.5.1 for a discussion of expected concentrations 
from literature. The XFCT technique was designed to induce and detect K-XRF as 
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opposed to L-XRF; this is beneficial for measurements at depth as higher energy x-rays 
are required to penetrate the required distance.  
The XRF properties of gold are displayed in Table 4 and Figure 4. 
Table 4 Theoretical energies and yields of the gold K-XRF and L-XRF emissions [31]. 
 
 Kα1 Kα2 Kβ1 Lα1 Lα2 Lβ1 Lβ2 L1 
Energy (keV) 68.80 66.99 77.98 9.71 9.63 11.44 11.58 13.38 
Emission relative to Kα1 (%) 100 59 23 37 4 25 8 4 
Absorption edge energy 
(threshold energy for 
fluorescence) (keV) 
80.7 80.7 80.7 11.9 11.9 13.7 11.9 13.7 
 
 
Figure 4 Theoretical Lα and Lβ gold x-ray emissions, taken from Winaxil X-ray Analysis Software are 
displayed. 
 
This chapter presents the measurements made with a novel system in assessing 
the ability of the fluorescence signal to determine nanoparticle concentration. The 
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sensitivity of the system was also found through measurement of the minimum 
detectable concentration of nanoparticles. Three different XRF systems are compared, 
one using synchrotron radiation, one a bench-top molybdenum target x-ray tube (both 
inducing gold L-XRF) and the other a higher energy tungsten target bench-top system 
(used to induce gold K-XRF). 
2.2 Nanoparticle samples 
The samples consisted of GNPs (Aurovist
TM
, Nanoprobes Inc., USA) suspended 
in a 1 ml de-ionised water buffer. The nanoparticles used had a 1.9 nm gold core and 
water soluble organic shell. Each sample solution was held in a plastic 1.5 ml 
Eppendorf tube (Eppendorf, Germany). Twelve samples were made with concentrations 
ranging from 0.001 – 8.0 mgAu/ml (made to an accuracy of ± 1%), selected to resemble 
possible tumour gold concentrations in vivo (refer to Section 1.5.1), and to test the 
minimum detectable concentration. The samples are displayed in Figure 5. 
 
Figure 5 GNP samples produced over different concentrations ranging from 0.001 – 8 mgAu/ml.  
  
The 1.9 nm GNPs are delivered freeze dried and are stored in a plastic pot. 
There is a mass of 40 mg GNPs per pot. The procedure used to suspend the GNPs in de-
ionised water (DIW) is as follows: 
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1. 0.2 ml DIW was added to 40 mgAu (using a micropipette (Eppendorf) 
with an accuracy of 1 µl. 
2. All 40 mgAu solution was pipetted into a centrifugal tube filter (provided 
by Aurovist
TM
) and centrifuged for 8 mins at 15,000 x g. 
3. Another 0.2 ml DIW was added to the remnants in the original pot, 
transferred to the tube filter and centrifuged again for another 8 mins. 
4. Step 3 was repeated. In total, 0.6 ml DIW was added to the 40 mg of 
GNPs. 
5. The filter piece was removed, and another 0.4 ml DIW added to make 
the volume of DIW added up to 1ml. This gave 1 ml of 40 mgAu/ml 
concentration. 
6. In order to minimise liquid losses when dealing with small volumes, the 
high concentration was diluted to produce a stock solution of 20 
mgAu/ml. 0.5 ml DIW was added to a clean Eppendorf tube, followed by 
0.5 ml of the 40 mgAu/ml solution. This made 1 ml of 20 mgAu/ml, and 
left 0.5 ml of 40 mgAu/ml for future use. 
7. When not in use, all GNP solutions should be refrigerated at ~ 5 °C. It 
was observed that samples not refrigerated for a time period of a few 
days suffered from the GNPs settling out and clumping together.   
Error observations: 
 Not all of the 40 mg gold was successfully transferred to DIW 
(negligible loss):  three filtrations were performed to maximise recovery 
of the GNPs. 
 Not all of DIW measured was transferred: some liquid remained on the 
pipette tip (this is a negligible loss, and may counteract the loss in the 
recovery of GNPs). 
2. Quantitative measurement of gold nanoparticle concentration  
 
54 
 
 The volume of DIW is accurate to 1 μl (the accuracy of the 
micropipette). 
 A 1 ml DIW sample was measured for background data. The samples were held 
on a water-cooled cooling plate during measurement, operating at a temperature of 5 ºC, 
to reduce the possibility of the sample liquid evaporating. No sample evaporation was 
observed during the measurements. 
The sample concentration error was determined by repeating the sample making 
process three times for the same concentration (0.03 mgAu/ml). Each sample was 
measured using the XRF technique and data analysis process described in the following 
sections. The percentage standard deviation of the measured XRF signal for the three 
samples was found to be 3.7% (the percentage error of each XRF measurement was 
1.3%). This demonstrates the repeatability of the sample making process.    
 
2.3 Synchrotron fluorescence system: L-fluorescence 
2.3.1 System design 
Measurements were made at the SYRMEP beamline at the Elettra synchrotron 
source, Trieste, Italy. The XRF system consists of a collimated silicon drift detector 
(SDD) [48], [49]. A laminar x-ray beam irradiated the sample close to the top surface to 
minimize self attenuation of the fluorescence signal (Figure 6). A charge-coupled device 
(CCD) camera located behind the sample was used to monitor the beam-sample 
alignment. 
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Figure 6 Experimental set-up of XRF measurement system. 
2.3.2 X-ray source 
The photoelectric cross section for XRF is greatest when the exciting x-ray is 
just above the absorption edge energy. The beamline energy was set to 15 keV (above 
the threshold for gold L-XRF of 11.9 keV and 13.7 keV for Lα / Lβ2 and Lβ1 
fluorescence respectively). The energy set was 1.3 keV above the highest L-edge of 
gold, a compromise between optimum excitation and minimization of the impact of the 
Compton shoulder background on the gold fluorescence line. The beamline collimators 
gave a beam 13 mm wide and 2.7 mm high, covering the full width of the sample.  
2.3.3 X-ray detector system 
A 10 mm
2
 SDD chip, produced in polysilicon technology by PNSensor GmbH 
and featuring an on chip JFET, was mounted in a dedicated vacuum-tight housing 
together with a Peltier cooler and dedicated front-end electronics in charge amplifier 
configuration with pulsed reset developed by Politecnico di Milano, Italy, and INFN 
Milano [50]. Optimum energy resolution is found at a 3 s shaping time. However, a 
sub-optimal shaping time constant of 1 s was chosen for the whole measurement as a 
compromise between energy resolution (still very high for this shaping time, with a 
measured value of 134 eV FWHM at 5.9 keV) and pulse pile-up occurrence. The 
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detector can operate at a maximum count rate of the order of 10
5
 s
-1
. The SDD, 
consisting of a 450 μm thick detector-grade silicon substrate, gives a high efficiency of 
gold Lα peak detection (97 %). No gold contacts are present in the detector 
arrangement, and so all gold signal measured derives from the samples. 
The preamplifier signal was fed to a 5th-order shaping amplifier with 1 s 
shaping time constant. A multichannel analyzer (MCA-8000A, Amptek Inc., MA, USA) 
interfaced the detector with a personal computer for data acquisition and spectrum 
analysis. 
2.3.4 Detector Collimator 
The detected x-rays consist of: (i) the desired gold XRF signal, and (ii) the 
unwanted background resulting from Compton and coherently scattered x-rays and 
fluorescence x-rays from other elements present in the sample and the experimental set-
up. For a fluorescence system to be able to detect elements present in low 
concentrations, the background signal must be minimised as much as possible in order 
for the XRF peak to be visible. Firstly, an optimum system geometry was used, 
involving mounting the detection module at 90° to the incident beam. This acted to 
minimize Compton background, profiting also from the fact that the synchrotron light 
was linearly polarized in a plane parallel to the detector surface. Secondly, a detector 
collimator consisting of a 2.9 mm hole set in a 15.4 mm long aluminium block reduced 
the detection of Compton scattered x-rays from the sample. The use of a collimator was 
a compromise between reducing the Compton scatter peak width to give a low 
background signal beneath the gold XRF peaks, and maintaining a high XRF count rate 
(and thus reducing exposure time). The detector collimation used improved the gold 
fluorescence signal to background ratio by 35% compared with no collimator. The 
detector collimator is displayed in Figure 7, alongside the sample held in measurement 
position. 
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Figure 7 Experimental arrangement of sample, detector collimator and SDD. 
 
2.3.5 Measurement procedure 
The main L-XRF lines of gold are peaked at 9.7 keV and 11.4 keV 
corresponding to gold Lα1 and Lβ1 respectively (see Table 4). The duration of spectra 
collection was set to keep the uncertainty due to counting statistics of the fluorescence 
peak below 1% for each sample concentration measured. Typical measurement times 
ranged from 20 s for the 8 mgAu/ml sample to 1800 s for the very low concentrations 
(down to 0.0032 mgAu/ml).  
 
2.4 Translation to a bench-top fluorescence system: L-fluorescence  
The XRF GNP concentration measurements were repeated by replacing the 
monoenergetic synchrotron source with a commercially available bench-top 
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molybdenum target x-ray tube to determine the clinical viability of the XRF 
measurement system. 
2.4.1 Difficulties involved in translating from a synchrotron source to 
a clinical x-ray tube 
2.4.1.1 Translation from a monoenergetic to polyenergetic source 
As stated previously, the ideal spectral shape to induce XRF is one consisting of 
many x-rays of energy just above the absorption edge of the sample. Ideally there 
should be as few as possible below the absorption edge energy, as these do not induce 
XRF and only contribute to the unwanted background signal. Likewise, x-rays of 
energy well above the absorption edge are less likely to induce fluorescence than those 
just above the absorption edge; these x-rays may be Compton scattered by the samples 
and will also contribute to the unwanted background. For this reason, monoenergetic 
synchrotron radiation sources provide the optimum spectral shape if they are tuned just 
above the absorption edge of gold. Bench-top x-ray tubes are polyenergetic sources, and 
so a greater proportion of the incident spectrum will not be converted to useful XRF 
signal than when using a monoenergetic synchrotron source. The spectrum shape of a 
bench-top x-ray source may be optimised for XRF measurements by selecting an 
appropriate filter material, filter thickness, and tube voltage (kVp). The combination of a 
filter and appropriate kVp can re-shape the spectrum to a more optimum distribution.  
The L-XRF system used a molybdenum target source, which produces a 
spectrum that has a major contribution from the characteristic K-lines of molybdenum. 
In this sense, it can be considered as a quasi-monoenergetic source (as demonstrated 
later in Figure 27).         
2.4.1.2 Translation from high to low intensity 
Synchrotron radiation sources are also ideal for XRF measurements as they are 
high intensity sources. Bench-top sources are approximately four orders of magnitude 
lower in spectral brightness (defined as photon fluence rate per solid angle per 0.1% 
bandwidth) [31]; however when considering spectral width the integrated intensity of a 
bench-top source is approximately two orders of magnitude less than a synchrotron 
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source. Therefore, translation to a bench-top system requires longer acquisition times to 
achieve similar counting statistics. However, integrating the intensity across all energies 
above the absorption edge leads to sufficient intensities for XRF measurement. Also, 
use of commercially available high power bench-top sources can boost the intensity. 
2.4.1.3 Translation from non-diverging to diverging source 
Synchrotron sources provide a non-diverging x-ray beam, which is beneficial in 
XRF measurements because: (i) it is easier to achieve a 90° detection geometry to 
minimise the Compton background and (ii) the beam can be easily collimated to be only 
incident upon the sample. The latter point minimises background scatter due to 
interactions of x-rays with other materials present in the system. Bench-top sources 
produce a diverging x-ray beam, and therefore a higher scatter background which can 
mask the XRF signal if measuring low concentrations. Bench-top sources are quasi-
parallel at a large distance from the target; however, the inverse square law decreases 
the x-ray intensity at distance.  
Polycapillary optic technology can be used to convert the diverging beam into a 
parallel beam. Polycapillary lenses are monolithic structures of bundles of hollow glass 
capillaries. X-rays are guided along the capillaries by total external reflection (TER), 
and only accepted into the optic channels if the incident angle of the x-ray is below the 
critical angle for TER at that energy (θc(E)). A collimating polycapillary optic works 
upon the following principle; if the curvature of the fibres is less than the critical angle 
for TER, the direction of the x-rays can be guided to exit the optic parallel to each other, 
as illustrated in Figure 8.   
 
Figure 8 Concept of a collimating polycapillary optic [51] 
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A collimating polycapillary optic was coupled to the bench-top molybdenum 
source in order to give a quasi-parallel beam. 
2.4.2 System design 
Measurements were made at the Dipartimento di Elettronica e Informazione, 
Politecnico di Milano, Italy. The bench-top L-XRF system consists of the same 
collimated SDD used for the synchrotron measurements. The same measurement 
geometry was used as for the synchrotron technique, as displayed in Figure 9.  
 
Figure 9 Experimental arrangement of bench-top L-XRF system. 
2.4.3 Bench-top x-ray source 
A molybdenum-anode x-ray generator (X-Beam
®
 Powerflux PC, X-ray Optical 
Systems, NY, USA) operating at 50 kVp and 1 mA was used to induce x-ray 
fluorescence of the GNP samples. This source makes use of a polycapillary semi-lens 
which acts to collect the divergent x-rays emitted by the anode and collimate them to a 
quasi-parallel beam. The divergence of the output beam is approximately 1.75 mrad 
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(0.1°) at the molybdenum Kα-line (factory data). The intensity of the molybdenum Kα-
line is of the order of 10
8
 photons/s at maximum anode voltage (50 kV) and beam 
current (1 mA) (factory data). The beam is approximately 6 mm in diameter.   
2.4.4 Beam collimator 
The incident beam was collimated using a Cross Slit Screen 3002.40 (Huber 
Diffraktionstechnik GmbH, Germany), consisting of tantalum blades and aluminium 
housing. The blades can be set to a precision of 0.02 mm. The slits were used to set a 
beam size of 1.5 mm high and 3.4 mm wide, the width covering the uniform portion of 
the beam. 
2.4.5 X-ray detector system 
The same SDD module was used as for the synchrotron measurements, with a 
slight modification. Zinc fluorescence lines were detected during the synchrotron 
measurements, which interfered with the Lα gold line. In order to reduce the unwanted 
zinc contribution to the detected spectrum, the beryllium window holder of the SDD 
(which is made of an aluminium-zinc alloy and was the source of zinc contamination) 
was enlarged to avoid interaction with incident x-rays. No zinc was then seen. The same 
aluminium collimator and MCA were used as for the synchrotron measurements. 
2.4.6 Measurement procedure 
The same measurement procedure was used as outlined in Section 2.3.5.  
2.5 Translation to a bench-top fluorescence system: K-XRF 
In order to perform fluorescence analysis at depth, higher energy XRF x-rays are 
required to penetrate through overlying tissue. The K-absorption edge of gold lies at 
80.7 keV, and so in order to induce K-XRF a higher energy source is required. In 
addition to this, a detector more suited to detecting higher energy x-rays is required. 
Therefore translation to a K-XRF system involved: (i) replacing the SDD with a high 
energy x-ray detector, and (ii) replacing the molybdenum x-ray source with a tungsten 
target higher energy source. Gold K-XRF characteristics are displayed in Table 4.   
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2.5.1 Difficulties involved in translating to a K-XRF system  
2.5.1.1 Translation from L-XRF to K-XRF 
In addition to the greater penetrations, another advantage of K-XRF is that the 
fluorescence yields for K-shells is more than a factor of three larger than for the L-shells 
(refer to Table 4). However, the photoelectric cross section just above the L-edge of 
gold (σ (11.98 keV) = 179.11 cm2/g) is over 21 times greater than that just above the K-
edge (σ (81.13 keV) = 8.2842 cm2/g) (values taken from [52]). Also, the ratio of 
photoelectric cross section to total scatter cross section (corresponding to signal to noise 
ratio) is greater for L-XRF than K-XRF (ratios of 43.4 and 22.0 at the L-edge and K-
edge energies respectively). This means that the scatter contribution to the background 
beneath the gold signal for the K-XRF system is double that for the L-XRF system, 
making it less sensitive to low concentration measurement.  
2.5.1.2 Translation from low energy to high energy source 
As mentioned in Section 2.4.1.3, bench-top x-ray tubes produce a diverging 
beam. An ideal XRF system uses a collimated parallel x-ray beam so that it is only 
incident on the sample (i) in order to avoid inducing fluorescence in other material 
present in the system, (ii) in order to minimise the background scatter contribution to 
the detected spectrum, and (iii) to fully benefit from Compton reduction in a 90° 
detection geometry. For the L-XRF bench-top system, this problem was solved through 
use of polycapillary x-ray technology to convert the diverging beam in to a parallel 
beam. However for high energy sources such as the one required to induce K-XRF, 
polycapillary optic techniques may not be implemented as the high energy x-rays will 
penetrate through the glass capillary fibres rather than being channelled between them 
[45]. Therefore, a high scatter background was present throughout these measurements. 
The source target used in the K-XRF measurements is tungsten which at high 
kVp settings produces a polyenergetic beam with tungsten characteristic lines. It is 
important to consider the effect of (i) the polyenergetic beam increasing the background 
beneath the gold signal, and (ii) the possible overlapping of the tungsten K-lines with 
the gold signal.       
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2.5.1.3 Translation from SDD to high energy detector 
The SDD is an ideal detector for use in an L-XRF measurement system; its high 
energy resolution and low noise makes it useful for measuring very low concentrations. 
However, the detection module being made of a 450 μm thick silicon substrate means 
that it is not efficient at absorbing and detecting high energy x-rays. The SDD was 
replaced with a high purity germanium (HPGe) detector of active depth 7 mm which is 
more efficient at K-XRF energies (99.7% efficiency of detection of the gold Kα1  68.8 
keV).  
2.5.2 System considerations 
The diverging nature of the tungsten source beam meant that careful 
consideration had to be given to component materials used in the system to ensure that 
no fluorescence lines of other materials interfered with the K-XRF lines of gold. The K-
lines of potential system materials were reviewed to identify problem materials. 
It can be seen that the fluorescence lines of lead (commonly used in shielding 
and collimation) and tungsten (the material of the x-ray source) are very similar to the 
gold K-lines, and so would complicate the measured spectrum and subsequent analysis. 
The fluorescence characteristics of lead and tungsten are displayed in Table 5. 
 
Table 5 Fluorescence characteristics of lead and tungsten  [31]. 
   Pb    W    Au  
  Kα1 Kα2 Kβ1  Kα1 Kα2 Kβ1  Kα1 Kα2 Kβ1 
Energy 
(keV) 
 
 74.96 72.79 84.92  
 
59.31 57.97 67.23  68.8 66.99 77.98 
Emission 
relative 
to Kα1 (%) 
 
 
 
100 60 23  100 58 22  100 59 23 
Threshold 
energy 
for 
fluorescence 
(keV) 
 88.01 88.01 88.01  69.53 69.53 69.53  80.7 80.7 80.7 
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The smallest difference between the significant K-lines of tungsten and gold is 
0.24 keV (gold Kα2 – tungsten Kβ1); this difference will not be resolved by the HPGe 
detector (measured energy resolution of 0.7 keV at 59.5 keV). However, use of a 
tungsten target was acceptable as long as no primary beam was incident on the detector. 
This was achieved by (i) using a 90° detection geometry, and (ii) using detector 
shielding to minimise the amount of primary beam incident on the detector. No direct 
primary radiation was measured by the detector; however Compton scattered tungsten 
Kα-peaks were found. The Compton scattering process reduced the energy of the 
tungsten lines and so they did not interfere with the gold signal.  
Lead XRF lines are at an energy that can be easily resolved from the gold signal 
using the HPGe detector, and so lead presence in the set up posed no problems. 
2.5.3 System design 
Measurements were made at the University College London Radiation Physics 
laboratory, London, UK. The K-XRF system consists of a collimated HPGe detector. 
An x-ray beam irradiated the sample and the HPGe detector was placed at 90° to the 
incident beam beside the sample (Figure 10). The detector was beside rather than above 
the sample due to practical problems in the detector holding module. A complementary 
metal-oxide-semiconductor (CMOS) sensor was located behind the sample to monitor 
the beam-sample alignment, and an ionisation chamber was used to correct for changes 
in incident beam intensity. 
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Figure 10 Experimental set-up of bench-top K-XRF measurement system, viewed from above. 
2.5.4 X-ray source 
The Kα1 fluorescence at 68.8 keV is the dominant emission and so the system 
was designed to increase sensitivity to this energy. The choice of exciting source is 
governed by several factors. Firstly a photon energy that is greater than, but as close as 
possible to, the gold K-edge at 80.7 keV is required to overcome the binding energy of 
the K-electrons and thus maximise the gold XRF yield. Secondly, the source should 
have as narrow a spectral width as possible in order to minimise the background due to 
scatter in the gold fluorescence peaks region. 
An industrial water-cooled x-ray tube (AGO installations, Philips) was used with 
a tungsten anode of nominal focal spot size 3 mm x 3 mm, and inherent filtration of 1 
mmBe. It runs in continuous mode with a maximum output of 160 kV and 19 mA. A 
specially designed lead collimating circular window of 5 mm diameter was mounted 
onto the front of the x-ray tube to act as an initial coarse collimator to reduce x-ray 
scatter in the room.        
2.5.5 X-ray filtration 
The simplest method of filtration is to use a material with a K-absorption edge at 
an appropriate energy that selectively allows a range of wavelengths to pass through and 
attenuates other wavelengths. The amount of attenuation is proportional to the thickness 
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of filter material, the thickness of which is a compromise between attenuation of 
unwanted wavelengths and intensity of the useful wavelengths.     
Lead has a K-absorption edge at 88.2 keV and therefore provides sufficient 
shaping of the beam. A simple simulation was performed to assess the effect of filter 
thickness on spectral shape. SpekCalc [53] was used to simulate an x-ray spectrum from 
a tungsten source set at 120 kVp, 30° anode angle, 1 mmBe inherent filtration 
(according to the specification of the x-ray unit used in these measurements). An inverse 
square law correction was made to calculate the spectrum at the position of the sample 
(70 mm from the source). An attenuation calculation was performed across the spectrum 
by performing a power fit to the x-ray attenuation coefficients of lead (taken from [52]). 
Figure 11 demonstrates the effect of using different thicknesses of lead filter upon 
spectral shape. 
 
Figure 11 Simulated spectral shape of x-ray beam at tube voltage 120 kVp with a range of lead filter 
thicknesses. 
  
Figure 11 demonstrates that the characteristic tungsten lines become reduced as 
lead thickness increases; this is beneficial as the tungsten lines contribute to the detector 
dead time without contributing to the gold XRF production. It can be seen that the 
spectral width of the spectrum becomes narrower with increasing lead thickness.  
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When selecting filter thickness, a compromise must be made between achieving 
a high enough x-ray intensity and narrow enough spectral width. A series of 
measurements of spectral width and intensity were made over a range of lead filter 
thicknesses; results are displayed in Figure 12. 
 
 
 
Figure 12 Measured effect of lead filter thickness on (a) x-ray intensity corrected by incident intensity 
measured using an ion chamber, and (b) spectral width (expressed as full width at half maximum 
(FWHM)). 
The low energy cut-off (minimum energy of the spectrum) of the filtered beam 
was measured for a range of lead filter thicknesses. The low energy cut-off is related to 
filter thickness. 
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Table 6 Measured minimum energy of filtered x-ray spectrum at different lead filter thicknesses. 
Filter thickness (mmPb) Low energy cut-off (keV) 
0.5 41.1 
1 47.9 
1.5 54.4 
2 58.6 
 
Table 6 shows that as the filter thickness increases, the minimum energy of the 
filtered spectrum also increases as the spectral width narrows. After consideration of all 
factors it was decided that use of a 0.5 mm lead filter and tube setting of 120 kVp gave a 
compromise between spectral width, minimum energy of beam and x-ray intensity.  
2.5.6 HPGe detector 
An HPGe detector (manufactured by EG&G Ortec) was used for the detection of 
scattered and fluorescence photons. The HPGe detector consisted of a single planar 
germanium crystal of diameter 36 mm with an active depth of 7 mm enclosed in a 
vacuum with a 0.254 mm thick beryllium window. The HPGe operated under liquid 
nitrogen temperatures. Spectrum Master 92X Multi Channel Analyser (EG&G Ortec) 
and Maestro 32 software was used to analyse the energy spectrum. The HPGe was 
positioned as close as possible to the samples (at a distance of 70 mm) in order to 
maximise the detection of the isotropically emitted XRF signal. Closer distances were 
not possible due to practical limitations in the experimental set-up. 
The energy resolution of the HPGe detector was measured to be always less than 
0.7 keV at 59.5 keV using an Americium-241 source. This measurement was repeated 
before and after each measurement session. The efficiency of the 7 mm thick 
germanium crystal was calculated as being 99.7% over the gold Kα1 energy (68.8 keV). 
The detector was encased in a purpose built lead x-ray shield with a circular aperture of 
diameter 10 mm on the front face of the detector, concentric with the Ge crystal. This 
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acted to shield from unwanted multiple scatter x-rays and to minimise the detector dead 
time.  
The HPGe detector energy to channel number calibration was found to drift over 
time. The XRF analysis was modified to account for the drift in the position of XRF 
peaks by giving a degree of freedom to the peak position of the Gaussian fit. 
A tube current of 12 mA was selected to avoid over-loading the x-ray tube. The 
dead time of the HPGe detector was below 10% at all times; greater deadtimes can 
result in pulse pile-up of the x-ray counts and can warp the energy spectrum. 
2.5.7 Measurement procedure 
The time duration of spectra collection was set to keep the counting statistics 
error of the fluorescence peak below 1% for each sample concentration measured. A 
measurement time of 1200s provided sufficient counting statistics. Ion chamber 
readings were recorded for each acquisition to perform an incident x-ray intensity 
correction, as the tube intensity varied between measurements. 
 
2.6 Data analysis procedure 
Each measured spectrum was analysed to extract the concentration information 
held by the gold XRF signal. 
2.6.1 Isolation of the gold L-XRF signal 
Example measured spectra are displayed in Figure 13, showing the presence of 
Lα, Lβ and also Lγ, Ll and Ln peaks (the latter three only visible for high concentration 
samples). 
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Figure 13 (top) Synchrotron measured spectra of two different GNP concentrations (4 mgAu/ml (60 s 
acquisition time) and 0.1 mgAu/ml (120 s)); (bottom) Laboratory measured spectra of 4 mgAu/ml (120 s) 
and 0.125 mgAu/ml (840 s). 
 
A region covering the Lα and Lβ peaks was selected for analysis (those lines being 
the strongest present in the range of concentrations measured). A 6-order polynomial 
least squares fit gave the best fit to the background non-peak regions (an improvement 
of 11% and 58% in the standard deviation of the fit was found using a 6-order 
polynomial compared with a 2-order polynomial and linear fit respectively), and was 
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interpolated to give an estimate of the background signal under each gold XRF peak (an 
example background fit is displayed in Figure 14).  
 
Figure 14 Data surrounding the gold Lα and Lβ peaks. A background fit (solid line) gives the background 
beneath each gold fluorescence peak. 
 
The background fit (Bi) was subtracted from the measured peak counts (Pi) to 
isolate the gold XRF signal (Fi). A Gaussian distribution was fitted to each prominent 
gold L-line. This was simple for the Lα peak where due to the intrinsic resolution of 
silicon detectors only one Gaussian was used to fit the two Lα lines. The negligible 
contribution of the K zinc line caused by zinc presence in the beryllium window holder 
of the SDD was not included in the fit. However, a more in-depth analysis was 
performed for the Lβ peak which contains three prominent lines (Lβ1,2,3). Gaussians 
were fitted with the following constraints: (i) the measured width of the Gaussian fitted 
to the Lα line (corresponding to the energy resolution of the detector) was set for all 
other gold L-lines, neglecting the 8% variation of the peak width due to intrinsic 
resolution between L and L lines; (ii) the peak position was fixed at the energy of 
each gold L-line taken from Table 4 (this required a good energy calibration); (iii) the 
peak heights of the Lα and Lβ1 lines were fitted, and used to set the secondary peak 
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heights using the relative contribution of the gold L-emissions (from Table 4). An 
example of the resulting data fits are displayed in Figure 15.    
The XRF signal for each peak (Inet) was found by summing the Gaussian fits of 
each XRF line. The XRF signals were divided by acquisition time and primary beam 
intensity. 
 
 
Figure 15 Gaussian fits to Lα (top) and Lβ (bottom) peak. The dots represent the intensity corrected data, 
the dashed lines are the fitted Gaussians, and the solid line the sum of all fitted Gaussians. 
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2.6.2 Isolation of the gold K-XRF signal 
Example measured spectra from the K-XRF bench-top system are displayed in 
Figure 16. 
 
Figure 16 Measured K-XRF spectrum of a 4 mgAu/ml GNP sample. 
 
A region covering the Kα1 and Kα2 peaks was selected for analysis (those lines 
being the strongest present in the range of concentrations measured). A 2-order 
polynomial least squares fit gave the best fit to the background non-peak regions, and 
was interpolated to give an estimate of the background signal under each gold XRF 
peak (an example background fit is displayed in Figure 17).  
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Figure 17 Data surrounding the gold Kα peaks. A background fit (solid line) gives the background 
beneath each gold fluorescence peak. The 95% confidence levels to the background fit are displayed as 
the dashed lines. 
 
The background fit (Bi) was subtracted from the measured peak counts (Pi) to 
isolate the gold XRF signal (Fi). A Gaussian was fitted to each prominent gold K-line 
(Kα1 and Kα2). Gaussians were fitted without the peak-position constraint of the L-XRF 
technique, because the channel to energy calibration drifted between measurements; a 
shortcoming in using the nitrogen cooled HPGe detector.   
2.6.3 Absorption correction technique 
Quantitative measurement of GNP concentration is achievable due to the 
calibrated relationship between GNP concentration and number of gold XRF events in 
the measurement volume. However, the latter is not completely described by the 
number of x-rays reaching the detector, because some of the emitted fluorescence x-rays 
are absorbed by the elements present in the sample. Attenuation of (i) the incident beam 
and, (ii) the gold XRF x-rays by the sample both act to reduce the amplitude of the gold 
XRF peaks and thus distort the GNP concentration information held within the gold 
XRF peaks.   
2. Quantitative measurement of gold nanoparticle concentration  
 
75 
 
Previous studies have shown that radiation Compton scattered by the sample can 
be used as an internal standard to correct for the effects of self-absorption and 
geometrical variations on measured XRF signal [54], [55]. The detected Compton 
scatter intensity Ic can be described as: 
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  Equation 5 
where µi is the attenuation coefficient at the incident x-ray wavelength, µc the 
attenuation coefficient at the Compton wavelength, and Sc is the Compton scatter 
intensity per atom.  
The fluorescence intensity If can be described as: 
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where t is the fluorescence emission coefficient and is proportional to Z
5 to 6
 for 
this range of Z, and µ0 the attenuation coefficient for the observed radiation.  
Sc is independent of Z at these energies; its intensity is due to the attenuation of 
incoming and outgoing radiation by the sample. In this way, normalising to the 
Compton scatter peak provides information on the attenuating properties of the sample, 
and so can be used to correct for absorption. 
Scatter normalisation will also correct for any small changes in source-sample or 
sample-detector distance errors in sample positioning. For a fixed geometry, the 
magnitude of the measured gold XRF signal is proportional to the gold concentration. 
However, the size of the gold XRF peaks is affected by the solid angle of x-ray 
detection and by any changes in the source-sample-detector geometry. Both the 
Compton and coherent scatter background and the XRF signal are measured in the same 
source-sample-detector geometry, and so the ratio of XRF to scatter will remain 
approximately constant for a given sample (as long as the GNPs are uniformly 
distributed throughout the irradiated volume).  
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The Compton peak of the incident 15 keV beam and molybdenum Kα line was 
used to perform this correction for the L-XRF synchrotron and L-XRF bench-top 
system respectively. The Compton peak of the tungsten Kα1 line was used to perform 
this correction for the K-XRF bench-top system. The resulting scatter corrected 
fluorescence signal IFS is: 
 
C
net
FS
I
I
I   Equation 7 
where Inet is the sum of the background-subtracted Gaussian-fitted XRF peak 
data, and IC is the intensity of the Compton-scattered x-rays. 
The scatter correction technique was tested by repositioning the same sample for 
five measurements. The standard deviation of the measured gold XRF signal over all 
measurements was 9.1% without the correction and 1.6% using a scatter correction.   
2.6.4 Detection limit 
The detection limit (DL) is a measure of the capability of the system to 
distinguish a true net peak intensity (taken as the peak height P of the Gaussian fit to the 
gold XRF peaks) from the random fluctuations of the background signal. The 
background noise (σb) was taken to be the standard deviation of the data points about 
the background least-squares fit. Signals below the threshold represented by the DL are 
indistinguishable from the background noise.  
The magnitude of P must be at least 1.96 σb to be able to distinguish the net 
fluorescence signal from statistical fluctuations with a 95% confidence level. It follows 
that the DL can be determined by finding the concentration at which 96.1bP  .  
2.6.5 Sensitivity 
The sensitivity of an XRF system is indicated by the gradient of a plot of XRF 
signal against GNP concentration, plotted without any absorption corrections, in terms 
of counts per second per mgAu/ml [56]. 
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2.6.6 Linearity and accuracy 
The linearity between the scatter corrected gold XRF signal and GNP 
concentration was investigated. A weighted linear least-squares fit was applied to the 
XRF signal measured at each concentration. Data points below the detection limit were 
not included in this fit. A weighting wi was applied to the ith measurement of magnitude 
 
2
1
i
i
E
w   Equation 8 
where Ei is the error of the ith XRF signal measurement and was calculated by 
summing in quadrature the statistical error in the gold and scatter signals. The gradient 
of the linear fit is related to the sensitivity of the system in measuring GNP 
concentration, and the error in the gradient of the linear fit determines the accuracy with 
which the GNP concentration can be measured, as illustrated in Figure 18. 
 
Figure 18 Illustration describing determination of accuracy of GNP concentration measurement. The 
solid line and black dashed lines represent linear fit and 95% confidence bounds of linear fit respectively. 
The accuracy is calculated by determining the range of GNP concentrations covered by a single XRF 
measurement.  
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2.7 Results 
2.7.1 Measured spectra 
Figures 13 and 16 display spectra obtained using each system for similar sample 
concentrations. It can be seen that the count rate of the gold XRF peaks of a 4 mgAu/ml 
GNP sample measured using the synchrotron L-XRF source is more than 15 times 
greater than for the L-XRF bench-top system. This is due to the greater incident x-ray 
intensity and larger beam area possible for a synchrotron source (the beam width of the 
bench top system is limited to 3.4 mm FWHM; widths greater than this degrade beam 
uniformity). The count rate of the gold peaks using the L-XRF bench-top system is 
approximately six times that of the K-XRF bench-top system for the 4 mgAu/ml 
sample. The background beneath the gold signal of the K-XRF system is much greater 
than for either of the L-XRF systems. This combined with the lower peak count rate 
makes the K-XRF system far less sensitive to low GNP concentrations.       
2.7.2 Absorption correction techniques 
The scatter normalisation technique resulted in a more accurate calibration line 
with more tightly constrained 95% confidence bounds. The accuracy of concentration 
measurement, taken to be the range of GNP concentrations covered by the 95% 
confidence lines for a single XRF signal value, was found to improve by 71% on 
performing the scatter correction. The difference in accuracy between the scatter 
corrected and non-scatter corrected data is illustrated in Figures 19 and 20. 
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Figure 19 Weighted least squares linear fit (solid line) of XRF signal over a range of measured GNP 
concentrations using the L-XRF synchrotron source. The XRF signals are without (top) and with (bottom) 
a scatter correction. 95% confidence levels of the linear fit are displayed as dashed lines. Error bars are 
present but smaller than the size of the plotted data points. 
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Figure 20 Weighted least squares linear fit (solid line) of XRF signal over a range of measured GNP 
concentrations using the L-XRF bench-top source. The XRF signals are without (top) and with (bottom) a 
scatter correction. 95% confidence levels of the linear fit are displayed as dashed lines. Error bars are 
present but smaller than the size of the plotted data points. 
 
Figures 19 and 20 graphically display that the scatter correction technique acts 
to linearise the data points, which results in a more closely fitting 95% confidence level. 
All further analysis has therefore utilised the scatter correction technique. 
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2.7.3 Linearity of calibration line and accuracy of concentration 
measurement  
Figure 21 displays the weighted least-squares linear fit and associated 95% 
confidence levels of the scatter-corrected XRF signal against GNP concentration for 
each XRF system. The magnitude of the scatter-corrected XRF signals of each system 
should not be directly compared as they are corrected by different scatter signals which 
vary in magnitude for each of the three systems.  
It was found that the linearity between the gold XRF signal and GNP 
concentration did not degrade when translating between the synchrotron source and the 
bench-top source. The accuracy of GNP concentration measurement was found to be the 
same for both L-XRF systems; concentrations may be measured to within ± 0.005 
mgAu/ml at low concentrations (between DL and 0.1 mgAu/ml). The K-XRF system 
could measure GNP concentration to within ± 0.02 mgAu/ml at concentrations between 
its DL and 2 mgAu/ml.        
The relative merits of one- and two-peak analysis were compared; analysis using 
the Lα peak and sum of the Lα + Lβ peaks gives a similarly accurate fit with tighter 95 
% confidence bounds. Sole use of the Lβ peak reduces the accuracy by a factor of 2.   
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Figure 21 Weighted least squares linear fit (solid line) of XRF signal over a range of measured GNP 
concentrations using the L-XRF synchrotron source (top), L-XRF bench-top source (middle) and K-XRF 
bench-top source (bottom). 95% confidence levels of the linear fit are displayed as dashed lines, and the 
detection limit plotted. 
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2.7.4 Detection limit 
The DL as defined in Section 2.6.4 was found for each XRF system and is 
displayed in Table 7. The Lα peak analysis gives the lowest DL for each L-XRF system, 
as it has a greater yield than the Lβ signal. Likewise, the Kα1 peak analysis produced the 
lowest DL, having a greater yield than the Kα2 line. It is worth noting that 0.008 
mgAu/ml was the lowest GNP concentration ≥ 0.005 mgAu/ml (DL of bench-top 
system) measured using a synchrotron source, and so does not imply that the DL of the 
L-XRF bench-top system is lower.     
Table 7 Detection limits of L-XRF systems (synchrotron and bench-top) and K-XRF bench-top system at a 
95% confidence level. 0.008 mgAu/ml was the lowest GNP concentration ≥ 0.005 mgAu/ml (DL of bench-
top system) measured using a synchrotron source, and so does not imply that the DL of the L-XRF bench-
top system is lower.     
 Detection limit (mgAu/ml) 
 L-XRF 
synchrotron 
L-XRF bench-top  K-XRF bench-top  
Lα < 0.008  0.005 Kα1 0.2 < DL < 0.6  
Lβ 0.008 0.005 < DL < 0.01 Kα2 0.6 < DL < 2.0  
 
2.7.5 Sensitivity  
The measured sensitivity to gold XRF signal is displayed in Table 8 for each 
system. The sensitivity was calculated by finding the gradient of a linear fit to the count 
rate per solid angle of each gold peak; no correction for beam intensity or self-
attenuation was performed to enable direct comparison of the three systems.  
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Table 8 Measured sensitivity to XRF signal of GNPs for each measurement system 
Sensitivity (XRF peak counts per mgAu/ml per second per solid angle) 
 L-XRF synchrotron L-XRF bench-top   K-XRF bench-top  
Lα ~95,200 ± 7% ~3700 ± 8% Kα1 ~400 ± 20% 
Lβ ~87,500 ± 8% ~3600 ± 9% Kα2 ~700 ± 18% 
Lα + Lβ ~182,700 ± 6% ~7300 ± 7% Kα1 + Kα2 ~1100 ± 15% 
L-XRF synchrotron beam size = 13 mm wide x 2.7 mm deep 
L-XRF bench-top beam size = 3.4 mm wide x 1.5 mm deep 
K-XRF bench-top beam size = 10 mm wide x 8 mm deep 
 
It is no surprise that two-peak analysis yielded a greater sensitivity than using 
either sole peak. This is due to the increase in signal intensity upon summing both peaks 
together. The synchrotron L-XRF system was approximately 25 times more sensitive 
than the bench-top L-XRF system. The L-XRF bench-top system was found to be 
between 5 - 9 times more sensitive than the K-XRF bench-top system (depending on 
which peaks were used for analysis). 
2.7.6 XRF measurements at depth 
The quantitative measurements of GNP concentration have been performed on 
small samples contained in thin plastic pots in order to minimise attenuation of the XRF 
signal. However, the eventual aim of the XRF technique is to measure GNP 
concentration in vivo or in thick ex vivo tumour biopsies; the GNPs will be distributed at 
depth and therefore the effect of overlying tissue must be considered. The extent of this 
effect will be different for L-XRF and K-XRF modes, the latter being of higher energy 
and therefore less attenuated by overlying thicknesses. 
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2.7.6.1 L-XRF measurements at depth   
The L-XRF synchrotron system was used to perform a series of XRF 
measurements of an 8 mgAu/ml GNP sample with five different thicknesses of Perspex 
(0, 2, 4, 8 and 16 mm) placed between the sample and detector (see Figure 22). Perspex 
has similar attenuating properties to tissue at these energies. An acquisition time of 180 
s was made for each measurement. 
 
Figure 22 Depth measurement of 8 mgAu/ml GNP sample; a range of Perspex thicknesses were added 
above the sample to test the effect of depth of measurement on the L-XRF method. 
 
The effect of adding Perspex thickness to the measured XRF spectra is displayed 
in Figure 23. 
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Figure 23 Measured L-XRF spectra of an 8 mgAu/ml sample acquired with a range of Perspex 
thicknesses above the sample.  
 
Figure 23 displays only a slight difference in the background of the gold XRF 
signal with increasing Perspex thickness. This is because the source was monoenergetic, 
and so Compton scatter x-rays are all of a similar energy (the Compton scatter peak is 
found at 14.6 keV at 90° detection) and do not contribute to the background of the gold 
signal. Figure 23 demonstrates that the gold L-XRF lines decrease in size with 
increasing Perspex thickness due to attenuation by the Perspex. The XRF signals of the 
Lα and Lβ lines have been plotted against Perspex thickness to illustrate this (Figure 24). 
 
Figure 24 Effect of Perspex thickness above an 8 mgAu/ml sample on measured L-XRF signal. 
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All gold signals were found to be above the DL of the system. 16 mm Perspex 
gave a 99.2% and 88.8% reduction in the detectability of the Lα and Lβ signals 
respectively. Even though the Lβ signal has a lower yield than the Lα peak, it was found 
to be less affected by overlying thicknesses as it is a higher energy signal and therefore 
more penetrating. For this reason, it may be beneficial to use the Lβ peak for analysis of 
measurements made at depth. 
2.7.6.2 K-XRF measurements at depth   
The K-XRF bench-top system was used to perform a series of XRF 
measurements of an 8 mgAu/ml GNP sample surrounded by four different thicknesses 
of Perspex (0, 6, 9 and 15 mm). The Perspex completely surrounded the sample rather 
than just being above the sample as for the L-XRF measurements. The effect of adding 
Perspex thickness to the measured K-XRF spectra is displayed in Figure 25. 
 
Figure 25 Measured K-XRF spectra of an 8 mgAu/ml GNP sample surrounded by a range of Perspex 
thicknesses. Each spectrum was normalized to the intensity measured by an ion chamber in the beam for 
each measurement. 
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Figure 25 displays an increase in the background scatter component with 
increasing Perspex thickness. This results from scatter interactions taking place in the 
Perspex both of the incident x-ray beam and of the x-rays exiting the sample; the thicker 
the Perspex, the greater the number of scatter interactions occurring. This increases the 
number of x-rays reaching the detector (as the detector is in a 90º geometry). A larger 
background component makes it more difficult to see the XRF signal from lower 
concentrations. An increase in unwanted background counts also acts to increase the 
detector dead time, which has a negative impact on the measurement by increasing 
required acquisition time and also can lead to distortion of the measured spectrum.    
Figure 25 also demonstrates that the gold K-XRF lines decrease in size with 
increasing Perspex thickness due to attenuation by the Perspex. The XRF signals of the 
Kα1 and Kα2 have been plotted against Perspex thickness to illustrate this (Figure 26). 
 
Figure 26 Effect of Perspex thickness surrounding 8 mgAu/ml sample on measured K-XRF signal. 
 
All measurements were above the DL of the system. An 84% decrease in 
detectability of the 8mgAu/ml sample was found when adding 15 mm Perspex around 
the sample. A Perspex geometry similar to that used in the L-XRF measurements would 
bring about a much lower decrease, as the incident beam would not have been 
attenuated. It can be concluded that the K-XRF technique is less affected by overlying 
thickness than the L-XRF technique, as expected. 
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2.7.7 Summary of results 
Three XRF systems have been compared in terms of sensitivity, accuracy of 
measurement and minimum detectable limit. The key results of all three systems are 
summarised in Table 9. 
Table 9 Summary of key results in order to compare the performance of each XRF system.  
 L-XRF synchrotron 
source 
L-XRF bench-top 
source 
K-XRF bench-top 
source 
Detection limit 
(mgAu/ml) 
< 0.008 0.005 0.2 < D.L. < 0.6 
Sensitivity (XRF peak 
counts per mgAu/ml 
per second per solid 
angle) 
 ~182,700 ± 6% ~7300 ± 7% ~1100 ± 15% 
Uncertainty 
(mgAu/ml) 
(for concentration 
range) 
± 0.005  
(DL – 0.1 mgAu/ml) 
± 0.005  
(DL – 0.1 mgAu/ml) 
± 0.02  
(DL – 2 mgAu/ml) 
 
2.8 Discussion 
2.8.1 Sensitivity 
The sensitivity defined as the measurable XRF signal per unit GNP concentration 
is affected by both the intensity and spectral shape of the x-ray source. The two 
translations made (from the L-XRF synchrotron system to the L-XRF bench-top system, 
and from the L-XRF to K-XRF bench-top system) will be treated in turn. The dominant 
factors contributing to the differences in performance between the systems will be 
identified. 
2.8.1.1 L-XRF synchrotron to L-XRF bench-top translation 
  The synchrotron system was 25 times more sensitive than the bench-top system, 
with typical counting times of 120 s necessary to achieve a 1% statistical error of XRF 
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peak counts for the 0.1 mgAu/ml sample. This difference in performance can be 
attributed to the following: 
a) The intensity of the synchrotron source is approximately two orders of 
magnitude bigger than that of the bench-top source. The intensity difference 
is the major contributing factor to the difference in performance of the two 
systems. A more intense source will result in a greater sensitivity per unit 
time. The intensity of the laboratory source may be increased by an order of 
magnitude by using one of the many commercially available higher power x-
ray generators. This will make laboratory measurement times of GNP 
concentrations more similar to when using a synchrotron source. 
b) The sample measurement volume was four times greater for the synchrotron 
system than the bench-top system. This is due to the limitations on beam size 
posed by beam uniformity of the molybdenum source.  
c) A smaller contributing factor is the difference in photoelectric interaction 
cross section between the main energies of each source; the synchrotron 
source set at 15 keV has a 1.5 times greater photoelectric cross section than 
the molybdenum Kα1 line of the bench-top system (158.6 cm
2
/g and 106.7 
cm
2
/g respectively).  
2.8.1.2 L-XRF to K-XRF bench-top transition 
The sensitivity of the L-XRF bench-top system was found to be 6.5 times 
greater than the K-XRF system. This difference in performance can be assigned to the 
following factors: 
a) The main contributing factor to the difference in L-XRF and K-XRF 
sensitivity is the difference in photoelectric interaction cross section, which 
is 13 times greater for the main energy of the L-XRF source than for the K-
edge energy of gold (taken to represent the greatest contribution to XRF for 
the polyenergetic K-XRF source). However, the fluorescence yields are also 
different for K and L fluorescence; the Kα1 and Kα2 emission rate is 2.15 
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times greater than for Lα and Lβ emission. These two factors together make 
L-XRF a factor of 6 more likely to occur than K-XRF. 
b) The sample measurement area of the K-XRF system was twice that of the L-
XRF system. 
c) The intensity of the K-XRF source was greater than the L-XRF source; 
however this cannot be directly attributed to the difference in sensitivity 
because the spectral shape must also be considered (further discussed in the 
following section).   
2.8.1.3 Effect of spectral shape on XRF signal   
The incident x-ray spectral shape also affects sensitivity; use of an optimum 
source energy just above the absorption edge of gold increases the photoelectric cross 
section and so will increase the rate of emission of XRF x-rays. Increasing the source 
intensity increases both the background and the peak counts equally, whereas 
optimising the spectral shape can result in increasing the number of peak counts whilst 
reducing the background. Beam filtration may be used to optimise the spectral shape, 
but this involves a compromise with beam intensity and results in longer acquisition 
times to achieve the same counting statistics.  
A comparison of spectral shape of the synchrotron source, and filtered and 
unfiltered molybdenum bench-top sources has been made to inform future work. 
Measured incident spectra using (i) no beam filtration, producing a more polyenergetic 
beam, and (ii) a 50 μm thick molybdenum filter, providing a quasi-monoenergetic beam, 
are displayed in Figure 27. The latter source-filter combination acts to reduce the 
component of the incident beam below the threshold energy required to induce 
fluorescence, which would add to unwanted background signal without contributing to 
gold XRF. The selected filter thickness is a compromise between removing the low 
energy x-rays and maintaining the intensity of x-rays above the gold L-edge.  
2. Quantitative measurement of gold nanoparticle concentration  
 
92 
 
 
Figure 27 Incident spectra of a molybdenum bench-top source with and without 50 μm molybdenum 
filtration. 
 
The number of incident x-rays that are involved in a photoelectric interaction (IPE) 
and may therefore contribute to an XRF event has been theoretically determined for 
each XRF system: 
  
max
)(
0 )1()(
E
E
xE
PE
edge
eEII   Equation 9 
where I0(E) is the number of incident x-rays of energy E and σ(E) is the 
photoelectric cross section at E. Eedge corresponds to the energy threshold for  
fluorescence (11.9 keV for L-XRF and 80.8 keV for K-XRF).  
The ‗useful‘ proportion of the total incident beam RXRF was calculated as the 
ratio of the number of incident x-rays that contribute to a photoelectric interaction 
against the total number of incident x-rays (Equation 10): 
 



max
0
0
E
E
PE
XRF
I
I
R                                           Equation 10 
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RXRF was calculated for the synchrotron L-XRF system using a simulated 
monoenergetic beam at 15 keV, the bench-top L-XRF system using the measured 
spectra in Figure 27, and the K-XRF system using an incident spectrum simulated with 
SpekCalc [53]. A power fit was used to interpolate values of gold attenuation 
coefficients [52]. A range of thicknesses of lead filtration were investigated for the K-
XRF system. Results are displayed in Table 10.   
Table 10  Characteristics of each source for gold XRF measurement (Cross sections interpolated from 
[52]). 
 Main x-ray 
energy (keV) 
PE absorption 
cross section of 
gold (cm
2
/g) 
Coherent and 
incoherent 
scatter cross 
section of 
gold (cm
2
/g) 
RXRF  (calculated for x-
rays passing through 0.1 
mm gold) 
Synchrotron 15 158.6 3.259 79.4% 
L-XRF bench-
top 
17.48 
(Mo Kα1 line) 
106.7 2.742 33.8% (unfiltered) 
60.1% (50 μm Mo) 
K-XRF bench-
top 
Polyenergetic 
source  
8.2842  
(81 keV) 
0.3722  
(81 keV) 
0.8% (no filtration) 
2.0% (0.5 mm Pb) 
3.0% (1 mm Pb) 
4.6% (2 mm Pb) 
 
Measurement found that the introduction of a 50 μm molybdenum filter acts to 
reduce the rate of L-XRF production almost by a factor of eight due to the decrease in 
intensity caused by attenuation by the filter. This reduction was confirmed by 
calculating the ratios of IPE between the unfiltered and filtered molybdenum source; the 
unfiltered beam produced 7.2 times more photoelectric events than the filtered beam. 
However, the filtered source yields a greater useful proportion of the incident beam that 
can induce L-XRF (1.8 times greater when using the molybdenum filter), and so has a 
smaller ‗useless‘ component that merely contributes background signal (values 
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displayed in Table 10). In order to improve both the sensitivity and DL of the bench-top 
system, it is recommended that use of molybdenum filtration be further investigated, but 
using a higher intensity x-ray tube to compensate for the reduction in beam intensity 
introduced by a filter. 
Simulations found that introduction of 0.5 mm Pb and 1 mm Pb filtration to the 
K-XRF system yielded a 2.6 and 3.8 times greater useful proportion of the incident 
beam respectively than when used without filtration. However, the rate of K-XRF 
production reduced by a factor of 6.2 and 21.6 when using these filter thicknesses due to 
the decrease in intensity. A filter thickness of 0.5 mm Pb was found to be a good 
compromise between lowering the background beneath the gold signal and keeping the 
rate of XRF production sufficiently high. Use of greater thicknesses of filter may be 
necessary in order to further reduce the background beneath the gold signal for 
measurement of lower GNP concentrations.     
2.8.2 Detection limit  
The detection limits of the L-XRF systems were found to be above the clinically 
required detectable concentration of ~0.01 mgAu/ml in the absence of overlying media 
(refer to Section 1.5.1). The K-XRF system was found to be unable to detect such low 
concentrations. However, it may have use in clinical techniques using higher 
concentrations of GNPs. 
The high energy resolution of the SDD module is responsible for the good 
performance of each L-XRF system, not only in terms of being able to resolve the x-
rays of each fluorescence peak but also in giving a low DL. To achieve a low DL, the 
XRF peak must be easily visible above the background upon which it sits. The energy 
deposited by an x-ray is represented by the area of the whole peak. If a sample 
containing a certain amount of gold is measured using two detectors of differing energy 
resolution R (where R = FWHM of the fluorescence peak), for the peak area to remain 
constant, a wider peak (poorer R) must be smaller, and a narrower peak (better R) must 
be taller. The DL also improves as detection time is increased, until the instrumental 
error (in this case the detector electronic noise) dominates above statistical noise. The 
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electronic noise charge of the SDD is very low at 8.3 electrons for a 1 μs shaping time, 
enabling very low detection limits.  
The DL is also smaller when the sample matrix (the material surrounding the 
GNPs) is less absorbing of both the incident and fluorescence x-rays, enabling higher 
measurement intensities for the lower concentrations. For this set of measurements the 
matrix was water, and is similarly absorbing to the clinical case of GNPs embedded in 
soft tissue. However, in the case of thicker samples where the gold is embedded more 
deeply, and also in regions of more highly absorbing anatomy such as bone, the DL will 
be degraded. 
The DL is closely related to the system sensitivity; a poorer sensitivity will result 
in a lower number of XRF peak counts above the background, and hence a degradation 
in ability to detect lower concentrations over a fixed period of time.   
2.8.3 Uncertainty in quantitative analysis 
The overall uncertainty in quantitative XRF analysis is a contribution of the 
random and systematic errors introduced at each stage of the analysis process [57]. 
Random errors include the counting statistical errors involved in the measurement of Bi 
and Pi, and determine the precision of measurement (i.e. the repeatability of a result). 
Systematic errors are introduced if a poorly determined calibration line is used, mainly 
caused by errors in sample preparation, errors in the calculation of the calibration line 
gradient, and corrections for sample absorption. Systematic errors determine the 
accuracy of an XRF measurement (i.e. the closeness of the measured concentration to 
its true value).  
Precision can be improved by: 
 Increasing counting statistics. Longer counting times were required for the L-
XRF bench-top source due to its lower intensity compared with the synchrotron 
source. It is suggested that a higher power bench top x-ray source be used for 
future measurements in order to attain measurements in similarly short times as 
2. Quantitative measurement of gold nanoparticle concentration  
 
96 
 
for synchrotron measurements. Increasing counting statistics also improves 
accuracy of the calibration line. 
 A repeatable sample positioning procedure. The scatter correction technique acts 
to correct for errors in sample repositioning. 
The main factor that affects accuracy is the integrity of the calibration line. Each 
component of the XRF system has an effect on this: 
 X-ray source: In order to achieve a good signal to noise ratio (SNR), a source 
must be used that provides an optimum spectral shape to encourage 
photoelectric events and minimise scatter events that will contribute to the 
background. A high SNR will produce a lower error on each data point and so a 
more accurate linear fit and more tightly constrained 95 % confidence bounds.   
 Sample collimator: The peak to background ratio improved by 35% when using 
a collimator in the L-XRF bench-top system. Further improvements to 
collimator design may be made to improve the accuracy.  
 Detector: As previously discussed, the detector energy resolution has a direct 
effect on SNR. The SDD and HPGe detectors used for this set of measurements 
have sufficient energy resolution.  
 Calibration samples: error in GNP concentration was kept as low as possible 
during the sample making process. Atomic absorption spectrometry may be used 
to give a gold standard measure of the gold concentration present in each sample 
if the samples are not needed for future measurements.  
 
2.9 Summary of key points learned 
In summary, each system component affects the performance of the XRF 
technique in the following ways: 
2.9.1 Effect of detector choice  
 Energy resolution: a high energy resolution is required to increase the signal to 
noise ratio in order to observe the gold XRF peak above the background. This 
will improve the detection limit and increase sensitivity. 
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  Efficiency of detection at relevant energies: the detecting layer should be of 
sufficient thickness and made of an appropriate material to maximise efficiency 
of detection. This will increase the sensitivity of the system. 
 Maximum detectable count rate: the detector should be able to operate at high 
count rates in order to reduce acquisition time, and thus improve sensitivity. 
Detectors that suffer from pulse pile up at high count rates degrade the 
measurement as the spectrum becomes warped due to dead time losses.  
 Peak drift: A detector with minimum peak drift is preferable, so that the effect 
of summing does not act to spread the XRF peak out (thereby degrading the 
detection limit). 
2.9.2 Effect of exciting source  
 Intensity: the rate of XRF production, and therefore sensitivity, increases as 
source intensity increases (as long as the detector can measure at sufficient count 
rates). 
 Spectral energy and shape: The energy should be optimised to increase the 
photoelectric interaction cross section (and therefore maximise gold XRF 
production). The spectral shape should be optimised to reduce useless low 
energy components of the beam that do not contribute at all to XRF production, 
and high energy components that do not contribute greatly to XRF production. 
An optimum spectral shape will improve both the sensitivity and lower the 
detection limit. 
 Divergence: a divergent beam increases the background signal by (i) increasing 
the background scatter signal from other components in the system, and (ii) a 
less well defined 90° geometry is achievable, and so there is a greater Compton 
background component. This acts to worsen the detection limit. 
 Stability: beam stability is not an issue as long as an ionisation chamber is used 
to correct for fluctuations in the beam. 
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 Beam area: a larger available beam size will increase sensitivity by increasing 
the rate of production of the XRF signal.  
2.9.3 Effect of signal (K- vs. L-XRF) 
 Fluorescence yield: the photoelectric cross section is greater at L-energies than 
K-energies. Even though the fluorescence yield per photoelectric interaction is 
greater for K-XRF, fewer photoelectric interactions occur for the K-XRF 
system. L-XRF is a factor of six times more likely to occur than K-XRF.  
Therefore, L-XRF systems are fundamentally more sensitive and have a greater 
signal to background ratio of the gold signal.  
 Depth measurements: K-XRF systems use higher x-ray energies, and are 
therefore less affected by overlying thicknesses. K-XRF may be more useful 
than L-XRF in at-depth measurements. 
 
2.10 Alternative method of quantitative measurement of GNP 
concentration: X-ray edge subtraction 
2.10.1 Background 
X-ray edge subtraction (XRES) techniques have proven beneficial for 
identifying high Z contrast agents. XRES makes use of the large difference in 
attenuation properties of high Z materials such as gold at energies either side of 
absorption edges (as illustrated in Figure 28), and can provide considerable 
enhancement in contrast over conventional x-ray imaging.  
XRES, in this case, is being used to locate the presence of GNPs. XRES 
techniques involve acquisition of two images just above and below the L3 edge of gold 
(11.92 keV).  
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Figure 28 Attenuation coefficients of gold (blue) and water (red) illustrating the achievable contrast. 
 
Figure 28 illustrates that the difference in attenuation coefficient value is much 
greater for gold than for water at the two image energies, and so a subtraction of the two 
images will enhance the gold contrast. A preliminary study has been undertaken to 
assess XRES for use in quantitative measurement of GNP concentrations in water. 
2.10.2 Method 
XRES images were taken of eleven GNP samples of concentrations ranging 
from 0.0005 - 4 mgAu/ml to investigate the relationship between concentration and 
subtracted pixel value, and to test the minimum detectable concentration. The 
experimental set-up is displayed in Figure 29.  
 
Figure 29 Schematic of the x-ray edge subtraction system. 
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Measurements were made at the SYRMEP beamline at the Elettra synchrotron 
source, Trieste, Italy. A Photonic Science X-ray Hystar 2048 CCD camera, with an 
equivalent pixel size of 9 μm, was used to acquire two x-ray transmission images of 40 
acquisitions each, taken just above (12.07 keV) and just below (11.77 keV) the L3 edge 
of gold (11.92 keV). An ionization chamber monitored the beam intensity in order to 
normalize the data.  
2.10.2.1 Samples 
The samples consisted of GNPs (Aurovist
TM
, Nanoprobes Inc., USA) suspended 
in a 1 ml de-ionised water buffer (introduced in Section 2.2). The sample concentrations 
were selected to resemble possible tumour gold concentrations in vivo [24], and to test 
the minimum detectable concentration. A 1 ml DIW sample was measured for 
background data. 
2.10.2.2 Image processing 
Each image was corrected for beam intensity using an ionisation chamber. A 
dark field image (an image acquired with no x-ray beam) and a flat field image (taken 
with no sample at both x-ray energies) were additionally acquired to perform 
background and flat field corrections.    
The images were then processed as follows. The dark field image (Idarkfield) was 
subtracted from each sample image (Isample) and flat field image (Iflatfield), and each 
sample image was flat field corrected according to Equation 11. 
darkfieldflatfield
darkfieldsample
corr
II
II
I


       Equation 11 
  The corrected sample images for the high and low energy acquisitions were 
then log-subtracted to give an image of the GNPs (Equation 12): 
][ln][ln ,, lowcorrhighcorrsub III       Equation 12 
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2.10.3 Results 
 Figure 30 displays the improvement in gold contrast using XRES over the gold 
L3 edge. No gold detail is visible in either the low or high energy transmission images. 
However, when the log-subtraction of the two is taken to form the XRES image, gold 
contrast improves.  
 
Figure 30 Transmission image of GNP sample at 12.07 keV (left), 11.77 keV (centre) and XRES image of 
same GNP sample (right). The XRES image on the right displays an image of the gold sample, with the 
sample holder detail present on the edges of the image.  
 
A profile plot taken across the XRES image displays a shape associated with a 
cylindrical uniform sample; the central component of the profile is non-flat due to 
greater attenuation occurring medially rather than at the sample edges (Figure 31). 
 
Figure 31 Profile plots across the XRES image. 
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As the samples were cylindrical, one would expect a greater amount of gold in 
the thicker central strip of the image than the peripheral regions. Figure 31 demonstrates 
that the XRES images show an increase in attenuation at the thicker, central portion of 
the sample, an effect that is more pronounced with increasing GNP concentration. 
Figure 31 also demonstrates that different GNP concentrations can be distinguished 
from each other. 
The relative heights of the water and GNP solution profiles show that the edge 
subtraction technique can be sensitive to lower GNP concentrations. The detection limit 
of the system was not fully determined, and further measurements at lower 
concentrations are required to further investigate this.  
The feasibility of the XRES technique to perform quantitative measurement of 
GNP concentration was assessed. The mean pixel value (MPV) over a region of interest 
covering the central portion of the sample was found for both the subtracted image set 
and the original high energy images. The MPV was plotted against sample GNP 
concentration, as illustrated in Figure 32. 
The MPV plots in Figure 32 illustrate that both the conventional transmission 
imaging and the XRES imaging techniques can be used as a method to quantify the 
concentration of GNPs; there is a downward trend in MPV across the range of measured 
GNP concentrations.   
 The gradient of the plots in Figure 32 indicate sensitivity of the imaging 
technique to GNP concentration. The XRES imaging technique displays a steeper 
gradient at higher GNP concentrations than the conventional transmission imaging 
technique. The XRES imaging technique therefore improves senstivity to quantitative 
measurement of GNP concentration. 
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Figure 32 Log-subtracted (top) and high energy transmission (bottom) MPV over central ROI. 
 
2.10.4 Discussion 
An XRES system consisting of a CCD camera and synchrotron radiation source 
was used to acquire transmission images above and below the L3 edge of gold over a 
range of GNP concentrations. This preliminary study of the XRES technique has 
demonstrated promising potential in measuring GNP concentrations expected to be 
found in vivo. Both the transmission and XRES image mean pixel values were found to 
be near-linear with gold nanoparticle concentration.  
It is recommended that further investigation is required to establish the detection 
limit and sensitivity of this technique. This study has not included as full a treatment as 
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that performed to characterise the XRF system, as its aim was to demonstrate the 
feasibility of the technique rather than fully assess it. It was decided that the XRF 
technique was the preferred technique to be developed for GNP concentration 
measurement in vivo. The reasons for this are as follows: 
 A greater sensitivity is gained from using L-edge XRES due to the greater cross 
section of absorption than at K-edge energies. As XRES is a transmission 
imaging technique, there is a limit in sample thickness due to the poor 
penetration of low L-energies. XRF is not a transmission technique, and instead 
uses a 90º geometry, enabling measurement of shallow sites in a thick sample. 
 XRES requires a dual-energy source (tuned just above and just below the 
absorption edge), that is near-monoenergetic to gain good quantitative 
information of elemental concentration. A bench-top source with these 
properties was not available to us. 
 The intensity of the XRF signal directly relates to the concentration of GNPs 
present, as a characteristic peak for gold is available. However, the mean pixel 
value of the XRES technique is a combination of the absorption of all elements 
present. The extent of the unwanted contribution of other elements present is 
related to the closeness in energy of the source used to acquire the two images.   
 XRF can easily distinguish two or more elements, but this is not straight forward 
for the XRES technique.  
It was therefore decided to leave assessment of the XRES technique at the 
preliminary stage, and pursue the use of the XRF technique to measure GNP 
concentrations in thick biological samples. However, the XRES technique will be 
returned to in the future if a fast imaging technique is required for thin samples. 
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2.11 Conclusions 
X-ray based techniques can be used to analyse GNP-biomarker distribution and 
concentration at depth (unlike NPs tuned for optical techniques). A novel system has 
been constructed that has successfully obtained XRF spectra over a range of clinically 
relevant GNP concentrations. The results show promising potential in meeting our 
initial aims in being able to quantitatively measure GNP concentration, with a linear 
relationship between GNP concentration and XRF signal found. Concentrations can be 
measured up to an accuracy of ± 0.005 mgAu/ml for both the L-XRF systems (using a 
synchrotron and bench-top source). The linearity extends down to the detection limit of 
0.005 mgAu/ml; a concentration that is lower than concentrations found in vivo as 
presented in the literature (~ 0.01 mgAu/ml) [25]. Our novel XRF system therefore 
meets the requirements set out at the design stage. Our system has a detection limit that 
surpasses the sensitivity of other x-ray based techniques found in the literature [24], 
[38], and could be used in the future to answer the clinical need for radiotherapy 
imaging of clusters of infiltrating cells. The measured DL was found to be the same for 
both the synchrotron and bench-top sources, showing potential for this technique to be 
used in the clinic. The sensitivity of the synchrotron system was 25 times more than the 
bench-top source, a difference that can be lessened through use of a higher power 
bench-top source. The main reasons for the novel system‘s high sensitivity to low 
concentrations are the excellent energy resolution of the SDD, use of an optimal 
experimental geometry and source and choice of detecting L- rather than K-
fluorescence. The XRF signal is low at small concentrations, and so it is suggested that 
a higher power bench-top source be used to gain sufficient counting statistics over 
shorter times. 
A K-XRF technique was also assessed, and its performance was found to be 
worse than for the L-XRF system, having 6.5 times less sensitivity than the L-XRF 
bench-top system, and a detection limit of 0.2 mgAu/ml. This can be attributed to lower 
photoelectric interaction probabilities at higher K-edge energies, and a higher spectral 
background contribution. The K-XRF technique is however less affected by overlying 
thickness, and so may have a future use in looking at thick samples of high GNP 
concentration.     
2. Quantitative measurement of gold nanoparticle concentration  
 
106 
 
A preliminary investigation of an alternative x-ray method of measuring GNP 
concentration was considered. An x-ray edge subtraction (XRES) technique was used to 
measure a range of GNP concentrations and successfully produce XRES images with 
mean pixel values that were found to be near-linear with GNP concentration. It was 
decided that the XRF technique was more appropriate to meet the aims of an in vivo or 
thick ex vivo measurement technique; XRES is a transmission technique and will not 
perform well for thick samples. XRF was also preferred as it can be used to image more 
than two elements simultaneously, enabling the future possible use of imaging more 
than one biomarker. 
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Chapter Three 
3 Development of tissue engineered bio-samples 
3.1 Aims and objectives  
An XRF system has been developed that is capable of quantitative measurement 
of GNP concentration. A range of GNP concentrations suspended in water have been 
successfully measured (Chapter Two) with a linear relationship between GNP 
concentration and gold XRF signal displayed down to a detection limit of 0.005 
mgAu/ml. In order to meet the eventual aims of the project, there is a need to test the 
newly developed XRF technique on appropriate biological samples that better represent 
the clinical situation.  
The aim investigated in this chapter is two-fold: 
1. To produce a set of cellular bio-phantoms with GNP inclusions at 
concentrations expected to be found in vivo. 
2. To produce a 3D in vitro cancer model which mimics the microarchitecture 
of solid cancers, with GNP inclusions, to provide a challenging test object to 
eventually assess the performance of 3D XRF imaging techniques.   
In order to meet these aims, the following objectives were set: 
1. Develop a protocol to achieve (i) cellular uptake of GNPs by (ii) a known 
amount.   
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2. Identify a method to construct reproducible 3D cellular phantoms suitable 
for XRF measurement techniques.  
In order to achieve the above objectives, I worked at the UCL Division of 
Surgery and Interventional Science, Royal Free campus, to learn 2D in vitro tissue 
culture techniques and to develop a procedure for GNP uptake into cells. I also spent 
time at the UCL Division of Surgery and Interventional Science, Stanmore campus, to 
learn tissue engineering techniques used in developing 3D in vitro cultures. 
 
3.2 Introduction to tissue culture and engineering 
Many avenues of investigation in cancer research make use of tissue culture 
techniques to study the properties of cancers, their response to therapeutics and the 
effect of the immediate microenvironment on their behaviour (including conditions such 
as pH, oxygen concentration, and presence of other cell types). 2D in vitro cell culture 
provides reproducible, dependable and robust techniques and models that have 
contributed considerably to the relevant body of knowledge. The 2D approach typically 
consists of seeding established cancer cell lines into culture grade plasticware, e.g. 
flasks, micro well plates and Petri dishes. The cells attach to the bottom plastic surface 
and grow to form a confluent monolayer,  in the presence of liquid nutrients (media 
comprising salt/sugar solutions, with amino acids and various growth factors). 
However, in the human body cells reside in 3D configurations and are often surrounded 
by ECM. Structure and positioning depends on cell type and function within the specific 
organs, e.g. hepatocytes are closely packed together in the liver in hexagonal-shaped 
lobules, lymphocytes are individually suspended in circulating blood or lymphatic 
vessels, and osteoblasts are located on the bone surface in a sheet-like arrangement of 
cuboidal cells. Phenotypes are not always retained in 2D cell culture conditions, where 
some in vivo characteristics can be lost: e.g. hepatocytes lose some liver-specific 
functions such as albumin production when in 2D, but retain these functions when 
maintained in 3D [58], [59]. Cell phenotype and biological activity can also be 
determined by cell-cell and cell-ECM interactions [60], [61] not always provided by 2D 
cultures. Cells present in a monolayer are generally exposed to uniform environmental 
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conditions whereas cells in tissues (particularly solid malignant tumours) are exposed to 
gradients of nutrients, pH and waste products [62]. 
Animal models, most commonly using the laboratory mouse (Mus musculus), 
have been used to address the limitations of 2D culture systems. Human tumour 
xenografts consisting of implanting human cancer cells in organs / tissues of the mouse 
offer the potential to mimic in vivo human tumours and the associated 
microenvironment [63]. Mice used for xenografts are immunocompromised so they do 
not reject human cells. Mouse models present a more realistic 3D model of disease and 
so cancer cells are thought to be closer to the phenotype found in native human cancers. 
However the mouse as a tumour host does not necessarily respond in the same way as 
the human body. For example, a study investigating endostatin (an angiogenic inhibitor) 
gave different results between mouse model experiments and human trials. Endostatin 
was administered to three groups of mice growing different tumours (Lewis lung 
carcinoma, fibrosarcoma and melanoma) [64]. All tumours regressed significantly. 
However, phase 1 clinical trials showed that endostatin works differently in humans; no 
significant biological activity was reported [65]. Only three out of 15 patients showed 
therapeutic benefits; one patient tumour showed slow regression (17% over a year) and 
tumours in two patients remained stable.    
More recently, the use of 3D in vitro models is gaining in popularity. 3D culture 
systems range in complexity from cancer cell spheroids to more complex tissue 
engineered models, and have been developed in an attempt to address the shortfalls of 
2D culture. As such, they also aim to provide viable, but presently limited, alternatives 
to animal models. Multicellular spheroids (MCS) are formed by culturing cells in 
spinner flasks or agar coated culture plates; cells form spherical clusters up to several 
millimetres in size that can survive for weeks [66]. MCS offer a reproducible model that 
more closely resembles in vivo tissue including production of an ECM and similar 
patterns of protein production [60]. In the later stages of growth, MCS mimic regions 
found in solid tumours including an outer proliferating region and a central necrotic 
core which develops due to lack of nutrients and oxygen [67]. However, MCS do not 
fully emulate native tumour tissue in that they do not include a complex ECM, and do 
not contain cell types typically found in the tumour stroma (supporting tissue). 
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3D culture matrices, also known as scaffolds, are porous structures that can 
support cell growth, organisation and differentiation, and in some circumstances may be 
used as an animal-model replacement. They are engineered to mimic the ECM, which in 
human tissue is composed of proteins, proteoglycans and polysaccharides such as 
collagen, hyaluronic acid (HA) and laminin [68]. Each component can be individually 
used (collagen type I hydrogel [69], HA hydrogel [70] and laminin rich BD Matrigel 
[71] are found in the literature) or combined together to form the scaffold. Engineering 
the scaffold enables control of matrix characteristics such as density and porosity. 
Synthetic materials may also be used, e.g. PEG, a biocompatible material that has been 
widely used in tissue engineering. PEG was used in the synthesis of a 3D tumour model 
of human epithelial ovarian cancer [72]. This model proved more resistant to 
chemotherapeutics (paclitaxel and cisplatin) than the 2D model, once again highlighting 
the difference in cell response to therapy in 2D and 3D geometries.       
This chapter presents work towards production of a novel 3D in vitro tumour 
model. A previously developed technique that embeds cells in a 3D collagen matrix 
[73] has been extended to create novel 3D phantoms consisting of cells incorporating 
GNPs. The cellular phantoms were designed with the ability to control parameters such 
as cell type, cell density, GNP concentration and GNP distribution. The capability to 
control the distribution and concentration of GNP-loaded cells provides a technique that 
can create challenging 3D imaging phantoms to test the performance of the developed 
novel XRF imaging techniques presented in Chapter Four. It should be noted that the 
phantoms were designed to incorporate 2D cultured cells into a 3D matrix with the 
purpose of measuring the cellular GNP concentration using the novel XRF technique. 
At this stage the aim is not to culture cells in 3D. However, this work will be extended 
in the future to 3D culture techniques in order to construct a more realistic tumour 
model consisting of dense artificial cancer masses (ACMs) that have taken up GNPs, 
nested into less dense ECM containing cell types which populate the tumour stroma 
(such as fibroblasts and macrophages). The eventual aim will be to mimic the tumour 
microenvironment to determine how cell-cell communication, cell-ECM interactions, 
ECM and cell density, and outside forces found physiologically such as mechanical 
stress and fluid flow, will affect uptake of NPs in cells.   
3. Development of tissue engineered bio-samples 
 
111 
 
3.3 Considerations involved in development of a 3D cellular model 
with nanoparticle inclusions 
The model development has involved two main steps: (i) internalisation of 
GNPs into tumour and non-tumour stromal cells, (ii) the engineering of a 3D structural 
scaffold in which to embed cells.  
3.3.1 Internalisation of GNPs into cells 
An understanding of cell uptake processes is required in order to be able to 
control cell uptake of NPs. The cellular plasma membrane is a dynamic structure of 
lipid bilayers and proteins that segregates the cytoplasm from the external environment 
and regulates transport of substances into cells. Oxygen, carbon dioxide, water, and 
small hydrophobic or non-polar molecules can pass through the membrane through 
diffusion (driven by concentration gradients). Small molecules such as amino acids and 
ions enter cells through active transport through the membrane protein pumps or ion 
channels. Nano-sized hydrophilic bio-macromolecules are transported into the cell 
through endocytosis, which is a form of active transport. This process involves the cell 
taking in objects by enclosing them into invaginations which form at the cell membrane 
and which develop into vesicles, as illustrated in Figure 33. Common endocytotic 
processes that engulf particles in membrane vesicles are: 
(i) Phagocytosis: this is mainly undertaken by monocytes, macrophages, and 
neutrophils, the purpose being to engulf particles such as bacteria with 
diameters > 750 nm. 
(ii) Pinocytosis: smaller particles (a few to several hundred nm in size) are 
internalised by this process. The fluid surrounding the cell is internalised, 
implying that all substances in the fluid area of invagination are taken up 
simultaneously [74]. This process occurs in almost all cell types. 
(iii) Clathrin-mediated endocytosis: this is the most studied endocytic pathway, and 
is a type of receptor mediated endocytosis (RME) [74]. When materials are < 
100 nm in size, their dimensions approach the size of biomolecules; this 
provides an opportunity since NPs can mimic biomolecules and be treated by 
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cells as such. Particles are deposited in small endocytotic vesicles (usual 
diameter < 100 nm) that fuse with early endosomes [75]. 
The processes leading to penetration of NPs through the cell membrane directly 
relates to cellular uptake; however, a systematic knowledge of these processes is still 
lacking from the literature [75]. 
Once particles are internalised and localised in vesicles, the vesicles degrade 
down to multivesicular bodies / late endosomes which then fuse with lysosomes. 
Lysosomes contain proteases and other enzymes that degrade most biological materials. 
Alternatively the particles may leave the cell surface directly through the early 
endosome or through recycling endosomes. This process is illustrated in Figure 33. 
 
Figure 33 Model of endocytotic mechanisms and intracellular transport [74]. 
 
The rate of transport of NPs into cells is governed by factors that affect the 
interaction between the NP and the cell membrane, the key factors being (i) NP size, (ii) 
NP shape, (iii) NP surface chemistry, (iv) NP charge and (v) properties of the cell 
membrane dependent on cell type. In order to achieve uptake of GNPs into the cell lines 
used in this study, each of the major factors were considered.  
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3.3.1.1 Size 
It was found that the uptake of GNPs in HeLa cells varies with their size [76], 
[77], with the most efficient uptake found for NP sizes 25 – 50 nm. It is proposed that 
this size gives good multivalent cross linking with membrane receptors and an optimum 
geometry for membrane wrapping involved in RME [78]. It is worth noting that most 
NPs used in medicine will have a size distribution that may result in a range of possible 
endocytotic routes into the cell.   
3.3.1.2 Shape 
Spherical GNPs enter cells more readily than gold nano-rods (GNRs), due to the 
longer membrane-wrapping time required for the rod-shaped particles [79]. Spherical 
GNPs were used in this study. Likewise, the aspect ratio of GNRs determines cell 
uptake efficiency; shorter GNRs are internalised more readily than longer GNRs with 
similar surface charges  [80]. 
3.3.1.3 Surface chemistry 
Surface chemistry is paramount in order to functionalise NPs for medical use, 
reduce surface reactivity and toxicity, and improve stability. Serum protein adsorption 
onto the NP surface occurring either in vivo (when in blood, plasma or interstitial fluid) 
or in vitro (when suspended in growth medium, as for this study) can mediate the 
cellular uptake process allowing NPs to be internalised by RME [81]. For example, the 
amount of serum proteins adsorbed on GNRs (particularly bovine serum albumin) 
showed a positive correlation with cell uptake [80]. Cell medium supplemented with 
10% foetal calf serum was used in GNP incubation of cells in this study.   
It has also been suggested that NPs may aggregate in electrolytic solutions, such 
as cell media, if they are not stabilised with serum proteins, the aggregation being 
caused by electrostatic interactions [81], [82]. NPs that have clumped together may 
potentially enter cells at a diminished rate due to the increased size of aggregates [77].       
The proteins adsorbed to the NP surface will vary depending on the biological 
microenvironment the NP is in. Also, distortion of the protein structure may occur upon 
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interaction with the NP, altering the way the protein interacts with the cell membrane 
[77]. Overall, effects on internalisation are not well understood. 
NPs can be further functionalised by adding ligands onto their surface that 
preferentially attach to (target) specific proteins on the cell surface [83]. This will be 
implemented in future studies to develop more complex 3D biological phantoms, but 
has not been included at this stage.   
3.3.1.4  Surface charge 
Modification of the surface of NPs may also change the particle surface charge, 
a factor that relates to cellular uptake. The cell surface contains charged phospholipid 
head groups and proteins, which are generally negatively charged. Thus, positively 
charged NPs are more readily internalised than negatively charged or neutral particles. 
The surface charge of the NPs also affects the internalisation mechanism, with 
negatively charged NPs not undergoing RME, and positively charged NPs being rapidly 
internalised by RME [75].   
3.3.1.5 Cell surface – protein interactions 
Data regarding cell surface-protein interactions with NPs is limited, and the 
available data are from in vitro measurements; further knowledge of interaction 
processes occurring in vivo is needed. The relationship between cell type and NP 
properties is not yet well understood; evidence suggests that the cell type affects both 
the endocytotic pathway and intracellular response to NPs [75]. Cell-specific uptake 
mechanisms can lead to increased sensitivity or resistance to NP toxicity [84]. For 
example, modified GNRs can selectively kill cancer cells (A549) but not normal cells 
(normal human bronchiolar epithelial cell 16HBE and mesenchymal stem cells) due to 
differences in intracellular trafficking of the NPs for each cell line [85], [86]. This has 
potential in clinical translation. 
3.3.1.6 Cytotoxicity of NPs 
Evidence for the cytoxicity of GNPs is equivocal. GNPs were reported to induce 
DNA damage and oxidative damage in lung fibroblast cells [87]. It has been recently 
reported that the cytotoxicity can be attributed to the cetyltrimethylammonium bromide 
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(CTAB) coating used to functionalise GNPs rather than the GNPs themselves [77], [80]. 
CTAB can enter cells with or without NPs, damage mitochondria and then induce 
apoptosis [80]. On the other hand, no cellular toxicity was associated with uptake of 
GNPs stabilised by citric acid ligands by HeLa cells (98% viability shown using a 
trypan blue exclusion staining assay) [81].   
No substantial changes in gene expression or cytotoxicity were found when 
incubating cells with gold nanorods (GNRs) alone [77]. This study proposed that as 
GNRs enter and leave cells in vesicles (as do GNPs), the GNRs are trapped in vesicles 
and are likely to experience little interaction with the nucleus and cytosol, and therefore 
have limited toxicity. The study conducted microarray experiments and examined gene 
expression profiles for HeLa cells incubated with GNRs. By studying gene expression, 
it is possible to map the direct effects that drive cell changes due to the presence of NPs. 
Some genes involved in apoptosis were found to be down-regulated, suggesting that 
GNRs cause changes in the apoptotic pathway. However, further investigation is needed 
before the relationship of NP and apoptotic genes is fully understood due to the 
complex involvement of many proteins and feedback loops in apoptosis [77]. 
Cytotoxicity may also depend on the cell line used, as the cellular uptake and removal 
of NPs differs for different cell types as previously noted [75].  
A study of the effect of GNP size on cell toxicity was undertaken for GNP sizes 
0.8 – 15 nm [88]. Connective tissue fibroblasts, epithelial cells, macrophages and 
melanoma cells (the four cell types tested) proved most sensitive to GNPs 1.4 nm in 
diameter. In contrast, 15 nm GNPs were found to be non-toxic at up to 60-fold higher 
concentrations than 1.4 nm GNPs. The cellular response was found to be size 
dependent; 1.4 nm GNPs caused mainly rapid cell death through necrosis within 12 
hours, while closely similar sized 1.2 nm GNPs effected cell death by apoptosis. The 
reason for this is currently unknown, but it may be due to differences in subcellular 
distribution of NPs dependent on NP size, particularly in terms of where the NPs are 
localised within the cell. 
A study using 3D tumour spheroids has shown that NP toxic effects are 
significantly reduced by up to a factor of five in 3D as opposed to 2D cultures [89]. It 
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was proposed that two important aspects explain this reduction in toxicity to 3D cultures 
(which more closely resemble the in vivo toxicity response): (i) 3D culture is denser due 
to cell clusters and contains an ECM layer; this better mimics tissue mass transport, (ii) 
cell phenotype changes due to intensified cell-cell interactions [89]. The data obtained 
from 3D cultures correlate well with the data from animal models, showing future 
potential of the use of GNPs.   
It has been proposed that GNPs can affect intracellular signalling by binding to 
cell surface receptors [90]. Cells control their function and state through signalling 
events triggered by binding of protein ligands with membrane receptors, and the extent 
of receptor-ligand binding and receptor cross-linking affects the intensity and duration 
of the signalling process. NPs coated with ligands could change the degree of surface 
receptor cross-linking by a controllable amount dependent on size, shape and coating of 
the NPs. It has been proposed to investigate this further to control subsequent cell 
responses and mediate biological effects to assist cancer treatment [90].   
3.3.2 Engineering of a 3D scaffold 
The second step of the phantom-making process involved constructing a 3D 
scaffold in which to embed the GNP-loaded cells. Choice of scaffold was influenced by 
available expertise but also by the scaffold having the desired characteristics for these 
studies and for future testing.  
It was decided to use natural (ECM proteins) over synthetic scaffolds (such as 
ceramics currently used in the Stanmore campus) since the ultimate aim was to develop 
a 3D in vitro model of cancer with a microarchitecture mimicking that found in situ 
(comprising of foci of cancer cells surrounded by tumour stroma, i.e. ECM and 
supporting non-cancer cell types).  
 The ECM of tissue is composed of four major proteins: collagen, fibronectin, 
elastin and laminin. Collagens are the most abundant and are so the logical choice to 
construct a scaffold. There are at least 19 types of collagen in the body, with collagen 
type 1 being predominant, and so a collagen type 1 gel was selected to comprise the 
scaffold. Collagen type 1 is present in scar tissue, and found in structures including 
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organic bone tissue and tendons. Collagen type 1 consists of three polypeptide α-chains 
arranged in a triple-helix forming sequence [91].   
The ability to engineer scaffolds means that characteristics such as density and 
porosity can be manipulated. Collagen density can be controlled through methods such 
as plastic compression, which impacts on the porosity [92]. Cellular densities within 
foci of tumour cells in tissue and surrounding tissues are not well documented, but 
generally solid cancers are quite hard, dense tissues (with an estimated cell density of 
10
7
 cells/cm
3
). This is rarely considered in cultured models. However the present 3D 
model made using collagen as the acellular component offers the opportunity to 
manipulate densities for sections of the phantom in further studies. Refer to Section 
3.4.10 for a full discussion of this technique. 
 
3.4 Development of bio-phantom construction protocol 
3.4.1 Aims of production of bio-phantoms 
A series of biological cellular phantoms were produced in order to demonstrate 
the use of the novel quantitative XRF technique developed in Chapter Two. The ability 
of the novel technique in sensitivity to GNP concentration and distribution needs to be 
assessed using samples that closely resemble the clinical situation. Two different types 
of cellular phantoms were constructed to achieve this: 
1. A set of bio-phantoms to investigate effectiveness of quantitative 
measurement of GNP concentration using the bench-top L-XRF technique 
developed in Chapter Two. These phantoms will consist of GNP-loaded cells 
uniformly embedded in an uncompressed 3D collagen matrix. The design 
criteria for this set of phantoms are outlined in Section 3.4.2. 
2.  A range of more complex 3D ACM phantoms will be produced for future 
testing of the imaging capabilities of both the L-XRF technique and a 
combined diffraction / fluorescence imaging system (proposed in Chapter 
Four). These phantoms will consist of a dense GNP-loaded cancer mass 
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surrounded by a less dense collagen gel embedded with non-cancer cells. A 
discussion of this set of phantoms is found in Section 3.4.10. 
3.4.2 Design criteria for a useful bio-phantom for XRF analysis 
In order to test the ability of the novel XRF system to quantitatively measure 
GNP concentration in cells, the biological phantoms were designed to meet the 
following criteria: 
a) A uniform distribution of GNP-filled cells in the scaffold was required; this 
is to relate the number of cells in the measurement volume to the total 
number of cells in the entire sample.  
b) The sample holder must be thin and of a low attenuation coefficient to 
enable x-rays to penetrate the sample and avoid inclusion of scatter from the 
holder.  
c) The cells must contain GNP concentrations similar to that found clinically. 
A literature search was performed to find typical in vivo GNP 
concentrations. The GNP concentrations found for a Her2+ breast cancer 
targeted GNP study using a mouse model have been presented in Chapter 
One (Table 3). The concentrations found ranged from 0.16 mgAu/ml 
(muscle uptake) to 3.48 mgAu/ml (periphery of Her2+ tumours) [24]. The 
authors explain that an unusually high GNP dose (22 mgAu) was injected 
into the mouse; our phantoms were designed to include even lower 
concentrations than those reported in Table 3 to represent a more realistic 
clinical situation.  
d) The concentration of GNPs in the sample must be above the detection limit 
of the system. The detection limit measured in Chapter Two was lowered 
further through modification of the system, now enabling sensitivity down to 
0.001 mgAu/ml (refer to Section 3.7.3.3 for details on the system 
modification). 
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3.4.3 Chronological steps towards a bio-phantom protocol 
The following iterative steps were undertaken in order to meet the design criteria 
for XRF imaging: 
1. Incubation of cells with NPs: This was first attempted by adding GNP 
containing-medium to a pre-prepared, live 3D culture of cells embedded in 
collagen gel. The sample was incubated for 48 hours. In this time, the 
peripheral ~1 mm layer of the gel darkened to a black colour (indicating 
GNP presence) with no colour change seen deeper into the sample, 
suggesting the GNPs did not penetrate through the collagen scaffold to reach 
cells deep in the sample. This mimics the in vivo situation of increased 
uptake in the periphery of tumours compared with the centre of tumours [24] 
and so could be useful in future studies of GNP transport throughout the 
ECM. However, this did not meet the design criteria of a known and 
controllable GNP distribution required for XRF measurement of GNP uptake 
(criteria (a) above)), and it was decided to incubate the cells with GNPs in 
2D culture. This resulted in a more even exposure of cells to GNPs, resulting 
in a more even GNP uptake. The GNP-loaded cells were then transferred to 
the 3D collagen gel and set. 
2. Uniformity of distribution of cells within the matrix: Iterative improvements 
in the sample-making process were made to achieve this; using a micro-
pipette to evenly disperse the cells throughout the collagen gel just before 
the gel set is standard practice to achieve a uniform distribution.  
3. Washing of cells: Dark spots of size ~ 2 μm were visible under a microscope 
in the first batch of samples, thought to be due to GNPs outside of the cells 
aggregating together. To ensure that all GNPs measured by the XRF 
technique were NPs taken up by cells, a rigorous washing procedure (with 
isotonic phosphate buffered saline (PBS)) was included in the protocol. It is 
evident from transmission electron microscopy (TEM) images (such as 
Figures 42 and 44) that washing the cells results in samples where the only 
detected GNPs are internalised by cells.    
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4. Sample size: Samples were initially set in a bijou sample holder of internal 
diameter 15 mm and height 50 mm. The size of the bijou was greater than 
the measurement volume, and so regions of the sample outside the 
measurement volume acted to attenuate the signal. Smaller sample pots of 
dimensions of inner diameter 8 mm and height 45 mm were used to reduce 
this effect. Another benefit of using a smaller pot is that less GNP solution is 
required to incubate the cells (as smaller flasks were used), to minimise 
experimental costs. 
The main problem encountered with the sample making procedure was the 
collagen gel setting process. One group of samples did not set correctly; it is thought 
this was due to the collagen not being at a low enough temperature. It is advised to keep 
the collagen refrigerated when not in use. Also, the most common reason for gels failing 
to set is incorrect pH. The optimum pH for gel-setting is indicated by colour changes of 
the indicator dye (methyl red) included in the medium from yellow to pink, and 
judgement on correct change is operator dependent. A more vigorous system would 
include development of an optical spectrometer to measure when the correct colour is 
reached. 
3.4.4 Cell Maintenance 
The cell lines used were the human colon adenocarcinoma cell line HT29 
(passage (p) 30-42) and the mouse embryonic fibroblast cell line 3T3 (p 28-32) (both 
from the European Collection of Cell Cultures, Sigma-Aldrich, Dorset UK). Colorectal 
cancer was chosen as the demonstrator cancer type because of the availability of a well 
characterised cell line (HT29). The cell lines represent tumour (HT29) and non-tumour 
(3T3) cellular components in the phantoms.  
Standard cell maintenance protocol was implemented throughout. Cells were 
maintained under sterile conditions as 2D monolayers in 100% humidity, 5% CO2 in air 
at 37 °C in an incubator. The cells were cultured in Dulbecco‘s Modified Eagle Medium 
(DMEM) with 1000 mg glucose/L, L-glutamine, NaHCO and pyridoxine HCl (Sigma-
Aldrich) supplemented with 10% Foetal Calf Serum (FCS, 5129, First Link UK Ltd, 
Birmingham UK) and 1% Penicillin/Streptomycin (P/S, GIBCO, Invitrogen, Paisley 
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UK). The latter was added as a prophylactic antibiotic. The DMEM contains nutrients 
that the cells require to function and stay alive, and must be changed frequently (~twice 
weekly) to replace nutrient levels that have been depleted and remove cell wastes.  
Once cells are seeded into a flask, they adhere on the bottom surface (this 
process takes less than 24 hours; usually up to 4 hours) and grow to form a monolayer. 
While populating the available space, cells continue to perform cellular functions. 
Optical microscope images of the cell lines used in this experiment are displayed in 
Figure 34.  
 
Figure 34 Optical microscope images of (a) HT29 and (b) 3T3 cells, at 100 X 
magnification. The cell lines have been incubated with 0.5 mgAu/ml GNPs. Black dots 
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within or on top of cells are thought to be GNP aggregates. The number of cells 
continuously increases as cells undergo mitosis. Biologists use the term ‗confluence‘ to 
numerically describe this; 100% confluency describes a flask surface completely 
covered in cells, 50% confluency is when the cells cover half of the surface, and so on. 
Once the cells become 100% confluent, there is no more space to support normal 
growth, and as a result growth slows down and eventually stops. This is due to contact 
inhibition (cells arrest growth when they come into contact with each other), and also a 
lower availability of nutrients and build-up of waste.  
To avoid overcrowding and maintain healthy cells in culture, cultures are 
propagated usually before they reach 100% confluence – at between 85-95% 
confluence. This is achieved by a process called passaging, which involves trypsinising 
(enzymatically detaching) cells from their adherent plastic surface, and adding a fraction 
of those cells to a new flask for seeding (not less than 10% of the original detached 
population). The process is as follows: 
1. Cell medium is removed from the flask, and the cells washed with PBS, 
followed by PBS-EDTA (ethylenediaminetetraacetic acid). Washing 
removes the medium and associated proteins which are able to bind trypsin 
and neutralize its action. EDTA chelates proteins present on the cell 
membranes that contain calcium, and so begins the process of breaking 
protein-protein links between cells.  
2. Trypsin (1 mg/ml trypsin in PBS-EDTA, Gibco) is added to the flask and 
incubated for approximately 30 seconds, along with mechanical disruption 
of the flask to mechanically encourage the cells to fully detach from the 
plastic, as determined using an optical microscope. The amount of trypsin 
added depends on the size of the flask used; 1.5 ml was used for the 75 cm
2
 
flasks routinely used for cell maintenance, and 0.5 ml for the 25 cm
2
 flasks 
used in the nanoparticle incubation studies. 
3. Cell medium is then added to the detached cells in order to neutralise the 
effect of the trypsin (12 ml or 5 ml medium for the 75 cm
2
 or 25 cm
2
 flasks 
respectively). If trypsin remains in the solution for too long it starts breaking 
3. Development of tissue engineered bio-samples 
 
123 
 
up cell membranes and killing cells. 10% of the cell / medium suspension is 
then transferred (passaged) into a clean flask, and the total volume made up 
to 10 – 15 ml or 3 – 5 ml using cell medium for the 75 cm2 or 25 cm2 flasks 
respectively. The two step addition of medium ensures that the trypsin is 
fully neutralized (this requires a 1:1 ratio of FCS:trypsin; or 10:1 ratio of 
FCS-supplemented medium:trypsin). The flask is then placed level inside the 
incubator and the process repeated once the cells have grown to near 100 % 
confluence. 
3.4.5 Incubation of cells with gold nanoparticles 
The GNP-PBS suspension was prepared as outlined in Section 2.2 under aseptic 
conditions, using PBS instead of DIW. Each pot of Aurovist
TM
 1.9 nm GNPs contains 
40 mg GNPs; the content of the pot was suspended in 4 ml PBS to give a final 
concentration of 10 mgAu/ml PBS. One of the smallest available culture flasks (25 cm
2
) 
was used in order to minimise the amount of GNPs required for each study but at the 
same time provide a few million cells for experimentation. This meant that 4 ml of the 
required GNP concentration was sufficient for incubation. Figure 35 displays the 
appearance of the flasks at the time of incubation.  
 
Figure 35 Cell culture flasks containing HT29 cells being incubated with GNPs (right) and without GNPs 
(left) 
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An example of the volumes of GNP-PBS solution and cell medium required to 
give the correct concentration is demonstrated in Table 11. 
Table 11 Quantities of GNP-PBS suspension and cell medium required for nanoparticle incubation of 
cells. 
GNP concentration 
(mgAu/ml) 
GNP mass in 4 ml to 
give this 
concentration (mg) 
Volume of GNP-PBS 
solution (10 
mgAu/ml) needed 
(ml) 
Volume of medium 
added (ml) 
4 16 1.6 2.4 
2 8 0.8 3.2 
1 4 0.4 3.6 
0.5 2 0.2 3.8 
0 0 0 4 
    
Once cells were 75% confluent, the cell medium was removed and replaced with 
4 ml of the GNP-containing medium and incubated for the required time at conditions 
outlined in Section 3.4.4. This procedure was based on the in vitro GNP incubation 
studies reported in the literature [88], [93]. A time of uptake study (described in Section 
3.6) found that the optimum incubation time was 24 hours for the 1.9 nm GNPs.  
After the incubation period, the cells were thoroughly washed with PBS 
followed by PBS-EDTA to remove GNPs not taken up by cells, trypsinised according to 
standard protocol, with 0.5 ml trypsin (procedure outlined in Section 3.4.4), re-
suspended in fully supplemented medium and a small amount (up to 50 μl) was 
removed to count cell numbers using a haemocytometer (under an optical microscope). 
The cell suspension was made into a final volume of 5 ml and spun at 400g for 5 min in 
a centrifuge in order to separate out the cells from the liquid medium, and retrieve the 
cells in the form of a cell pellet. Figure 36 displays a photograph of an example cell 
pellet. The cells are then ready to be resuspended in very small volumes (100 μl) and be 
included in a 3D collagen gel model, as described in Section 3.4.7. 
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Figure 36 Photograph of cell pellet formed after centrifuging a cell suspension. The black colour of the 
cell pellet is due to the GNP inclusions in the cells (1.9 nm GNPs are black in colour). 
 
3.4.6  Cell counting 
It is important to know the number of cells included in a 3D collagen gel model 
in order to perform gold XRF signal corrections. Standard cell counting protocol was 
used. A haemocytometer is a device used to count cells; it consists of a thick glass slide 
with an indentation that creates a chamber when a thinner glass coverslip is in contact 
with it (Figure 37).  
 
Figure 37 Haemocytometer with glass coverslip being viewed with an optical microscope. The right hand 
side image displays cells (white spots) contained within the etched haemocytometer grid as viewed under 
a microscope.   
 
3. Development of tissue engineered bio-samples 
 
126 
 
A small volume of the cell suspension is applied to the edge of the coverslip 
using a micro-pipette, and is sucked into the chamber by capillary action, completely 
filling the chamber. The chamber is engraved with a laser-etched grid of lines that are 
visible under a microscope (illustrated in Figure 37). The area bound by the lines and 
the chamber depth is known, and so it is possible to count the number of cells per unit 
volume of fluid through a microscope. An appropriate dilution of the cell suspension 
should be used in order to reach a compromise between achieving a large enough 
sample size and avoiding overcrowding making it difficult to count (not less than 100 
cells per central chamber; empirically no more than 300). 
The accuracy in the cell counting technique is ± 10% [94]; this was achieved 
through the counting of over 100 cells per sample. Between 3 – 5 readings from 
separate chambers were carried out for each cell population to average numbers and 
reduce errors due to pipetting or dispersal. In practice, this error is driven by operator 
practice; the same operator was used for each sample thereby inducing the same error in 
all readings. Flow cytometry provides an alternative method of cell counting, which 
could be implemented as a faster and more accurate cell counting technique in future 
work. 
3.4.7 Preparation of a 3D collagen model 
Collagen lattices are formed by allowing fibrillogenesis to occur; this is a 
thermodynamically driven aggregation of fibrils following neutralisation of native 
collagen solution (implemented in our procedure). The collagen lattice is made of 
narrow fibrils at extremely low density (0.2 – 0.4% collagen in > 99% fluid) [73]. Cells 
within such reconstituted lattices are thought to bundle fibrils together over time [95]; 
however, our collagen gels were fixed one hour after the collagen set and so the fibrillar 
architecture did not have time to be remodelled.   
A standard protocol was followed to produce the cell-embedded collagen 
phantoms [73]. 1 ml of cell populated collagen gel was produced for each sample using 
0.8 ml collagen type I (rat-tail collagen type I, protein concentration 2.035 mg/ml in 
0.6% acetic acid, First Link UK Ltd.), 0.1 ml of Minimum Essential Medium (MEM, 
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10X with Earle‘s Salts, without L-glutamine, sodium bicarbonate, GIBCO 21430, 
Invitrogen) and 0.1 ml of cell suspension.   
 Collagen type I was mixed with MEM and its pH was neutralised by the 
addition of 1 M sodium hydroxide in a dropwise fashion until a colour change from 
yellow to cirrus pink was observed (pink indicating the pH required for the gel to set (7 
– 7.7) [96]. The cell suspension was immediately added and the mixture micro-pipetted 
to ensure a uniform suspension of the cells in the collagen, taking care to prevent the 
formation of air bubbles which would affect the required cell density uniformity. The 
mixture was then transferred to a plastic container of inner (outer) diameter 8 mm (9 
mm), height 45 mm, and the gel set in a humidified incubator with 5% CO2 at 37 °C for 
30 minutes. An example of the appearance of the collagen embedded samples is 
displayed in Figure 38. 
 
Figure 38 3T3-embedded collagen samples over a range of initial GNP concentrations.  
 
3.4.8 Fixation of samples 
Gel samples were fixed one hour after setting up the collagen gel. 0.8 ml of 
gluteraldehyde fixative (10% gluteraldehyde, 90% PBS) was added to the gel pot and 
left at room temperature for 24 hours until the gel fully fixed (this is indicated by a 
progressive lightening in colour of the pink gel). The gluteraldehyde solution was then 
removed, the gel washed with 0.8 ml PBS, and then finally covered in 0.8 ml PBS. The 
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samples were then stored at 5 °C in order to minimise the risk of infection or bacteria 
formation. 
3.4.9 TEM imaging protocol 
TEM imaging is a widely used technique to determine NP distribution within 
cells. The TEM imaging for this study was performed by the Electron Microscopy 
service at the Royal Free Hospital, London, using the following procedure. 
Following fixation in gluteraldehyde, the samples were cut into cubes < 2 mm in 
thickness which were washed with several changes of PBS and postfixed using 1% 
osmium tetroxide  / 1.5% potassium ferricyanide (BDH, Leicester, UK) for 1.5 hours. 
The samples were then washed using distilled water and dehydrated using graded 
alcohols from 30% to 100%. They were then placed in 50% alcohol / 50% Lemix 
(TAAB Laboratories Equipment Ltd, Reading, UK) epoxy resin mixture overnight, and 
the following day infiltrated with 100% Lemix resin for two days (Lemix epoxy resin 
consists of 25 ml Lemix A, 55 ml Lemix B, 20 ml Lemix D and 2 ml 
benzyldimethylamine). They were finally embedded in fresh Lemix resin and 
polymerised at 70 °C overnight.   
Ultrathin sections were cut using a diamond knife (Diatome) and collected on 
300HS, 3.05 mm copper grids (Gilder). The ultrathin sections were stained with 
saturated uranyl acetate in 50% ethanol (TAAB) for four minutes followed by 
Reynold‘s lead citrate for five minutes (Reynold‘s lead citrate: dissolve 1.33 g lead 
nitrate (BDH, Leics UK) in 15 ml distilled water, and 1.76 g sodium citrate (BDH) in 15 
ml distilled water). Solutions were mixed together and the resulting precipitate 
dissolved with 8 ml 1M sodium hydroxide (BDH, Leics UK) making up to a final 
volume of 50 ml. 
The ultrathin sections were viewed using a Philips CM120 TEM and 
photographed with an AMT Digital Camera (Deben UK). 
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3.4.10 Development of a novel 3D artificial cancer mass with GNP 
inclusions 
The collagen hydrogels described in Section 3.4.7 consist mainly (> 99%) of 
water and are therefore of a much lower density than that found in vivo. Advances have 
been made to increase the density in a controlled way to more closely resemble native 
tissue. Simple engineering principles can be used to squeeze out excess fluid and so 
increase collagen density. Techniques include use of a load to plastically compress the 
hydrogel, capillary suction of fluid into porous layers and also self autocompression 
under the gel‘s own weight [92]. Plastic compression technology can be applied to 
increase matrix density by up to 30% (similar to solid cancer densities) [97]. Cell 
viability is retained in cells embedded in the scaffold during compression; the standard 
compression method results in only a 10% reduction in viability [92].  
The compression process was found to produce structuring consisting of 
compacted lamellae of collagen fibrils parallel to the fluid-leaving surfaces [92]. This 
was proposed to be a consequence of the directional flow of fluid from a single surface. 
It was found that collagen fibrils and cells were retained at the leaving interface, 
increasing the density at the surfaces of the compressed gels. Structuring can be further 
controlled by applying uniaxial strain to the hydrogels to generate alignment of cells 
[98]. Greater control of the mechanical properties and dimensions of the compressed gel 
may be achieved through selection of the compaction technique used and the extent and 
speed that the interstitial fluid is expelled [92]. For example, slowing the process down 
and having greater control of fluid removal through use of blotting paper rather than a 
load will enable more control over compacted gel dimensions.   
Previous work by the UCL Division of Surgery & Interventional Science 
enabled the construction of samples that closely mimic colorectal cancer. The samples 
were composed of a dense ACM embedded in a less dense collagen gel containing 
sparse fibroblasts and endothelial cells [99]. The constructed 3D model had the 
advantages of controllable matrix density and spatial position of different cell types. 
The compressed ACM showed a major feature of in vivo cancer masses, namely 
hypoxia was confirmed in the cells in the central core, and release of VEGF (vascular 
endothelial growth factor, a proangiogenic factor relating to hypoxia and tumour 
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growth) was detected in cancer cells present at the tumour mass edges [63], [100]. Work 
in similar 3D non-cancer models by the same group has demonstrated that increasing 
collagen density in cell-seeded scaffolds results in the formation of oxygen gradients, 
where cells on the surface are exposed to higher oxygen levels compared to the core. 
The level of hypoxia is controllable and dependent on the cell and matrix density. 
Reversal of angiogenic up-regulation is also possible through simple perfusion features 
that mimic vasculature [101]. We hope to make use of such tissue engineering strategies 
in the near future to create 3D tumour models with hypoxic cores to investigate the 
effectiveness of GNPs targeted for hypoxia.         
This project has aimed to extend the 3D ACM technique [99] to incorporate 
cells with GNP inclusions with the aim of providing a novel 3D GNP imaging phantom 
of similar cell type and density found in vivo. The produced samples will act as complex 
imaging phantoms to test the XRF imaging system (and enable 3D XRF images to be 
acquired) and also to enable future testing of the combined fluorescence / diffraction 
imaging system proposed in Chapter Four.       
 
Figure 39 Illustration of the novel 3D tumour model with GNP inclusions. 
 
The procedure used to produce the 3D GNP-loaded imaging phantom is as 
follows: 
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1. All cells were incubated with GNPs of required concentration in 2D culture, 
according to the procedure described in Section 3.4.5. This step brings novelty 
to the previous ACM technique through incorporation of GNPs. 
2. A collagen gel was created by populating collagen with HT29 cells. 
3. The unset gel was poured into a cuboidal mould and allowed to set at room 
temperature for 30 minutes. 
4. The gel-containing mould was placed onto a nylon mesh which was in turn 
placed on top of a 165 µm stainless steel mesh resting on absorbent paper [73]. 
The gel was compacted using a standard plastic compression protocol modified 
from [92] (compression under a load (73.55 g) for five minutes). This process 
was repeated on the other side of the gel to reduce cell concentration gradients 
resulting from directional fluid flow. It has been previously demonstrated that 
this compression technique brings approximately a 16 – fold increase in collagen 
density from the uncompressed gel, giving a final collagen density of 6.7% [99].  
The mould and load are displayed in Figure 40. 
 
Figure 40 Mould and compression load used to compress the gel to form an ACM. 
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5. A portion of the dense ACM was cut from the bulk cuboid gel using a surgical 
knife (Figure 41), and placed in a non-dense surrounding collagen gel which was 
populated by 3T3 fibroblasts. 
 
Figure 41 (a) Cuboidal ACM once removed from mould, (b) ACM components to be inserted into a low 
density collagen gel seeded with 3T3 cells (image taken from [99]). 
 
6. The finished sample was incubated for 30 minutes, and the sample fixed 
according to the procedure outlined in Section 3.4.8. 
3.4.11 Discussion 
The initial aim of producing a set of 3D GNP-loaded cellular phantoms in order 
to test the L-XRF measurement system was met. We achieved GNP uptake in both cell 
lines used, confirmed with TEM analysis, as will be shown in Section 3.5.3. We also 
successfully adopted a standard collagen construction procedure in order to uniformly 
embed the GNP-loaded cells in a 3D matrix. Further discussion of the optimisation 
process of the phantom making procedure is found in Section 3.5 (comparing the uptake 
of two GNP sizes) and Section 3.6 (assessing appropriate incubation times to use). This 
set of phantoms was successfully used to demonstrate the ability of the L-XRF 
technique in measuring GNP concentration in cells (refer to Section 3.7).     
A range of ACM imaging samples were produced and taken to the Elettra 
synchrotron source, Trieste in order to test a novel XRF imaging technique (details of 
the system can be found in Section 4.4). The cells were incubated with 15 nm GNPs, 
which were subsequently shown to be not taken up by the cells in Section 3.5. The 
decision to make this set of samples using 15 nm GNPs was based on results reported in 
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the literature saying that they were less cytotoxic than the smaller GNPs [88]. However, 
results discussed later in the thesis indicate that 15 nm GNPs are not taken up by cells in 
sufficient numbers; this result was confirmed when no gold XRF signal was detected 
from the ACM set of samples. This meant that on this occasion no XRF images were 
possible as there were very few GNP inclusions in the phantoms. However, the phantom 
production technique in terms of the tissue engineering procedure involved worked 
well; the produced set of samples successfully consisted of a dense ACM of HT29 cells 
surrounded by a less dense collagen matrix with 3T3 cells embedded at a lower density.  
 
3.5 GNP cell uptake of two different GNP sizes 
3.5.1 Aim of investigation 
GNPs of two different diameter sizes were available for this work, 1.9 nm and 
15 nm, both commercially available from Aurovist
TM
, Nanoprobes Inc., USA. The 
uptake of the two NPs was compared in order to select the NP size to use for subsequent 
experiments. 
3.5.2 Method 
HT29 and 3T3 cell cultures were incubated with both NP sizes at a GNP dose of 
2 mgAu/ml (as outlined above). The 1.9 nm GNPs were incubated for 24 hours, 
whereas the 15 nm GNPs were incubated for 48 hours (the 15 nm measurement being 
performed prior to knowing the optimum time of uptake of GNPs). The difference in 
incubation time still enables a broad comparison to be made of uptake of different GNP 
sizes, as it is demonstrated in Section 3.6 that uptake still occurs at 48 hours.  
3.5.3 Results 
TEM images of 3T3 and HT29 cells are displayed in Figures 42 - 45. Figures 46 
and 47 display TEM images of a greater magnification to illustrate the distribution of 
GNPs within each cell type. 
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Figure 42 TEM image of a 3T3 cell incubated with 1.9 nm GNPs. 
 
3. Development of tissue engineered bio-samples 
 
135 
 
 
Figure 43 TEM image of a 3T3 cell incubated with 15 nm GNPs. 
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Figure 44 TEM image of HT29 cells incubated with 1.9 nm GNPs. 
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Figure 45 TEM image of a HT29 cell incubated with 15 nm GNPs. 
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Figure 46  High magnification TEM images of 3T3 cells incubated with (a) 1.9 nm. Images (b) and (c) 
both show 3T3 incubation with 15 nm NPs. No size measurements could be made of the 1.9 nm as the 
GNPs were too densely packed within the endosomes. The range of GNP sizes found for the 15 nm 
nominal size was 9.41 nm – 18.0 nm (image (c)).  
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Figure 47  High magnification TEM images of HT29 cells incubated with (a) and (b) 1.9 nm and (c) and 
(d) 15 nm. The size of GNPs found within the cells ranged between 1.91 nm – 5.98 nm for the 1.9 nm 
nominal size, and between 6.35 nm – 14.0 nm for the 15 nm nominal size. 
  
TEM analysis of the cells showed that the 1.9 nm variety was more avidly taken 
up by cells than the 15 nm GNPs for both cell lines and so it was decided to use 1.9 nm 
GNPs in subsequent experiments. X-ray microanalysis was performed to confirm gold 
presence within the cells; this involved a TEM technique that bombards the sample with 
electrons and detects the emitted x-rays (the energy of the emissions being characteristic 
to elements present).  
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3.5.4 Discussion 
The TEM images demonstrate uptake of the GNPs into the cells; as 
ultramicrotome sections are approximately 100 nm thick, and one can visualise cell 
organelles in the slices, we can conclude that the GNPs are inside cellular/intracellular 
vesicles as opposed to just on the surface of cells. The cells in the TEM images appear 
viable; the darkness of the cytoplasm indicates presence of ground substances and 
health of the cytoplasm, and organelles required for healthy cell functioning are present 
(such as the nucleus, endoplasmic reticulum and mitochondria).     
This study showed a greater cellular uptake of 1.9 nm GNPs than 15 nm GNPs 
for both HT29 and 3T3 cells lines, and so 1.9 nm GNPs were used in subsequent 
experiments. This result conflicts with the limited literature available, which suggests 
the optimum size of GNPs for cell uptake is 25 – 50 nm [76], [93]. However, the 
reported study was undertaken using transferrin-coated NPs, whereas our study was 
performed using NPs coated in serum proteins adsorbed from the growth medium and 
this may lead to different cell uptake. Extensive investigation of other protein coatings 
is required to completely understand the effect of GNP size on cellular uptake [76].  
It is interesting to note that literature reports that large GNPs (~ 50 nm) can enter 
cells as a single NP, whereas interaction of NPs smaller than 50 nm with the cell 
membrane does not produce enough membrane bending energy to completely wrap the 
NPs on the surface of the cell membrane; at least six 14 nm GNPs must cluster together 
to enable uptake [76]. Other literature contradicts this; endosomes containing single 10 
nm NPs were observed [102]. We have observed that 1.9 nm GNPs are visibly clustered 
/ aggregated together inside vesicles (as demonstrated in Figures 42 and 44) but single 
15 nm GNPs were found within vesicles in the cytosol, with no clustering evident over 
the incubation time period. The conflicting results in the literature may be explained by 
differences in functionalisation of the NPs (transferrin vs. peptide for the first and 
second studies mentioned respectively, and a possible difference in protein coating 
between the 1.9 nm and 15 nm GNPs in our study) and its effect on uptake mechanism. 
Real-time single particle imaging is necessary to understand the effect of clustering and 
protein coating on cellular uptake. 
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The TEM images of the 1.9 nm uptake (Figures 42 and 44) shows that the GNPs 
are localised within vesicles located in the cell cytoplasm. It is thought that GNPs are 
initially contained in endosomes after undergoing endocytosis, and then travel through 
the cytoplasm within the endosomes to fuse with lysosomes (the larger densely filled 
vesicles present in Figures 42 and 44). Figure 47 (a) demonstrates an example of both a 
GNP-containing endosome and a GNP-filled lysosome. This observation is consistent 
with NP uptake theory described in Section 3.3.1, and provides evidence that the GNPs 
were internalised through the cellular process of endocytosis. This contradicts a 
previously reported study using 2 nm GNPs coated with Herceptin which showed no 
uptake into human breast cancer cells (compared with 40 nm GNPs which were taken 
up by RME [90]). This study reports that the 2 nm GNPs only fix to the surface of the 
cell, and do not penetrate the membrane. However, this study uses a different protein 
coating and cell type, which may explain the difference in result to our findings.  
Figure 48 shows further evidence of endocytosis; this TEM image has captured 
the steps of endocytosis, including GNP-cell membrane interaction, membrane 
invagination and endosome formation, and travel of endosome towards GNP-filled 
lysosomes.  
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Figure 48  TEM image of cell membrane surface of HT29 cell incubated with 1.9 nm GNPs. The image 
has captured each step of endocytosis: (1) NP-membrane interaction, (2) membrane invagination to take 
up GNPs into cell, and (3) resulting endosome carries GNPs towards lysosomes. 
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Figures 43 and 45 demonstrate the lack of presence of GNP-filled lysosomes in 
cells incubated with 15 nm GNPs. The few 15 nm GNPs that were internalised are 
located in vesicular structures. The comparatively poor uptake of the 15 nm GNPs may 
be due to differences in serum protein adsorption depending on NP size but 
investigation as to the possible reasons why the proteins preferentially bound to the 
smaller GNP size is required. There is currently insufficient information to draw 
conclusions about this, but some initial ideas include the possibility of a bad batch of 15 
nm NPs with problems with the surface coating.  
The effect of GNP size on cellular removal of GNPs (exocytosis) must also be 
considered. Literature proposes that the rate of exocytosis decreases linearly with 
increasing GNP size; the rate of exocytosis of 14 nm GNPs was found to be five times 
higher than 100 nm GNPs [76]. Our result also appears to conflict with this postulation, 
in that there were more 1.9 nm NPs present in the cell than 15 nm. However, it appears 
that the reason there are so little 15 nm GNPs present in the cells is due to ineffective 
cellular uptake (endocytosis) of 15 nm NPs rather than an increased rate of exocytosis. 
This can be inferred since exocytosis was not observed over similar timescales and 
conditions in a case which should be more likely (i.e. during 1.9 nm NP incubation).   
Referring to the incubation time study reported in Section 3.6, we can infer that 
the marked difference in uptake between 15 nm and 1.9 nm GNPs is not due to the 
difference in incubation time (48 hours and 24 hours respectively for these 
experiments); there was an increase and not decrease in uptake between 24 and 48 hours 
incubation (refer to Figure 49). However, this was tested for 1.9 nm GNPs and may be 
different for 15 nm GNPs; further investigation is required if future work requires the 
use of 15 nm GNPs.      
The final possible reason for the result may be explained by the health of the 
cells in the 2D culture; the cells in the TEM images of the 1.9 nm GNP study appear 
healthier than those exposed to 15 nm GNPs. The latter showed particularly distended 
mitochondria (Figures 43 and 45), indicating that the cells are undergoing the first steps 
of necrosis [103]. Mitochondria were correctly identified through the presence of double 
membrane features characteristic to these structures. The 15 nm and 1.9 nm studies 
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were performed on different days. It may be possible that the cells involved in the 15 
nm GNP study were not healthy, and under sub-optimum incubation conditions which 
affected their ability to take up GNPs. Another alternative explanation is that the 15 nm 
GNPs may have been cytotoxic to both cell lines and induced poor health in the cells. 
This postulation is contradicted by literature which reports that GNPs 15 nm in size 
were found to be non-toxic up to 60-fold higher concentrations than 1.4 nm GNPs [88]; 
refer to Section 3.3.1.6 for further discussion. Cells were incubated with the 15 nm 
GNPs for double the incubation time than with 1.9 nm GNPs; this may have increased 
cytoxicity as they were exposed to NPs for a longer period of time. It was recommended 
in Section 3.6 that 24 hours rather than 48 hours is sufficient to achieve GNP uptake 
without obvious signs of cytotoxicity.     
Further investigation is necessary to establish the difference in uptake between 
the two GNP sizes. There is insufficient information in the literature to enable a full 
explanation of the results of this study. However, within the scope of this project the 
conclusion was that 1.9 nm GNPs were to be used for producing the cellular phantoms 
as they had proved to be readily taken up by cells. 
 
3.6 Selection of GNP incubation time 
3.6.1 Aim of investigation 
The aim of this study is to determine an appropriate GNP incubation time that 
achieves sufficient GNP uptake without impacting on cell health. The findings of this 
study will be fed into the cellular phantom making procedure. GNP incubation times 
quoted in the literature range from six hours [77] to 48 hours [88], and a recommended 
time was not reported in the literature for the cell lines and NP size used in our study.  
3.6.2 Method 
Samples were prepared as outlined in Section 3.4. Five flasks were plated with 1 
M HT29 cells. On reaching 70% confluence the cells were incubated with 4 ml GNP-
medium suspension at a concentration of 2 mgAu/ml over a period of 4, 10, 24 and 48 
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hours (covering the time intervals mentioned in the literature). A control flask did not 
receive GNPs. The samples were fixed according to the above protocol (Section 3.4.8), 
and TEM images obtained according to the protocol outlined in Section 3.4.9. 
3.6.3 Results 
TEM images of samples incubated with GNPs over 4, 10, 24 and 48 hours were 
taken. The resulting images are displayed in Figure 49. 
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Figure 49 TEM images of HT29 cells exposed to 1.9 nm GNPs over a range of incubation times: (a) 4 h, 
(b) 10 h, (c) 24 h and (d) 48 h. Magnifications of 7100 x and 53000 x were used for the cell (right) and 
endosome (left) images respectively. Two cell images of the 48 h incubation time are displayed to 
illustrate the wider variation in the number of GNP-containing endosomes per cell. 
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3.6.4 Discussion 
The NP uptake appeared to increase with incubation time as displayed in Figure 
49. This is in agreement with the literature [78]. There was no great difference in the 
number of vesicles containing GNPs for the 4 and 10 hour incubation time sample, but 
an increase in GNP internalisation is seen at 24 hours incubation. The 48 hour 
incubation time sample displays the greatest number of GNP-filled endosomes inside 
one cell. However, it was decided that 24 hours was an appropriate incubation time to 
use for the biological phantom making technique because the cells in the 2D culture 
looked stressed and became over confluent at 48 hours and started to detach from the 
culture plastic.       
Typical HT29 cell diameters were measured to be ~ 10 μm but each TEM image 
in Figure 49 is of a tissue section ~ 100 nm thick, and so each TEM section only 
represents a small portion of the cell that can be from anywhere across the cell. 
Therefore TEM images can only give a qualitative comparison of GNP uptake at 
different incubation times unless hundreds of sections are analysed. The 48 hour TEM 
images present two different cell sections: one that contains a high amount of cytoplasm 
(left hand side image), and the other that contains less cytoplasm and more nucleus 
(central image). The images show a factor of two increase in densely filled lysosomes 
present in moving from 24 hours to 48 hours incubation, but there is also twice the area 
of cytoplasm in the 48 hour image and so a firm conclusion cannot be made. However, 
the 10 hour and 24 hour TEMs have a more similar area of cytoplasm, and so a better 
comparison can be made with the number of densely filled lysosomes doubling between 
10 and 24 hours incubation.     
The cells present in Figure 49 appear to be undergoing necrosis, characterised by 
the breaking up of membranes and degradation of cytoplasm and nuclear material. 
Necrosis occurs rapidly in response to sudden stress of the cell, and results in the 
rupturing of cellular membranes and release of the cell contents to extracellular space. 
The gel preparation for this batch of cells may explain the poor state of the cells. Cell 
death can be induced by cells being present in a sub-optimum pH. The production of the 
gels involves a pH neutralisation process, and the gels can successfully set over a pH 
range of 7 – 7.7 [104]. However, cells require a pH of 7.3 – 7.4. The under- or over-
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neutralisation of the gel may have provoked cell death. Apoptosis on the other hand is 
slower acting; cells undergo a pre-programmed sequence of events, resulting in 
fragmentation of nuclei and cytoplasmic organelles into small apoptotic bodies that can 
be cleared by phagocytes. Membrane blebbing and vesicle formation is typical of 
apoptosis [88]. Figure 49 displays more signs of necrosis than apoptosis. However, the 
conclusion that there was uptake of GNPs can still be drawn, and it is evident that the 
amount of uptake is incubation time dependent.      
As in the previous study, and in agreement with the literature, the TEM images 
show that the GNPs are all localised inside vesicles within the cell cytoplasm. This once 
again provides evidence for the uptake mechanism of endocytosis, suggesting that the 
cells were behaving as normal at the incubation stage of the experiment.  
Further work could investigate the time taken to internalise and externalise 
GNPs for each cell line and GNP size / coating (this level of detail was not necessary to 
meet the aims of this study). Literature reports that 50 nm GNPs reside in lysosomes in 
cells within 40 minutes of incubation [93]; this should be slower for smaller NPs as the 
rate of uptake is less. The time of uptake should also vary with protein coating and cell 
type, as discussed in Section 3.3.1. Chitrani showed that once deposited inside vesicles, 
the vesicles diffuse through the cytoplasm at a speed of 10.2 ± 1.8 µm/hr [93]. 
Chitrani‘s group reported that nanovesicles were found to move toward the cell interior, 
followed by upward motion toward the cell periphery. The cytoplasm is a densely 
entangled network of actin bundles interpenetrated by a fluid phase that is crowded with 
globular macromolecules; the cytoplasm components differ between cell lines, and so 
the speed of nanovesicles is cell-type dependent [93].  
The results of this study were fed into the cellular phantom making procedure, 
and an incubation time of 24 hours was used at the GNP incubation stage. 
3.7 GNP dose uptake measurement 
3.7.1 Aim of investigation 
The aim of this study was to establish a technique to attain a known GNP uptake 
in the cell lines used by altering the incubation GNP dose. The phantoms created were 
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used to demonstrate the ability of the XRF system in quantifying GNP concentration in 
the bio-phantoms. XRF measurement of GNP concentration may be used to infer typical 
numbers of NPs per cell in order to assess the potential of the technique in meeting the 
clinical aims outlined in Section 1.2. TEM images of each sample were also made to 
demonstrate GNP uptake to corroborate with XRF measurement. The results of this 
study will be used to create ACMs with known concentrations of GNP inclusions in the 
different phantom components. Cells were incubated with a range of GNP 
concentrations, and measurements of the internalised GNP concentration performed 
using (i) the developed XRF technique, and (ii) TEM analysis.   
3.7.2 Production of samples 
1 M cells were seeded of each cell line: five flasks each of HT29 cells and 3T3 
cells. Once 70% confluent, the cells were incubated with 4 ml of GNP concentrations 
ranging from 0.5 – 4 mgAu/ml to investigate the effect of initial incubation GNP 
concentration on cellular GNP uptake. The GNP incubation time was selected to be 24 
hours; this was found to be an appropriate time interval (refer to Section 3.6). The 
number of cells embedded into the collagen gel is displayed in Table 12. 
Table 12 Number of HT29 and 3T3 cells embedded into collagen scaffold for each sample. 
3T3 cells HT29 cells 
Initial GNP 
concentration 
(mgAu/ml) 
No. cells in sample 
(million) 
Initial GNP 
concentration 
(mgAu/ml) 
No. cells in sample 
(million) 
4 3.30 ±  0.33 4 3.90±  0.39 
2 1.50 ±  0.15 4A 2.73±  0.27 
1 4.95 ±  0.50 2 4.20±  0.42 
0.5 3.06 ±  0.31 1 5.25±  0.53 
0 (Control) 1.05 ±  0.11 0 (Control) 3.10±  0.31 
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No relationship was evident between the number of cells counted in each flask 
and GNP dose. A variation in cell growth between different flasks is expected (even 
when seeded and incubated concurrently). Variation in the number of cells in each flask 
can be attributed to the following factors: 
 Conditions within the multiuser incubator may be non-uniform: e.g. CO2 
and H2O droplets may not circulate equally to all flasks, and there may 
be temperature gradients within the incubator. Flasks were stacked on 
top of each other for this set of experiments, which may further increase 
non-uniformity of conditions.  It is recommended to place flasks side by 
side to reduce this effect. This is thought to be the most significant effect 
on cell number variation. 
 A tilted incubator shelf results in a non-uniform coverage of the cells by 
growth medium. This may result in preferential cell death at the edges of 
the flasks. This effect is heightened as only 4 ml medium covered the 
cells.  
 Pipetting errors in the seeding phase. 
Once fixed, the GNP concentration of each sample was measured using the 
novel XRF analysis technique of Chapter 2. 
3.7.3 X-ray fluorescence analysis of samples 
3.7.3.1 Purpose of XRF measurement 
The ability of the bench-top L-XRF system (described in Section 2.4) in 
measuring GNP concentration within bio-phantoms was assessed in order to determine 
the system‘s potential in sample analysis in future work, and also to assess the system‘s 
role for in vivo use. Quantitative XRF measurement of GNP concentration will be used 
to determine cellular uptake of GNPs, required to inform the manufacture of ACMs 
with components of known GNP concentration.   
Chapter Two demonstrated that L-XRF techniques can be used to quantify GNP 
concentration down to a detection limit of 0.005 mgAu/ml. A great advantage of the 
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XRF technique in measuring GNP concentration is that the sample does not have to be 
destroyed, and so further analysis using other techniques such as TEM may be 
performed. Also, as XRF measurement does not destroy the sample, there is future 
potential in performing real-time monitoring of NP motion through biological 
phantoms. 
A technique widely used in the literature to measure NP concentration is 
inductively coupled plasma atomic emission spectroscopy (ICP-AES). ICP-AES digests 
the cell pellet in nitric acid at 110 °C to perform the analysis, and so the cells cannot be 
further analysed [77]. XRF provides a much better alternative with potential to measure 
live 3D cultures. 
3.7.3.2 Method 
A bench-top molybdenum x-ray source operating at 50 kV and 1 mA was used 
to induce XRF in the GNPs, with a beam size of 3.7 mm (horizontal) x 2.1 mm 
(vertical). An iterative improvement was made to decrease the detection limit of the 
system by adding a 20 μm molybdenum filter. This acted to filter out lower energy 
components of the incident spectra which would not contribute to XRF of gold, but 
would increase the background beneath the XRF signal. The filter thickness was a 
compromise between minimising the unwanted background beneath the XRF peaks and 
attaining a high enough incident x-ray intensity. This modification led to an 
improvement in the sensitivity of the system to lower concentrations, with a minimum 
detection limit of 0.001 mgAu/ml now being detectable (a factor of five lower than the 
previous system). 
3.7.3.3  Assessment of optimum filter thickness 
A range of filter thicknesses were tested to see the effect on the emitted x-ray 
spectrum. Results are displayed in Figure 50. 
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Figure 50 X-ray spectra measured in L-XRF mode of a 0.04 mgAu/ml calibration sample using a range of 
molybdenum filter thicknesses (0, 20, 40 and 70 μm thickness measured over 600 s, 1200 s, 1500 s and 
4000 s respectively). 
 
A 6-order least-squares polynomial fit was made to the background data either 
side of the gold XRF peaks, and the standard deviation of the data points about this fit 
(σfit) was found. The ratio of the height of the gold Lα signal to σfit was used to indicate 
the signal to noise ratio for each filter thickness used. Results are displayed in Table 13. 
Table 13 SNR of a range of molybdenum filter thicknesses of XRF spectra acquired of a 0.04 mgAu/ml 
GNP calibration sample. 
Filter thickness (μm) Signal to noise ratio 
(SNR = Lα peak 
height / σfit ) 
Acquisition time (min) SNR per minute (min
-1
) 
0 2.6 10 0.26 
20 3.8 20 0.19 
40 4.3 25 0.17 
70 7.1 66.7 0.11 
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 The 20 µm molybdenum filter was selected as it provided a good compromise 
between gold XRF signal to noise ratio and attenuation of the incident beam which 
would reduce the rate of XRF.  
3.7.3.4 Results 
A. Measured spectra 
Figure 51 displays spectra obtained using each system for two initial GNP 
concentrations (4 mgAu/ml and the control (0 mgAu/ml)). Typical measurement times 
ranged from 40 minutes for high concentration samples to 400 minutes for the lowest 
concentration.    
 
Figure 51 Measured spectra of 4 mgAu/ml GNP incubation dose sample and 0 mgAu/ml (control sample) 
acquired over 2400 s. 
 
The cell samples that have been incubated with gold present a spectrum with the 
characteristic gold fluorescence lines, compared with the control samples which showed 
no gold presence (Figure 51). 
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B. Calibration curve   
XRF analysis was performed on a range of known GNP concentration solutions 
in order to determine the actual GNP concentration present in the biological phantoms. 
The calibration curve is displayed in Figure 52. 
 
Figure 52 Calibration curve relating scatter-normalised XRF signal to GNP concentration. The XRF 
signal has been normalised to the Compton peak and acquisition time. A weighted linear fit (solid line) 
and boundary levels (dashed lines) are shown. The boundary levels were fit to fully include 100% of the 
data points and their error bars. Measurements were made over a range of known GNP concentration 
solutions. 
 
C. Gold concentration per sample 
XRF measurements were acquired for each sample, and the XRF signal was 
converted to GNP concentration using the calibration curve (Figure 52). The boundary 
levels of the calibration linear fit were used to determine the error on each sample GNP 
concentration measurement (refer to Section 2.6.6 for a description of this), which was 
then added in quadrature to the error in the XRF measurement resulting from statistical 
fluctuations. All gold concentrations were measured to be above the detection limit of 
the system (0.001 mgAu/ml). Figure 53 displays the measured GNP concentration 
found for the 3T3 and HT29 samples. 
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Figure 53 Measured GNP concentrations found in 3T3 and HT29 samples over a range of four and three 
initial incubation doses respectively. A repeat sample of HT29 cells given an initial dose of 4 mgAu/ml 
was made to test repeatability in the sample making process. 
 
An order of magnitude estimate of the number of GNPs taken up per cell has 
been undertaken for the highest measured GNP uptake (the 3T3 sample given an 
incubation dose of 4 mgAu/ml), in the following way: 
 The mass of gold per cell was estimated: A GNP concentration of ~ 0.015 
mgAu/ml was measured for this sample using XRF analysis (Figure 53) in a 
sample that was normalised to 1 million cells per ml. This corresponds to 0.015 
ngAu per cell. 
 The mass of one 1.9 nm GNP was estimated: Each NP was assumed to be a solid 
sphere of gold of calculated volume 4.2 nm
3
. The volume was multiplied by the 
known density of gold (19.32 g/cm
3
) to give an estimated mass of 7 x 10
-11
 ng 
per NP. 
 The XRF signal from the sample incubated with 1 mgAu/ml is measured to be 
four times lower than that incubated at 4 mgAu/ml. Therefore, it can be 
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estimated that the number of NPs per cell for this particular incubation dose is 5 
x 10
7
 NPs per cell. 
This number of NPs per cell is in agreement with literature; one study reports a 
value of NP uptake per cell four orders of magnitude lower (3000 per cell) than the 
estimated value above for HeLa cells given an incubation dose four orders of magnitude 
lower (0.14 µgAu/ml) with 14 nm GNPs [81]. A different NP size, GNP coating 
(stabilised with citric acid in the literature) and different cell line means the results are 
not directly comparable, but indicates that our estimate of number of GNPs per cell is 
sensible. 
In order to determine the minimum number of GNP-filled cells that the 
developed XRF technique is sensitive to, the number of GNP-filled cells corresponding 
to the detection limit (0.001 mgAu/ml) has been estimated in the following way: 
 Assuming we set an incubation dose of 4 mgAu/ml, Figure 53 shows a bulk 
measured concentration of ~ 0.015 mgAu/ml per million cells. Extrapolating 
down to the measured detection limit of 0.001 mgAu/ml indicates that the 
current system is sensitive to ~ 70,000 cells per cm
3
 in a sample that has been 
given the same incubation dose. Based upon the above assumptions this equates 
to a minimum number of detectable NPs 70,000 cells x 2 x 10
8
 NPs which is 1.4 
x 10
13
 NPs per cm
3
. 
3.7.4 TEM analysis of samples  
The group of HT29 samples were measured using TEM analysis; resulting 
images can be found in Figure 54. 
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Figure 54 TEM images of HT29 cells incubated with three different GNP doses: (a) 4 mgAu/ml, (b) 2 
mgAu/ml, (c) 1 mgAu/ml. An image (d) is displayed of 3T3 cells incubated with 2 mgAu/ml as a 
comparison to (b). 
 
It can be seen that the GNPs have been internalised into the cells and are 
contained within vesicles (lysosomes) located in the cell cytoplasm.  
The number of nanoparticle-containing vesicles was found to increase with GNP 
incubation dose in the cell sections displayed in Figure 54. The visible density of GNPs 
per vesicle was also found to increase between GNP incubation doses 2 and 4 mgAu/ml, 
with no great difference found between 1 and 2 mgAu/ml (Figure 55). It was also found 
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that the density of GNPs per vesicle varied within one cell as illustrated in Figure 55 
(d). The vesicles were too densely packed to quantify the number of GNPs per vesicle.  
 
Figure 55 TEM images of GNP-filled vesicles within HT29 cells incubated over a range of GNP 
concentrations: (a) 4 mgAu/ml, (b) 2 mgAu/ml and (c) 1 mgAu/ml. Image (d) displays that vesicles within 
one cell are filled at different densities.  
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3.7.5 Discussion 
Figure 53 demonstrates that the measured sample GNP concentrations display a 
positive correlation with incubation GNP dose for both cells lines, as expected. The 
XRF signal from the sample incubated with 1 mgAu/ml is measured to be four times 
lower than that incubated at 4 mgAu/ml. This is supported by the TEM images in Figure 
54, which shows an increase in GNP presence within cells with incubation dose (and an 
increase in the number of GNP-filled lysosomes). This result is in agreement with the 
literature; a study that exposed HeLa cells with GNRs over a range of incubation doses 
found a positive correlation of uptake with incubation dose [77]. Our study showed no 
saturation (i.e. no further increase in GNP uptake once a certain number of GNPs per 
cell were reached) at the incubation GNP concentrations tested. Saturation of cell 
uptake is reported in the literature; HeLa cells were found to take a maximum number 
of 3000 citrate-stabilised 14 nm GNPs per cell, corresponding to an incubation dose of 
0.14 µgAu/ml [81].   
Both of the repeat HT29 samples of incubation dose 4 mgAu/ml gave the same 
final GNP concentration within measurement error, demonstrating the repeatability of 
the sample making process. 
The percentage uptake of initial incubation GNP dose per million cells was 
found to range between 0.3 – 0.5% and 0.1 – 0.3% for the 3T3 and HT29 cell samples 
respectively. The efficiency of uptake could be improved in the future by actively 
targeting the cells using a protein coating on the cell that is more likely to selectively 
interact with the cell membrane. It has been reported that GNPs stabilised by citric acid 
ligands had three times the cell uptake than transferrin coated GNPs (transferrin is one 
of the many proteins in serum) [81]. Serum proteins contain a diverse set of proteins, 
and so the surface of the citrate-stabilised GNPs may contain a variety of serum proteins 
on its surface (including α- and β-globulin known to be taken up by cells). The diversity 
of the proteins will enable entrance into cells via multiple receptors as compared with 
transferrin which only has two corresponding receptors [81]. It should be noted that the 
rate of uptake may also depend on the number of available proteins present in the 
DMEM and serum not absorbed onto the GNPs; these unbound proteins can compete 
for receptor sites on the cell membrane. It is the aim of future work to identify an 
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antigen that is expressed by the HT29 cells that can be used to inform the choice of 
protein coating/conjugated antibody on the GNPs. We also aim to look at GNP size in 
greater detail in future work to optimise the efficiency of uptake.   
3T3 cells showed a marginally greater uptake of GNPs than HT29 cells in this 
study. The dependence of cell type on GNP uptake is little understood in the literature, 
and further investigation in the field is required. NP uptake through RME occurs when a 
NP-ligand binds onto a receptor on the cell‘s surface and enters the cell when the 
membrane invaginates. Cells have a maximum receptor density dependent on cell type 
for a specific protein (the number of receptors per cell surface area), and available 
receptors determine whether the NP enters the cell via RME. However, it is understood 
in the literature that the receptor recycles itself back to the membrane after releasing the 
ligand into the cell, and so it is not a straight forward relationship between number of 
receptor sites and GNP uptake [81]. However, for the aims of this project in using GNPs 
to target cancer in vivo, it can be inferred that tumour masses in vivo will passively take 
up a greater amount than healthy tissues/cells. This is due to a combination of leaky 
vasculature and poor lymphatic drainage around tumour sites, an effect referred to as 
EPR (a concept introduced in Section 1.5.1). Results presented in the literature show 
enhanced uptake by tumour cells than healthy cells due to this effect [24]. Preferential 
tumour uptake can be further improved through functionalising the NPs with ligands 
that are actively taken up by proteins present on tumour cell membranes. This will 
enhance GNP uptake by increasing the probability of a GNP – cell membrane 
interaction, resulting in membrane wrapping and endocytosis of the GNP into the cell.     
We have demonstrated that the bench-top L-XRF technique developed in 
Chapter Two can be used to measure GNP uptake in cellular phantoms. The XRF 
technique was used to perform an order of magnitude estimate of the number of GNPs 
per cell (at the highest given GNP dose of 4 mgAu/ml); it is estimated that ~ 5 x 10
7
 
GNPs are present per cell. It was found that the detection limit of the system (0.001 
mgAu/ml) is capable of measuring ~ 1.4 x 10
13
 GNPs per cm
3
, i.e. 70,000 cells in a 1 
cm
3
 volume (of cells incubated with a dose of 4 mgAu/ml). The amount of uptake can 
be increased through active targeting of the GNPs, and so the system could be sensitive 
to even less than this cell density.     
3. Development of tissue engineered bio-samples 
 
161 
 
3.8 Conclusions 
An XRF system capable of quantitative measurement of GNPs has been 
developed and tested on GNP-water samples in Chapter Two. The aim of the sample 
development in this chapter was to produce a range of biological phantoms with GNP 
inclusions at concentrations that represented the clinical situation in order to 
demonstrate the XRF measurement technique in a more realistic case. Production of the 
phantoms involved two stages: (i) effecting GNP uptake in cells, and (ii) embedding the 
cells in a 3D scaffold. The former stage was successfully achieved; it was found that 
using 1.9 nm GNPs and an incubation time of 24 hours gave sufficient GNP uptake. It is 
thought that GNP uptake was facilitated by protein adsorption onto the GNP surface of 
proteins found in the growth medium. TEM analysis confirmed that GNP uptake was 
achieved in both cell lines, through the mechanism of endocytosis. A second size GNP 
of nominal size 15 nm was found to be taken up much less readily by cells. The toxicity 
of 15 nm GNPs was brought into question and a further study to measure the toxic 
effects of the 15 nm GNP is required. The latter stage built on previous work in 3D cell 
culture that provides a technique to embed cells uniformly in a collagen type I matrix 
[73]. The 3D phantoms were successfully made according to the design criteria outlined 
in Section 3.4.2 in order to ensure that the XRF technique could be used as a tool for 
GNP uptake measurement. In summary: 
 Samples contained a GNP concentration above the minimum detection 
limit of the XRF system (> 0.001 mgAu/ml) 
 Cells were thoroughly mixed into the collagen gel to give a uniform 
distribution of cells 
 A thin sample holder was used to minimise x-ray signal loss and reduce 
scatter from the holder 
It was found that GNP uptake increases with incubation dose. Attaining a known 
GNP uptake was shown to be repeatable within measurement error. The XRF technique 
(a technique that doesn‘t destroy samples) successfully measured GNP concentration in 
the cellular samples; concentration measurement could be used to determine the 
efficiency of uptake. The percentage uptake of initial incubation GNP dose per million 
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cells was found to range between 0.3 – 0.5% and 0.1 – 0.3% for the 3T3 and HT29 cell 
samples respectively. TEM images qualitatively corroborated the XRF technique‘s 
findings that uptake was proportional to initial GNP dose. The passive GNP uptake 
demonstrated here may be extended through functionalisation to meet the overall 
eventual aim of this project in using GNPs as a contrast agent to image the distribution 
of bio-parameters of a tumour. The measured uptake efficiency could be increased in 
the future by coating the GNPs in a protein taken up by the specific target cells. In an in 
vivo situation tumour cells will take up more GNPs than healthy cells due to leaky 
tumour vasculature and poor lymphatic drainage at tumour sites. It was estimated that a 
4 mgAu/ml incubation dose resulted in ~ 5 x 10
7
 GNPs taken up per 3T3 cell. It was 
also estimated that the measured detection limit of the XRF system (0.001 mgAu/ml) 
enables ~ 1.4 x 10
13
 GNPs to be detected per cm
3
. The number of cells that this 
corresponds to is dependent on incubation dose, and other factors that affect NP uptake 
such as surface properties and size of GNPs.  
  A set of artificial cancer mass phantoms were successfully constructed, 
building on the work previously undertaken [99]. This work was extended to produce a 
set of novel phantoms with GNP inclusions for XRF imaging. A new batch of 3D 
artificial cancer mass samples will be made in 2012. Our previous studies demonstrate 
that we have developed a GNP uptake procedure whereby cells were proven to take up 
known concentrations of 1.9 nm GNPs. We will use 1.9 nm GNPs at the cell incubation 
stage instead of 15 nm GNPs, and so we can infer that will be able to successfully 
produce the ACM phantoms with no issue. A repeat set of XRF imaging experiments 
are due to take place shortly at the Diamond synchrotron source, Oxford, with results to 
be published in 2012. 
The 3D cellular phantoms with GNP inclusions are planned to be used in future 
work investigating the dose enhancement effect of GNPs. Radiobiological studies will 
be performed on GNP-filled cells to determine the extent of the dose enhancement 
effect. 
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Chapter Four 
 
4 Towards a real system 
Chapter Two has demonstrated the sensitivity of XRF techniques in quantitative 
measurement of GNP concentration. Spectroscopic measurements were found to show a 
linear behaviour down to the lowest measured concentration of 0.001 mgAu/ml. 
Chapter Three has shown that cell uptake of GNPs can also be measured and quantified 
by XRF techniques. This Chapter presents a feasibility study looking at key aspects 
towards a real imaging system. The XRF spectrometer has been developed with the 
ability to be coupled to mechanical collimators or polycapillary lenses in order to form 
pixellated images. The scope of this work was to demonstrate the feasibility of 
performing energy resolved imaging of GNP distribution at concentrations relevant for 
in vivo and in vitro studies. Preliminary XRF images of GNP concentration will be 
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presented. The scope of this chapter is also to assess the feasibility of a proposed 
combined system that can measure both XRF and XRD signals. Some key design 
elements of a novel combined XRF/XRD technique have been investigated to inform 
future development of the multi-modality system. A series of diffraction measurements 
have been performed to assist in assessing the feasibility of the combined technique in 
tissue discrimination. The diffraction measurements presented in this chapter act as 
exploratory work, and are not the main focus of the project. 
4.1 Requirements for biomarker imaging 
Chapter One introduced the idea that GNPs may be used as a contrast agent to 
identify tumours and attached to antibodies to provide information about tumour 
characteristics, particularly radiosensitivity for radiotherapy applications. The case 
study of hypoxia was presented in Section 1.1.2 as a potential use of GNP measurement. 
Section 1.5.1 introduced the clinical need for imaging GNP distribution, particularly for 
GNPs located (i) in vivo, and (ii) in ex vivo samples or in vitro research samples. The 
key imaging requirements are outlined for each potential use, in order to inform the 
design of a GNP imaging system.     
4.1.1 Sensitivity to NP concentration 
Chapter 2 demonstrated that the L-XRF spectroscopic systems were more 
sensitive to measurement of GNP concentration than the K-XRF system, and could 
achieve sensitivity in quantitative measurement down to the detection limit of 0.005 
mgAu/ml. Further improvements made to the bench-top XRF system in Chapter 3 
(through the use of a molybdenum filter) showed that the system can be sensitive to 
even lower GNP concentrations (0.001 mgAu/ml).  
When translating the 1D spectroscopic system to a 2D or 3D imaging system, 
the GNP concentration inside each pixel must be considered, as does the partial volume 
effect (discussed in Section 4.1.3). The measurement time must be increased to 
compensate for a decrease in measurement volume (i.e. when forming a pixellated 
image). Higher intensity sources can be used to minimise acquisition times, and 
focussing polycapillary optics may be implemented to focus x-rays to a point on the 
sample.    
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4.1.2 Spatial resolution 
The spatial resolution requirements depend upon the application of the imaging 
system. Radiotherapy techniques clinically treat to within 1 mm of the defined treatment 
volume; therefore an imaging system that can image to at least this resolution is 
required. The margins of treatment volumes are extended beyond the visible tumour in 
order to incorporate sub-clinical disease. As already mentioned in Chapter One, small 
clusters of proliferating cancer cells on the periphery of the bulk tumour mass are not 
easily imaged using current techniques. A technique that is sensitive to the presence of 
such small clusters of cells would have a great impact on treatment volume delineation. 
The partial volume effect in imaging modalities has an impact on achievable spatial 
resolution; refer to Section 4.1.3 for a further discussion of this.     
The demands of imaging research samples are different, as the technique will be 
used to provide maps of different tumour characteristics. Hypoxia is an example tumour 
characteristic that will be mapped. An example of the distribution of hypoxic cells 
found in a sample is displayed in Figure 56. The image is of a slice of tissue taken from 
a hypoxic mouse model, and was produced using optical fluorescence imaging 
techniques (with hypoxia tracer pimonidazole shown in green) that can view details on 
the level of ~10 μm. Being an optical fluorescence technique, the sample had to be 
sufficiently thin to allow transmission of the optical signals. 
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Figure 56 An optical fluorescence image of murine carcinoma, labeled with hypoxia marker 
pimonidazole (green), acquired by Dr A Ammar, UCL Cancer Institute. The red indicates functioning 
blood vessels, and blue indicates oxygenated cells. 
 
Figure 56 shows that typical regions over which tumour characteristics change 
are of the order of 100 – 200 µm in size. A useful GNP imaging system would be able 
to image sample regions at this size scale.  
4.1.3 Partial volume effect 
The partial volume effect occurs when a single voxel contains a mixture of 
different tissue types. For example, if a group of GNP-filled cells take up 50% of the 
voxel volume, then the apparent GNP concentration measured in that voxel will by half 
of what is actually present in the cells, and the apparent tissue volume will appear more 
than the actual cell cluster size. This is illustrated in Figure 57. 
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Figure 57 Illustration of the partial volume effect  
 
The partial volume effect is decreased when the voxel size is decreased, as the tissue is 
better resolved. Therefore this effect will be greater for radiotherapy applications than 
for research sample measurement, the latter technique requiring a better spatial 
resolution. 
 
4.2 Development of nanoparticle imaging phantoms 
A range of GNP imaging phantoms were designed to test the performance of 
different XRF imaging systems.  
4.2.1 Sensitivity 
It is important to be able to test the ability of the XRF imaging system to 
quantitatively measure GNP concentration. A phantom was designed, composed of a 
series of holes of diameter 9 mm drilled into a Perspex block of thickness 10 mm. The 
distance of the hole periphery from the x-ray entrance side is 1 mm (Figure 58). 
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Figure 58 Sensitivity phantom consisting of 9 mm holes drilled into a 10 mm thick Perspex slab. The 
holes can be filled with GNP solutions of varying concentrations. 
 
Each hole can be filled with a different GNP concentration, and a profile scan 
taken across to assess the XRF measurement technique. Two methods of filling the 
holes were attempted: 
a) Suspending the GNPs in a low temperature agar gel (Agarose A2576, 
Sigma Aldrich, Dorset UK). This was considered to enable the sample to 
be more easily transportable, and to see if the agar gel suffered less from 
evaporation over time, as longer measurement times were envisaged for 
imaging mode. The procedure involved dissolving agar crystals in water 
at 80°C. The required GNP concentration was added and thoroughly 
mixed in the solute. A fine needle syringe was used to transfer the liquid 
agar solution into the phantom, taking care not to form air bubbles. The 
filled phantom was refrigerated at 5°C and left to set for 1 hour. 
b) Filling the holes with GNPs suspended in DIW. This technique involved 
the same preparation as in Section 2.2. The filling process was carefully 
achieved using a fine needle syringe to smoothly fill the hole without 
creating air bubbles. 
The agar gel technique was not successful, and the gel volume was found to shrink over 
the measurement time. This affected the XRF measurement too much and so it was 
decided to use the water-suspension technique, with the sample resting on a cooling 
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plate to minimise evaporation. No evaporation was noticed throughout the course of 
measurement. 
4.2.2 Contrast resolution 
A phantom was designed in order to assess the ability of the XRF imaging 
system to resolve different GNP concentrations. A donut configuration was selected, 
enabling one GNP concentration to be surrounded by a GNP solution of different 
concentration. The phantom consisted of a series of 9 mm holes drilled into a 10 mm 
thick Perspex slab; an inner hole of diameter 5mm was drilled in the centre of the 9 mm 
hole to contain a straw of 5 mm diameter. This straw acted as a barrier between the two 
GNP concentration solutions.  
 
Figure 59 Contrast phantom; 9 mm hole including a straw located centrally to provide a barrier between 
two different GNP concentration solutions. 
 
The difference in the concentration can be made large (high contrast phantom) 
or small (low contrast phantom). The outer concentration was selected to be lower than 
the inner concentration in each case to mimic the in vivo situation of greater uptake in 
the tumour with lower uptake in surrounding tissues.  
In order to test the performance of the XRF imaging technique the literature was 
searched for typical GNP concentrations found in tumours and the tumour stroma, and 
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the phantoms constructed in order to mimic the reported GNP concentrations. The 
typical GNP concentrations taken found from a mouse study investigating GNP uptake 
[24] are displayed in Section 1.5.1 (Table 3).  
Figure 60 displays a photograph of the phantom filled with GNP solutions. 
 
Figure 60 High contrast phantom filled with GNP solutions 4 mgAu/ml (central) and 0.2 mgAu/ml (outer 
ring) 
 
4.3 Imaging system 1: SDD step and scan with mechanical 
collimator 
In order to test the imaging capability of the XRF technique, the synchrotron L-
XRF system characterised in Section 2.3 was used to perform a 1D profile scan of the 
sensitivity phantom. Measurements were made at the B16 beamline at the Diamond 
synchrotron source, Didcot, UK. A profile scan was thought sufficient as a first 
indicator of the usefulness of the imaging system.  
4.3.1 Experimental arrangement 
Figure 61 displays the sample and detector arrangement, and illustrates the 
spatial coordinates used in this section. 
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Figure 61 Experimental set-up of scanning imager 
 
A CCD camera behind the sample was used to monitor the beam-sample 
alignment and make conventional transmission images. An ionization chamber was 
used to monitor beam intensity. 
4.3.2 X-ray source 
The synchrotron source was set to 15 keV with a beam size of 0.8 mm (x) x 4 
mm (y) with 1 mm aluminium filtration in the beam. The aluminium filtration acted to 
reduce the intensity of the beam to levels that the SDD can operate at without count rate 
problems. 
4.3.3 Nanoparticle phantom 
The sensitivity phantom was filled with GNP solutions of concentrations 0.016, 
0.1, 0.5, 2 and 8 mgAu/ml.  
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4.3.4 X-ray detector 
The SDD detection module (first introduced in Chapter 2) was mounted with a 
90° geometry in order to minimize the Compton background, and positioned on the z-
axis in line with the centre of the GNP inclusions of the phantom. The SDD was 
operated at a shaping time constant of 1 s for the whole measurement for reasons 
explained in Section 2.3.3. 
4.3.5 Collimation 
The mechanical collimator described in Section 2.3.4 was attached to the SDD 
for reasons outlined in Section 2.3.4.  
4.3.6 Measurement volume 
The voxel size of each profile scan measurement is defined by the beam size in 
the x- and y-direction (0.8 mm x 4 mm), and the sample thickness in the z-direction (10 
mm). Refer to Figure 61 for spatial coordinate definitions. The detector-sample distance 
was sufficiently great that the detection solid angle covered the whole sample in the z-
direction. The voxel size in the x-direction, being set by the 0.8 mm beam width, was 
not affected by the detector collimator hole size; this meant that a mechanical collimator 
could be used instead of an optic, in order to increase the count rate of the gold XRF 
signal.      
4.3.7 Imaging procedure 
The GNP-filled hole was automatically scanned at a 1 mm step interval in the x-
direction, setting the resolution of the profile scan, and the energy spectrum was 
acquired at each point with a measurement time of 60 s per point for the highest two 
concentrations, and 120 s per point for the remaining concentrations. The sample scan 
procedure is illustrated in Figure 62. 
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Figure 62 Illustration of 1D profile scan procedure. A represents the chord of the circle of 9 mm 
diameter, representing the GNP inclusion.  
    
4.3.8 Results of 1D scan of sensitivity phantom 
Figure 63 shows the recorded spectra as a function of the x-scanning coordinate 
for the 8 mgAu/ml hole. The attenuation of the elastic and Compton scattering peaks in 
the hole region and the build up of the gold XRF lines is clearly visible.  
 
Figure 63 Recorded spectra as a function of the x-scanning coordinate in the case of the highest probed 
concentration hole (8 mgAu/ml). The attenuation of the coherent and Compton scattering peaks in the 
hole region and the build-up of the gold fluorescence lines is clearly visible. 
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The integral of the counts under the gold Land Lpeaks were plotted against 
the scan coordinate. Normalising to the beam intensity was not necessary as the beam 
was found to be stable to within 1% during all measurements.  
The experimental data points were fitted according to Equation 13, derived to 
describe the fluorescence yield (FY) as being proportional to the chord length of the 
GNP inclusion circle (found by a simple application of Pythagoras‘ theorem), expressed 
as a function of the scanning coordinate xsample: 
    222)( osample xxRkxFY      Equation 13 
where R is the hole radius, x0 is the centre of the hole and k is the constant of 
proportionality representing the fluorescence yield in the given solid angle. Figure 64 
displays the gold XRF signal plotted against scan coordinate. The purple line shows the 
best fit of the experimental data according to Equation 13. 
 
Figure 64 Gold XRF signal vs. scan coordinate. The GNP concentration is indicated over each hole. The 
purple line shows the best fit of the experimental data according to Equation 13. 
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The 0.015 mgAu/ml detail is not plotted, as the system was not sensitive to its 
presence over the measurement time of 120 s.  
4.3.9 Discussion 
It can be seen that the measured XRF signal was found to be proportional to the 
chord length of the GNP inclusion at each xsample position, with Equation 13 found to 
describe the measured data (Figure 64). The width of the holes was measured to be 9 
mm, in agreement with the phantom geometry.  
Chapter Two has already demonstrated the ability of the synchrotron L-XRF 
technique used here in quantitative measurement of GNP concentration. The ability to 
quantify GNP concentration is equally applicable in this profile scan study, but has not 
been reported in this case because the purpose of this study was to demonstrate imaging 
feasibility of the technique. This aim has been met, as discussed in the previous 
paragraph. In order for the profile scan measurement performed here to give 
quantitative information on GNP concentration, a more full analysis would be required, 
including attenuation corrections and treatment of the partial volume effect. Analysis of 
the relative heights of the measured XRF signals for each concentration was not 
performed, and quantitative information about GNP concentration cannot be directly 
found at present as the system was not calibrated for absolute concentration 
measurement.  
This series of measurements indicate that the XRF technique is able to perform 
1D profile scans of GNP distribution. This result was then translated to a 2D imaging 
technique to assess the role of the XRF system in acquiring 2D images. 
 
4.4 Imaging system 2: SDD step and scan with a focussing 
polycapillary optic 
2D images of two contrast phantom details were performed using the same set 
up as in the previous system, replacing the mechanical collimator with a focussing 
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polycapillary optic.  The optic enables smaller voxel sizes in both the x and z directions 
than when using a mechanical collimator.  
4.4.1 Translating from a mechanical collimator to focussing 
polycapillary optic 
Focussing polycapillary optics are generally used to capture x-rays emitted from 
a source and focus them to a small spot area to increase the intensity over small areas of 
a sample to enable high intensity XRF measurement. Focussing optics are designed to 
have gently bending hollow capillaries of curvature smaller than the critical angle that 
propagate x-rays through them to focus them to a point. According to the physics of x-
ray optics smaller focal spot sizes are expected with increasing x-ray energy [47]. 
The XRF imaging system described here has utilised a focussing polycapillary 
optic to collect the x-rays emitted from the sample after XRF excitement, and to 
transport the collected x-rays to the detector chip. The lens enables an increased 
distance between the sample and detector without a decrease in effective collection 
angle of the XRF x-rays. Their use can potentially increase the spatial resolution of the 
image by allowing measurement of small areas of the sample, with particular 
improvements made compared with the mechanical collimator system in the z-direction. 
The lens used in this system was measured to have a nominal focussing spot size of ~ 
300 μm FWHM in the energy range 5 – 10 keV [47]. The mechanical collimator system 
could spatially resolve the sample in one direction (along the x-axis) by an amount 
dictated by the beam width set (0.8 mm), and in the z-direction an amount governed by 
the solid angle of collection (dictated by the sample-detector distance and collimator 
hole size). The focussing lens also enables the detector to focus measurement at a 
specific depth in the sample (along the y-axis) according to the focal point of the lens.        
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4.4.2 Experimental arrangement 
The experimental set-up of the 2D scanning system making use of a focussing 
polycapillary optic is displayed in Figure 65. 
 
Figure 65 Experimental set-up for 2D scanning system. 
4.4.3 X-ray source 
The primary beam was set to 4 mm (x) x 4 mm (y) with no filtration. 
4.4.4 Nanoparticle phantom 
The contrast phantom displayed in Figure 59 was filled with the following GNP 
solution concentrations: (i) high contrast phantom: 4 mgAu/ml (inner) and 0.2 mgAu/ml 
(outer), a factor of 20 different, and (ii) low contrast phantom: 0.125 mgAu/ml (inner) 
and 0.025 mgAu/ml (outer), a factor of five different.  
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4.4.5 Polycapillary x-ray optics 
An 84MLS11 polycapillary optic lens (Institute for Scientific Instruments 
GmbH, Berlin, Germany) was coupled to the SDD for 2D step and scan imaging. The 
lens is slightly focussing, measured to have a nominal focal spot size of ~ 300 μm 
FWHM in the energy range 5 – 10 keV [47].   
 
Figure 66  84MLS11 polycapillary optic lens (Institute for Scientific Instruments GmbH, Berlin, 
Germany) in its vacuum tight case. 
 
The detector is sealed in a custom compact case, vacuum-tight down to 10
-4
 
mbar. The housing is sealed with an 8 μm thick beryllium entrance window [105]. 
 
Figure 67 Designed vacuum tight detection module with the polycapillary lens [105]. 
 
Lens parameters given by the manufacturer are displayed in Table 14: 
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Table 14 Geometrical parameters of the 84MLS11 x-ray polycapillary optic lens [47]. 
Parameter Value 
Capture angle 0.095 rad 
Capillary diameter 30 μm 
Focal distance – sample side 60 mm 
Focal distance – detector side 100 mm 
Lens length 85 mm 
Lens curvature radius 1050 mm 
 
4.4.6 Gold nanoparticle imaging procedure 
The beam, sample and SDD were aligned as follows. A transmission CCD 
image of the sample was used to align the inner high GNP concentration component in 
the beam. The beam size was collimated down to 4 mm x 4 mm to cover the centre of 
the sample. The SDD was then scanned across in the x-direction in 0.5 mm steps; the 
profile of gold XRF counts was plotted, with the centre of the profile corresponding to 
the position of alignment of the SDD with the beam. The SDD scan was repeated in the 
z-direction. At this point, the centre of the sample, the beam and the SDD are aligned. 
The sample was then scanned in both the x- and z- directions with a 600 μm x 600 μm 
pitch to build up a pixellated image. The scanned area was 12 mm x 7.2 mm. An X-Y-Z 
micrometric stage system was responsible for sample movement and remote control 
management by the DAQ enabled automatic X-Y scans. An acquisition time of 40 s per 
point was taken and the full energy spectrum obtained at each point.  
4.4.7 Image reconstruction 
The images were reconstructed by collaborators in Politecnico di Milano, Italy, 
with results published in [105]. The GNP images were reconstructed off-line by 
computing the integral counts under the gold Lα and Lβ peaks. Figure 68 displays 
example energy spectra within the Perspex component of the phantom, and within the 4 
mgAu/ml GNP solution volume. It can be seen that the background was negligible 
beneath the gold peaks, and so no background subtraction was made when integrating 
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the gold peak counts. The tails of the elastic scattering peak and of the Compton 
scattering peaks show an overlap that has been neglected in this analysis.   
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Figure 68 Sample energy spectra collected in two different points of the scan in pure Perspex (top) and 
within the hole filled with 4 mgAu/ml GNP solution (bottom). Coloured lines show the ROIs used for the 
computation of the integral counts- from left to right: gold L line (pink), gold L line (green), Compton 
scattering peak (orange) and elastic scattering peak (blue). 
 
The image reconstruction protocol did not attempt to quantify GNP 
concentration in each pixel, and was undertaken to demonstrate the feasibility of 
forming an image of GNP distribution. GNP concentration sensitivity has previously 
been demonstrated in Chapter Two. This approach provides the same information but 
from a smaller volume. Therefore sensitivity is expected to be lower than reported in 
Chapter Two.  
4.4.8 Results 
Figure 69 displays the 2D pixellated images obtained by plotting the logarithm 
of the gold Lα and Lβ peak ROIs as a function of scan position for the high contrast 
phantom (with and without normalising to the coherent scatter peak), and also the 
scatter normalised low concentration phantom. The primary beam is incident on the 
right side of the images in Figure 69. 
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Figure 69 2D gold XRF images in log scale of GNP contrast phantoms acquired using an SDD coupled 
to a focusing polycapillary optic. (Top left) un-normalized high contrast phantom, (top right) coherent 
scatter normalized high contrast phantom, and (bottom) coherent scatter normalized low concentration 
phantom.   
 
4.4.9 Discussion 
 Figure 69 demonstrates that the developed XRF imaging system can be used to 
image GNP concentrations as low as 0.025 mgAu/ml. Lower concentrations were not 
tested in this study due to restrictions on acquisition time at the synchrotron source. It 
can be inferred from the detection limit measurements in Chapter Two that the system 
will have sensitivity to even lower concentrations. The results also demonstrate that 
GNP concentrations differing by factors of twenty and five can both be distinguished by 
the novel imaging system. This achieves the aim of the project in distinguishing tumour 
cells from surrounding healthy cells; in vivo uptake between the tumour periphery and 
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surrounding tissue are reported to be a factor of 22 and 14 different for functionalised 
and unfunctionalised GNPs (refer to Table 3) [24].     
The crescent shape seen in the right of the left hand image is due to attenuation 
of the primary beam in penetrating the sample. In order to account for beam absorption 
a scatter normalisation technique was implemented (refer to Section 2.7.2 for a 
discussion of why scatter normalisation is effective in correcting for absorption). This 
was achieved in this case by normalising to the image obtained using the integral counts 
of an ROI covering the coherent scatter peak of each spectrum. The image of the 
resulting normalised image in log scale is also displayed in Figure 69, and shows the 
effectiveness in correcting for attenuation effects. 
At this stage, the imaging system does not provide absolute quantitative 
information of GNP concentration. In order to achieve this in future system 
development, the following must be considered: 
 Partial volume effect and correction methods to account for this. 
 The system must be fully calibrated so that the gold XRF signal at a 
known beam thickness and solid angle is known. 
 Further methods of attenuation correction should be investigated. One 
possibility is the use of transmission images to measure the attenuation 
coefficient of each pixel in order to perform the absorption correction.  
4.5 Imaging system 3: Use of an energy resolving pixellated detector 
In order to avoid step and scan XRF imaging techniques which potentially 
require long measurement times, the feasibility of excitation of the whole sample with a 
wide beam and detection of the XRF x-rays with a 2-D energy resolving pixellated 
detector has been investigated. Use of a collimating polycapillary optic coupled to the 
detector preserves the positional information from where fluorescence was emitted. 
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4.5.1 Controlled drift detector 
A Controlled Drift Detector (CDD) (Politecnico di Milano, INFN Milano and 
MPI Munich) of pixel size 180 µm x 180 µm, and 24 drift channels each with 34 pixels 
was used to form the XRF images. The CDD was coupled to a collimating polycapillary 
optic angular filter (IfG Berlin), of channel size 30 µm.  
The CDD is a fully depleted silicon detector that operates in single-photon 
counting integrate-readout mode and allows detection of position and energy of each 
photon in the range 0.5-30 keV. High frame rates (up to 100 kHz) are achievable [106]. 
The chip thickness was 300 μm allowing absorption efficiency of 93% for the gold Lα 
line. 
Equally spaced potential wells are generated along the length of the detector; the 
charge generated by the interacting photon is collected in these wells. The potential 
barriers are then removed and the charge collected drifts towards the readout located at 
the end of each column. One positional coordinate is given by drift time, the other by 
knowing which drift column the event occurred. The amplitude of the signal pulse 
provides the energy information. 
Use of the CDD / parallel optic system improves the achievable resolution of 
XRF imaging by a factor of 1.6 compared to using the SDD / focussing optic system. 
There are no differences in efficiency of detection of the gold signal, or achievable 
count rate between the CDD and SDD. The ~1 keV energy resolution of the CDD can 
distinguish the gold Lα and Lβ peaks, and can also easily distinguish the scatter peaks 
from the gold XRF signal. The only effect the degradation in energy resolution will 
have compared to the SDD is that the detection limit of the system will worsen (refer to 
Section 2.8.2 for a discussion of this effect). A more detailed study in the future is 
required to quantify the achievable detection limit of the CDD system. Use of the CDD 
also enables quicker acquisition times, as it is used to simultaneously collect the XRF 
spectra for 816 pixels; in order to acquire data for an image with the same number of 
pixels, the SDD system would have to perform 816 individual scans leading to 
acquisition times nearly three orders of magnitude greater. In order to calculate the 
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actual difference in acquisition time, the sensitivity to the gold XRF signal of each 
system must be considered. 
The characteristics of both the CDD and SDD systems have been compared in 
Table 15. 
Table 15 Characteristics of the SDD and CDD systems for use in XRF imaging. The image pixel size of 
the CDD was calculated as a quadrature sum of CDD pixel size and polycapillary optic channel size. 
Parameter SDD + focussing optic CDD + parallel optic 
Energy resolution  350 eV at 20 keV 1 keV average at 20 keV 
Max count rate 100 kHz 100 kHz 
Substrate thickness 450 μm Si 300 – 450 μm Si 
Efficiency at Lα 97% 93 – 97% 
Image pixel size 300 μm (focus spot size)  182 μm  
    
4.5.2 Selection of detector collimator 
In order to acquire a 2D XRF image of the sample on the detector in one shot, a 
detector collimator is required. The spatial resolution of an XRF image is a summation 
in quadrature of the detector pixel size and the collimator hole size. A multi-hole 
mechanical collimator (typically with hole dimensions limited to ~0.5 mm) may be used 
(refer to Figure 81 for illustration of such a collimator). The hole size therefore 
dominates the spatial resolution. To overcome the practical limitations of mechanical 
collimator hole size polycapillary optic technology may be used. A parallel 
polycapillary optic acts as a fine angular selector with a divergence of collection of the 
order of a few millirads. Optic channel sizes of the order of a few tens of micrometers 
means that the detector pixel size (180 μm for the CDD) sets the limiting factor for the 
spatial resolution. Use of a parallel optic improves the spatial resolution by a factor of 
~2.5 compared with using a typical multi-hole collimator (each collimator giving pixel 
values of ~180 μm and ~500 μm respectively).      
Use of the parallel polycapillary optic acts to greatly reduce the collection angle 
of x-rays emitted from the sample; this acts to decrease the scatter component of the 
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measured spectrum. However, this also acts to reduce the count rate of the gold XRF 
signal, which will have a negative impact on the sensitivity of the system. The system 
sensitivity is also decreased due to transmission losses in the optic. The transmission 
efficiency of optics is a function of x-ray energy (due to the dependence on the critical 
angle on energy). Further discussion of parallel polycapillary optics and a 
demonstration of the angular acceptance of a parallel polycapillary optic are presented 
in the following section. 
4.5.3 Demonstration of angular acceptance of parallel polycapillary 
optics  
This section presents results that indicate the superior angular acceptance 
capabilities of parallel polycapillary optics, a characteristic that makes the optics useful 
as a fine angle collimator. Polycapillary lenses are monolithic structures of bundles of 
hollow glass capillaries. X-rays are guided along the capillaries by total external 
reflection (TER), and only accepted into the optic channels if the incident angle of the 
x-ray is below the critical angle for TER at that energy (θc(E)). The proposed system 
will use an optic made of borosilicate glass, for which θc(E) is: 
       Equation 14 
where E is the photon energy in keV [107].  
 
Figure 70 Relationship between critical acceptance angle of the polycapillary optic and x-ray energy. 
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θc(E) is larger for lower x-ray energies than higher energies. θc(E) is of the order 
of a few mrad for x-rays in the 5-30 keV energy range, and the fibres therefore act as 
fine angular collimators, filtering through x-rays at the selected scatter angle and 
rejecting x-rays incident at all other angles. This allows formation of a 2D image (across 
the area of the optic) of the x-rays emitted in the solid angle of collection of the optic, 
and therefore enables faster image acquisition than point-by-point scanning. 
A parallel polycapillary optic angular filter (XOS, New York) was characterised 
in order to investigate its use as a collimator in imaging systems. It is made from 
parallel borosilicate glass capillaries each of diameter 5.0 µm forming a monolithic 
structure of outer diameter (flat-to-flat) 11.0 mm. The capillaries are 20 mm in length. 
The x-ray transmission efficiency is quoted as 47% at 17.4 keV by the manufacturer.             
Polycapillary optics require a careful performance qualification (particularly for 
beams with broad spectral properties). The angular / energy dependence of the optic was 
measured using a CMOS pixellated sensor.  
A motorised linear translation stage (Newport, USA) of movement resolution 
0.1 μm was used to scan the CMOS sensor across an uncollimated x-ray beam to locate 
the area of maximum x-ray intensity; this area corresponds to the central axis of the 
beam. The central axis refers to the central component of the x-ray beam that describes 
the direction of the beam, and is the area of greatest x-ray intensity. At each position an 
average image was taken over 100 frames, and the mean pixel value (MPV) from a 
region of interest 170 x 170 pixels central to the image was measured. Figure 71 
displays the location of maximum intensity.   
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Figure 71 Position of maximum intensity measured across the face of the beam. 
 
The angular position of maximum x-ray intensity was then found. With the 
CMOS sensor in the location of maximum intensity, a fine cross wire was used to 
visualise the centre of the beam. The cross wire was mounted on an x-y linear 
translation stage in front of the sensor and positioned so that its image lay at the centre 
of the CMOS sensor. A tungsten target x-ray source was used in fine focus setting 
giving a focal spot size of 0.4 x 0.4 mm; fine focus was selected in order to produce a 
sharp image of the fine cross wire and collimator edges. The beam was collimated 
around the cross wire to 1 mm at the detector face.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
With the CMOS sensor in this position, the optic was placed into a purpose built 
holder that was mounted in front of the sensor. The detector-collimator system was 
rotated around the direction parallel to the central axis of the x-ray beam using a rotary 
stage with an angular precision of 5 minutes. At each rotation angle, 100 frames were 
acquired to produce an average image of the beam. Measurements were made at 30, 40 
and 50 kV. The mean pixel value of a region of interest 200 x 200 pixels at the centre of 
the beam cross section was plotted as a function of optic angle (rocking angle) for each 
x-ray energy. As the centre of the collimator face was not perfectly on the centre of 
rotation, each rotation produced a slight beam translation. The data was fitted with a 
Gaussian distribution and the corresponding FWHM of the rocking curves were found 
(refer to Figure 72).  
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Figure 72 Energy and angular dependence of x-ray acceptance of polycapillary optic 
 
This measurement has demonstrated the potential use of a parallel polycapillary 
optic in acting as a fine diffraction collimator; the angular acceptance of the optic was 
found to be independent of energy over the range 30 - 50 kVp, with an average FWHM 
of 0.2°, as displayed in Figure 72. The angle of peak transmission was found to be at the 
same rotation stage setting for each energy. 
It should be noted that the optic cannot be employed at high x-ray energies (such 
as for K-XRF techniques) due to penetration of x-rays through the glass fibres; a 
collimator with different glass composition could be designed with high Z components 
for use at high energies. The use of the current optic is limited to application in L-XRF 
techniques. 
4.5.4 Experimental arrangement 
Measurements were made at the SYRMEP beamline at the Elettra synchrotron 
source, Trieste, Italy. The CDD module was mounted with a 90° geometry and coupled 
with a parallel polycapillary optic to ascertain the position of emission of gold 
fluorescence. A CCD camera behind the sample monitored the beam-sample alignment 
and made conventional transmission images to assist beam-sample-detector alignment. 
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An ionization chamber was used to monitor beam intensity. The experimental set up is 
displayed in Figure 73. 
 
Figure 73 Experimental set up of CDD XRF imaging system. 
4.5.5 X-ray source 
The synchrotron source energy was set to 15 keV. A beam size was set to 
completely cover the detection area of the sample (detector dimensions 4.3 mm x 6.1 
mm). The sample thickness measured was 3.8 mm, and the view area limited to the field 
of view of the polycapillary optic lens and the detector area.  
4.5.6 Nanoparticle phantom 
The contrast resolution phantom was filled with different concentrations of 
GNPs (4 mgAu/ml (central) and 0.25 mgAu/ml (peripheral) for the high-contrast 
phantom, and 1.6 mgAu/ml (central) and 0.5mgAu/ml (peripheral) for the low-contrast 
one). The high contrast detail had concentrations different by a factor of 16, and the low 
contrast a factor of 3.2 different. 
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4.5.7 Detector collimator 
A parallel polycapillary optic (model 72MLS) made available by IfG GmbH, 
was used with glass capillary channel diameter 30 μm ± 1 μm, bunched together to form 
a monolithic structure of total diameter 8 mm. The capillaries are 40 mm in length. The 
capillaries are encased in a metal cylinder of outer diameter 12 mm and total length 44 
mm.   
4.5.8 X-ray detector 
A description of the CDD module used can be found in [106]. In summary, the 
CDD had a silicon substrate thickness of 300 μm and measured energy resolution of 320 
eV at the manganese Kα line (5.9 keV).  During measurement at Elettra, the energy 
resolution was found to degrade to 460 eV FWHM measured at the copper Kα line (8 
keV), due to the noisy environment of a synchrotron beam. The parallel collimating 
optic was coupled to the CDD. 
4.5.9  Gold nanoparticle imaging procedure 
An iron slab was placed beside the phantom hole detail to facilitate sample-
beam alignment, and the detector scanned to align the detector with the beam (iron – 
beam – detector alignment was achieved when iron XRF lines were detected), using the 
same procedure as outlined in Section 4.4.6. The sample image area was fully 
illuminated by the synchrotron beam, and the CDD set to acquire for 6500 s for the high 
contrast phantom and 11,000 s for the low contrast phantom. 
4.5.10 Image reconstruction 
Reconstruction was performed by collaborators in Politecnico di Milano, Italy, 
with results published in [105]. ROIs were set over the gold Lα, gold Lβ and coherent 
scatter peaks for each detector pixel spectrum. The latter ROI was set to perform a 
scatter normalisation to the XRF image to correct for sample absorption.    
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4.5.11 Results 
Two XRF images of a high contrast and low contrast phantom are displayed in 
Figure 74.  
 
Figure 74 XRF images (log scale) of GNP contrast resolution phantom using the CDD – polycapillary 
optic XRF system. The images are of high contrast (left) and low contrast (right) details. GNP 
concentrations are labeled on the images. 
 
4.5.12 Discussion 
The novel CDD-parallel optic XRF imaging technique demonstrated sensitivity 
to GNP concentrations as low as 0.25 mgAu/ml (the lowest measured concentration). 
The technique was able to distinguish GNP concentrations that were different by a 
factor of 16 (high contrast phantom) and 3.2 (low contrast phantom). The system 
therefore achieves the requirement needed to distinguish tumour from surrounding 
healthy tissue (refer to Table 3). The images in Figure 74 achieve the purpose of this 
study, which was to demonstrate the ability of the one-shot system to image GNP 
distribution. These images do not provide absolute quantitative information of GNP 
concentration at this stage. In order to achieve quantitative images in future work, a 
complete calibration of the CDD to gold XRF signatures is required, and this 
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information is not available at present. Refer to Section 4.5.2 for a discussion of how 
the CDD specifications (energy resolution and efficiency) will affect this system‘s 
performance compared with L-XRF systems using the SDD. 
The high contrast image in Figure 74 displays presence of the iron slab 
alignment tool as a cold spot on the image (i.e. very few x-rays were detected in the 
gold ROI at the position of the iron). A cold spot is also present on the bottom of the 
low contrast image due to the location of the lens border.  
 
4.6 Summary of key results of XRF imaging of GNPs 
An XRF spectrometer (SDD) has been developed with the ability to be coupled 
to mechanical collimators and polycapillary lenses which define measurement volumes 
in order to build up pixellated images. The feasibility of performing energy resolved 
imaging of GNP distribution at concentrations relevant for in vivo and in vitro studies 
has been demonstrated. GNP concentrations different by a factor of 20 down to a factor 
of 3.2 have been shown to be easily resolvable, making this system capable of 
distinguishing tumour from non-tumour (refer to Section 1.5.1). Further work is 
required to test the contrast resolution capability of the system further. Details of 
phantoms with concentrations as low as 0.025 mgAu/ml (the lowest concentration 
present in the phantom) have been successfully imaged in this study. It can be inferred 
from the detection limit measurements in Chapter Two that the system will have 
sensitivity to even lower concentrations.  
In order to avoid step and scan XRF imaging techniques (potentially requiring 
long measuring times) the feasibility of excitation of the whole specimen with a wide 
beam and detection of the fluorescent x-rays with a 2-D energy resolving detector 
without scanning has been investigated. A parallel polycapillary optic coupled with the 
detector has been successfully used to ascertain the position where fluorescence is 
emitted. 
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Further work is required to investigate methods to perform absolute quantitative 
imaging. This is not an easily solved problem, and will involve development of 
correction procedures for sample attenuation, partial volume effect and calibration 
techniques to gain absolute concentration information. 
 
4.7 Development of a combined XRF/XRD system 
Both XRD and XRF techniques have proven beneficial for identifying and 
characterising biological tissues. Section 1.5.5 introduced the concept of using XRD 
analysis to discriminate between tissue types based on differences in structural 
composition of tissues. XRD techniques can provide a considerable enhancement in 
contrast over conventional x-ray imaging [46]. XRF was also introduced in Section 
1.5.4 as a potential method to locate the presence of nanoparticles, such as gold, which 
are embedded into tissues as biomarkers to map the disease state. The sensitivity of the 
XRF technique to GNP concentrations in water and in cells has been demonstrated in 
Chapters Two and Three respectively, and extension of the technique as a GNP imaging 
modality has been displayed in this Chapter. 
The final part of this thesis proposes to determine the feasibility of combining 
these techniques to both locate tumours and provide information on tumour conditions, 
using GNPs as a contrast agent labelled to biomarkers. The following sections will 
detail ideas to develop a high resolution, combined imaging system, and will present a 
key set of preliminary measurements in order to determine the potential of the proposed 
combined imaging technique.  
In order to assess the feasibility of a combined XRF/XRD system as a technique 
that meets the aims detailed in Chapter One (Section 1.3), the following questions will 
be answered in the final sections of this thesis: 
1. Does XRD have a role in identifying tissue type to distinguish tumour 
from healthy tissue? Refer to Section 4.7.2 for a discussion of the 
potential use of XRD in tissue discrimination. 
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2. Can XRD discriminate between tissue types used in the bio-phantoms 
developed in this project? Section 4.7.3 displays measurements 
performed to determine differences (if any) between XRD signals from 
different phantom components. 
3. Do GNPs have an XRD signature of their own that could add to that of 
the tissues being measured? Do GNPs have an XRD signature that may 
interfere with the signature of the measured tissues? Section 4.7.4 
reports results of measured GNP XRD signals and draws conclusions 
based on these findings.  
Each subsequent section will aim to answer the above questions in turn. All 
XRD measurements reported in the following sections are preliminary results, and are 
not the main focus of the project.  
4.7.1 X-ray diffraction techniques 
Coherent scatter contains useful information about the structure and elemental 
composition of the scattering material, as introduced in Section 1.5.5. XRD techniques 
measure coherent scatter to determine molecular structure, chemical bonds and bond 
lengths, and can identify protein types. The momentum transfer value (Equation 3) of 
diffraction peaks relates to the elemental composition and structure of the material, 
while the peak widths relate to the order of the material (more crystalline structures 
have narrower peaks). Soft tissue has short range order producing broader diffraction 
peaks at lower scattering angles than crystalline materials. In terms of imaging different 
tissue types, the combination of position and intensities of all peaks provides a unique 
diffraction signature for each tissue type.  
As the momentum transfer is related to x-ray energy and scatter angle (Equation 
3), there are two ways to extract the diffraction signature from a material: (i) angular 
dispersive x-ray diffraction (ADXRD) and (ii) energy dispersive x-ray diffraction 
(EDXRD). EDXRD uses a polyenergetic source (a conventional x-ray tube) and an 
energy resolving detector, such as the SDD, set at a fixed angle. The incident 
polyenergetic beam is collimated to a pencil beam, and further collimated before 
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arriving at the energy resolving detector to define the scatter angle (as displayed in 
Figure 75). The scatter signature is measured as a function of energy by the detector. 
ADXRD uses a monoenergetic source and measures the scatter intensity as a 
function of angle. Synchrotrons are commonly used to produce the monoenergetic 
beam. Standard laboratory x-ray diffractometers use a copper target and nickel filter to 
produce monoenergetic copper Kα characteristic x-rays of energy 8 keV. This low 
energy is not suitable for imaging of thick samples due to its small penetration depth. 
Alternatively, filters may be chosen to filter a standard tungsten x-ray tube to create a 
narrower spectral width, though not completely monoenergetic (as demonstrated by 
[108]); however Bragg law interference conditions will be met by a range of scatter 
angles leading to a blurring out of the diffraction peaks. A compromise must be made 
between the increase in x-ray fluence and the degradation of momentum transfer 
resolution this will produce.         
 
Figure 75 EDXRD and ADXRD experimental set-up using a HPGe detector and CMOS sensor 
respectively [108]. 
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4.7.2  The role of x-ray diffraction in tissue discrimination 
Knowledge of scatter cross sections and momentum transfer values of scatter 
peaks assists in the design of diffraction systems in terms of optimising x-ray energy 
and scatter angle. The literature contains measured form factors and coherent scatter 
coefficients for a range of materials relevant to this project.  
Kidane et al. (1999) examined 100 breast tissue samples (including adipose, 
fibrosis, fibroglandular, benign, fibrocystic change, fibroadenoma and carcinoma) using 
the EDXRD technique [41]. Figure 76 presents the linear differential scatter coefficients 
of normal breast tissue and breast carcinoma as measured by Kidane et al.  
 
Figure 76 Comparison of the scatter signatures for the ‘pure’ carcinoma sample with that of both normal 
breast tissue (50:50 fat/fibrous mixture) and a pure fibroglandular sample [41]. 
 
Poletti et al (2002) used ADXRD and examined both healthy (glandular and 
adipose) and cancerous breast tissue [109]. Both studies agreed that x-ray signatures of 
adipose show a relatively sharp peak at momentum transfer 1.1 nm
-1
, whereas 
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carcinoma showed a broader peak at a higher momentum transfer value of 1.6 nm
-1
 with 
a lower intensity due to the reduction of structural order in cancerous tissue.     
4.7.2.1 Role of XRD techniques in collagen measurement        
 Collagen is the main protein of connective tissue in the human body with more 
than 20 different collagen types identified so far [91]. Collagen molecules are rod-
shaped approximately 300 nm long and 1.5 nm wide. Fibrils (collagen molecules 
packed into an organised overlapping bundle) have a characteristic periodicity of 65 nm 
(referred to as the d-spacing) [91]. 
It is known that the extracellular matrix (ECM) components of the breast 
degrade in the presence of malignancy, with collagen undergoing significant structural 
alterations on the nano-scale [110], [111], [112]. Collagen may also have a significant 
role in both metastasis [113] and cancer invasion. Cancer invasion is associated with the 
destruction as well as synthesis of collagen matrix proteins. Invasive carcinoma cells 
migrate along collagen strands and the invasive tumour front is rich in loose newly 
formed fibrils [114]. 
Small angle x-ray diffraction (SAXS) has been used as a contrast mechanism 
showing the structural differences in collagen between normal and cancerous tissue 
[114], [112]. This technique uses synchrotron radiation and much lower scattering 
angles than used in the measurements performed throughout this project. The scattering 
pattern results from the size, shape and ordering of large structures with typical 
distances 100 to 10,000 times the distances between neighbouring atoms (length scales 
from 10 to 1000 nm). The SAXS patterns were analysed in terms of intensity and 
position of reflections resulting from the axial period, orientation and diameter of 
fibrils. Ordered collagens were found in benign tumours and far away from malignant 
regions, whilst poorly ordered collagens were found in invaded tissue. Scattering 
intensity was greater for areas invaded by cancer indicating that the supra-molecular 
structure breaks down into smaller structures which have a larger specific surface area. 
Small but distinctive differences in axial period (d-spacing) was found; where the 
collagen was embedded in invaded adipose tissue or near a necrotic region the axial 
period was found to be 65.3 ± 0.2 nm, whereas the period in benign tumours or healthy 
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connective tissue was 65.0 ± 0.1 nm. Necrotic areas were found to have no trace of 
ordered collagen, but do contain molecular coils [114].     
Round et al. (2005) used a laboratory-based diffractometer instead of 
synchrotron radiation to collect SAXS data from cancerous and non-cancerous breast 
tissue [115]. The data were analysed using multivariate analysis (MVA), a statistical 
technique applied to complex systems (e.g. a biological system) for which each 
measurement holds many aspects of the object. 
It can be inferred from the literature that XRD does have a role in identifying 
tumour from healthy disease, and that there is a role for small angle XRD in measuring 
collagen structure as an indicator of tumour state. Therefore it is proposed that a 
combined XRF/XRD system could be useful. 
4.7.3 The role of x-ray diffraction in distinguishing bio-phantom tissue 
The role of XRD techniques in distinguishing components of the bio-phantoms 
developed in Chapter Three has been considered. 
4.7.3.1 Measurement of diffraction signals from bio-phantoms 
In order to determine if there is a diffraction signature difference between the 
biological components of the research samples, a series of diffraction measurements 
were made using the diffractometer at the B16 beamline at the Diamond Light Source, 
UK.  
The beam was set to 15 keV (to meet the requirements of an XRF system) and a 
beam size 0.8 mm high and 4.0 mm wide was set to fully illuminate the sample. The 
samples were contained in a 5 ml bijou pot made of low scattering plastic. The samples 
consisted of: (i) set collagen type I hydrogel, (ii) 3T3 cells embedded in collagen and 
(iii) water. The samples were made using a standard 3D cell culture technique [92]; 
refer to Section 3.4 for further details of the samples.  
Measurements were made between scatter angles 3.5° – 35° in 0.5° steps to 
cover the momentum value range of interest for soft tissue. Each scatter angle was 
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measured over 20 s. Momentum transfer calibration was performed by scanning a water 
sample of known diffraction peak at 1.6 nm
-1
. 
The measured diffraction signatures are displayed in Figure 77. The diffraction 
signatures were measured to a level of accuracy needed to provide the necessary 
information required at this stage (i.e. to determine if there is a diffraction signal for the 
phantom components, and if there is any difference in this signal between the 
components). No attenuation correction has been applied to account for different x-ray 
path lengths over the range of scatter angles.  
 
Figure 77 Measured diffraction signatures of the collagen type I hydrogel, with and without 3T3 
presence, and a water sample. Detected counts were normalized to the total sum of all counts in the 
spectrum. No attenuation correction for x-ray path length through the sample has been made.  
 
Figure 77 illustrates a strong diffraction peak at 1.68 nm
-1 
for the two collagen 
samples (both with and without 3T3 cells). This peak is not present in the water sample. 
Therefore, it is thought that this peak may be due to collagen type 1 presence, and its 
sharpness indicates a non-amorphous, well structured material. There is a difference in 
this peak intensity between the two collagen samples; it is proposed that this intensity 
difference is due to different collagen densities in the measurement volume. Further 
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measurement is required to confirm this. It can be seen that each sample measurement 
shows a contribution from water; water is a main constituent of the collagen gel and so 
this result is expected.  
A second set of diffraction measurements was performed at the Elettra 
synchrotron source, Italy, in order to compare the diffraction signals of HT29 cells and 
3T3 cells. The cells in each sample were embedded in a collagen type I hydrogel, using 
the procedure outlined in Section 3.4.7. The cell phantoms are not completely 
representative of tissue found in vivo. They form a simplified model of human tissue in 
which only one cell type is present in the measurement volume. A major difference 
between the bio-phantoms and real tissue is the ordering and distribution of the cells; 
cells in human tissue are distributed according to the function of the cell, e.g. 
endothelial cells line up to form sheets. This structure is not present in the bio-
phantoms, and cells are uniformly embedded into the pores of the collagen type I gel. 
However, the elemental composition of the cells should be representative of in vivo 
tissue. This set of phantoms has a low collagen density, being composed of ~ 0.4% 
collagen (by percentage weight), not having undergone the plastic compression as 
outlined in Section 3.4.10, which is more than an order of magnitude lower collagen 
density than typically found in tissue. The water content (> 99% by percentage weight) 
is therefore much greater than that expected in vivo. The cell density is also a lot less 
than that found in vivo and so will result in a weaker diffraction signal from the cells, 
with a greater contribution from water than if an ex vivo sample was being investigated.        
A parallel polycapillary optic (model 72MLS of channel size 30 μm) was 
coupled to the SDD to provide a high angular resolution in the measurement system. 
This optic has previously been characterised to have an angular acceptance of 0.14° at 
16.5 – 18.5 keV [45]. The SDD was mounted on a swinging arm that rotated about the 
sample, defining the scatter angle. An angular range of 11 – 26° was covered in 1° 
steps; this covered the momentum transfer range of interest at the incident x-ray energy 
setting of 15 keV.  
The data was corrected as follows: (i) an ionisation chamber reading corrected 
for fluctuations in beam intensity at each scatter angle, (ii) each signature was 
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normalised to the total number of counts in each spectrum. No attenuation correction 
was applied, nor sample holder subtraction performed. It was decided not to perform the 
latter as no attenuation correction has been applied and so the measured contribution 
from the pot could not be directly stripped from each sample signal. Furthermore, a thin 
walled low Z container was used and so the contribution from the pot was small. The 
results are displayed in Figure 78. 
 
Figure 78 Measured diffraction signatures of biological phantoms composed of HT29 and 3T3 cells 
embedded in a collagen matrix. Each data point was normalized to incident beam intensity measured 
using an ionization chamber, and each profile normalized to the integral sum of counts for each 
spectrum. No attenuation corrections or empty pot subtraction were performed. 
 
Both samples show a diffraction peak at momentum transfer value 1.68 nm
-1
 
corresponding to the collagen peak. The measurements suggest there is a measurable 
difference between the signatures of 3T3 and HT29 cells, with the HT29 sample being 
more scattering between 2.1 – 2.4 nm-1, and less scattering at lower momentum transfer 
values. It can be inferred from this result that the diffraction signature can be used to 
distinguish the different cell type components in future research samples. 
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4.7.3.2 Discussion  
A literature review of clinical uses of XRD has presented a clear answer to 
Question 1: XRD does indeed have a role in tissue discrimination. Literature reports 
that the XRD signatures of healthy and tumour tissue are sufficiently different to enable 
the tissues to be distinguished. The XRD measurement performed in Section 4.7.3.1 
highlights the potential use of the diffraction signal thought to be from collagen (at x = 
1.68 nm
-1
)
 
for clinical applications. It can be inferred from the literature discussed in 
Section 4.7.2.1 that there is a role for XRD in measuring collagen as an indicator of 
tumour state. It is recommended that further work is undertaken to develop bio-
phantoms that mimic collagen structural differences found between tumour and healthy 
tissue through use of tissue engineering techniques and 3D live cultures (refer to Section 
3.4.10 for a discussion of such tissue engineering techniques). XRD measurement of the 
phantoms will investigate the sensitivity of our XRD technique in measuring collagen 
structural changes.      
In answer to Question 2 asked in Section 4.7, no firm conclusions can be made 
at this stage as to whether XRD can be used to distinguish bio-phantom components 
under imaging conditions; the differences between XRD signatures are measurable but 
small. Further work should be undertaken in order to quantify the difference in XRD 
signals between the sample components. It would be beneficial to measure the 
diffraction signatures of cultured cells before being embedded in collagen in order to 
understand the contribution from each sample component. 
4.7.4 XRD measurement of GNP samples 
There are many XRD measurements covering a range of sizes of GNPs (between 
0.8 – 20 nm in diameter) present in the literature, all measured using the copper Kα line 
(8 keV) [116], [117], [118]. All groups are in agreement with a main GNP diffraction 
peak at 38º, i.e. a momentum transfer value of 2.1 nm
-1
. This peak corresponds to the 
(111) d-spacing of gold [116].   
 The diffraction signature of a high concentration 1.9 nm GNP-DIW solution (8 
mgAu/ml) was measured at the Elettra Synchrotron source, Italy, and compared to the 
XRD signature from water. An incident x-ray energy of 15 keV was selected to assess 
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the XRD signal that is induced at the energy used in the XRF system. The same 
measurement procedure as described in Section 4.7.3.1 was used. An angular range of 
11 – 25° was measured in 1° steps; this covered the momentum transfer range of 
interest. Figure 79 displays the measured diffraction signals.  
 
Figure 79 Measured diffraction signature of an 8 mgAu/ml GNP sample and water. The measured count 
rate was normalized to the integral sum of the whole spectrum. 
 
Figure 79 displays a peak at 1.6 nm
-1
; this corresponds to the known momentum 
transfer of water. There is a slight but measurable difference of 3.1% (greater than the 
percentage error of < 1%) between the diffraction signals of water and GNP solution at 
the expected GNP momentum transfer value of 2.1 nm
-1
.  
4.7.4.1 Discussion 
We have demonstrated a small (but still measurable) difference of 3.1% between 
the diffraction signals of water and GNP solution at the expected GNP momentum 
transfer value of 2.1 nm
-1
. This indicates that there is a diffraction signal from the 1.9 
nm GNPs, but it is very slight and will lessen at lower GNP concentrations. The 
literature reports that the strength of the XRD signal is proportional to the size of the 
NP, with larger NPs having a higher degree of crystallinity and therefore a stronger 
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XRD signal [119], [120]. Smaller NPs have a larger surface area / volume ratio, and 
atoms at the particle‘s surface are not as densely packed as those in the core of the 
particle [119]. Figure 80 displays the broadening of the gold XRD peaks due to the loss 
of structural order at lower GNP sizes. 
 
Figure 80 XRD spectra for four different GNP sizes: (a) 20.2 nm, (b) 6.8 nm, (c) 3.0 nm and (d) 1.6 nm. 
Spectra were measured using the copper Kα line. The main GNP peak occurs at x = 2.1 nm-1. Figure 
taken from [120]. 
 
Literature suggests that GNPs of a size less than 2 nm are structurally disordered 
and their atomic arrangements exhibit amorphous-like rather than crystallographic 
features [120]. This explains why the measured XRD signal from 1.9 nm GNPs is so 
small.  
In answer to Question 3 posed in Section 4.7, two useful conclusions may be 
made from these measurements: 
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 The XRD signal from GNPs is small and will not contribute much 
information to imaging GNP concentrations in a combined XRF/XRD 
system.  
 The XRD signal from the GNPs is at a momentum transfer value that is 
significantly different to those of interest in the biological tissue 
components, and so will not interfere with XRD measurement of tissue.   
If larger GNPs were used in future work, the first conclusion may not apply; it is 
expected that the XRD signal increases with GNP size, and may then contribute a useful 
signal to the combined technique.  
4.7.5 Towards the design of a combined XRF/XRD system 
A multi-modality XRF/XRD system has been proposed to acquire images 
sensitive to GNP concentration and distribution and tissue type The system 
requirements for measuring XRF and XRD signatures of tissues embedded with GNPs 
will be outlined, proceeding to a discussion of feasibility of the combined system. 
4.7.5.1 Limitations of previous systems 
Current fixed angle scattering systems produce 2D images by raster scanning a 
narrow pencil beam across the sample. This limits the speed of image acquisition. The 
speed has been increased by using a multiple parallel holed mechanical collimator, 
displayed in Figure 81 [121].  
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Figure 81 Schematic diagram of a multi-hole mechanical collimator [121]. 
The achievable spatial resolution is governed by the size of the pencil beam 
incident on the sample and the size of the scatter collection area, which in turn is 
dictated by the collimator hole size (of the order of 500 µm). Systems using mechanical 
collimators therefore do not benefit from the smaller pixel sizes of currently available 
imaging detectors (~10 µm). An XRD system design consisting of polycapillary optic 
technology overcomes these limitations. 
Two novel fixed-angle x-ray scatter imaging systems with multi-momentum 
transfer capability were developed by Politecnico di Milano (our collaborators on this 
project) making use of the SDD and CDD module coupled to a parallel polycapillary 
optic [46], [122]. The systems featured improved spatial resolution through use of the 
optic, and spatial resolution was limited by the detector pixel size and not collimator 
hole size. The CDD, having spectroscopic resolution, enables use with both 
monoenergetic and polyenergetic sources, making the system translatable from 
synchrotron sources to a bench-top source. Simultaneous acquisition of images at 
multiple momentum transfer value is also possible enabling images of different tissue 
types to be acquired concurrently to assist tissue identification. 
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4.7.5.2 Spatial resolution of the system 
The dimensions of the scatter volume are related to the incident collimated beam 
size Δx, the detector-collimator resolution Δd (the sum in quadrature of the hole size of 
the scatter collection collimator Δc and the detector pixel size Δp (Equation 16)), and 
the scatter angle θ as illustrated in Figure 82: 
 
Figure 82 Voxel size of image produced by polycapillary optic system. The sample may be scanned in the 
x-direction to produce data required for a 3-D image. 
 
The red beam indicates an image slice of the system. The voxel size in the y 
direction is Δd, in the x direction is Δx, and in the z direction (describing the voxel 
depth in the direction of the beam) is: 
 tansin
xd
z



        Equation 15 
where 
22 pcd         Equation 16 
The improvement in spatial resolution resulting from the use of a polycapillary 
optic rather than a mechanical collimator has been calculated. For example, a collimator 
with 500 μm hole size collecting at scatter angle 6° and a beam size of 500 μm, using 
the CDD module of pixel size 182 μm results in a voxel size of 500 μm x 532 μm x 
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9847 μm. Replacing the scatter collection collimator with a polycapillary optic of 
channel size 5 μm improves the spatial resolution to 500 μm x 182 μm x 6498 μm; an 
improvement of 66% in the y direction and 34% in the z-direction. In order to reduce 
the voxel size even more, the incident beam size may be reduced to shrink the voxel 
depth along the length of the beam. This will also lessen the partial volume effect (the 
impact of the partial volume effect on tissue discrimination was discussed in Section 
4.1.3).   
4.7.5.3 Momentum transfer resolution 
Tissue discrimination depends on momentum transfer resolution. The resolution 
is a combination of the x-ray source spectral width (or energy resolution of the detector) 
ΔE for an ADXRD (or EDXRD) system respectively, and the angular resolution of the 
system:  
22
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Equation 17 
The angular resolution of the system is given by the Equation 18: 



 minmax 

       
Equation 18 
where θ is the nominal scatter angle, and θmax and θmin are the maximum and 
minimum scatter angle respectively through which a photon can be scattered and still 
reach the detector (Figure 83). The angular resolution can be greatly improved by 
replacing a mechanical collimator with a polycapillary optic angular filter. To illustrate 
this, θmax and θmin have been calculated geometrically for a mechanical collimator set 
up: 
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Figure 83 Schematic of general XRD system, used to calculate the momentum transfer resolution 
components [123]. 
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where      11
tan2 dLh div        Equation 21 
d1 and d2 are the primary and secondary collimator diameters 
l1 is the primary collimator exit to sample distance 
l2 is the sample to secondary collimator exit surface 
The effect of each system parameter has been theoretically calculated, and the 
results shown in Figure 84. In summary: 
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1. Doubling d1 increases (worsens) angular resolution by a factor of ~ 1.04 - 1.1 
2. The same is true for d2 
3. Doubling the angle of divergence increases (worsens) angular resolution by a 
factor of ~ 1.8 
4. Doubling L1 increases (worsens) angular resolution by a factor of ~ 1.05 – 1.1 
5. Doubling L2 decreases (improves) angular resolution by a factor of ~  0.8 
The angular acceptance of the mechanical collimator shown in Figure 81 has 
been calculated to be 1.9°, whereas the angular acceptance of a polycapillary optic has 
been measured as 0.2° (see Section 4.5.4); this corresponds to a 9.5 times improvement 
in angular acceptance on using the optic.    
The achievable momentum transfer resolution values have been estimated for 
each XRD system using Equation 17 at the momentum transfer value of breast 
carcinoma (1.6 nm
-1
): (i) optic coupled to CDD (Δx = 0.1 nm-1), (ii) optic coupled to 
SDD (Δx = 0.06 nm-1).  
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Figure 84 Effect of collimator width (d1 and d2), angle of divergence, L1 and L2 on angular resolution. 
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4.7.5.4 Discussion 
The previous sections have outlined some thoughts towards the design of a 
novel XRF/XRD system. The combined system will enable imaging of GNP 
distribution and discrimination of tissue type using XRF and XRD techniques 
respectively. The clinical need for a system that is sensitive to sub-clinical disease with 
the ability to distinguish cancer from healthy tissue and measure GNP concentration 
was introduced in Section 1.3. The novel system was designed in answer to this clinical 
need; the estimated resolution capabilities are better than those of systems present in the 
literature. A high spatial resolution will act to reduce the partial volume effect to enable 
discrimination of tissue type and GNP concentration over smaller volumes. Preliminary 
calculations and measurements have demonstrated that use of a polycapillary optic can 
improve spatial resolution by up to 66% compared with use of a mechanical collimator. 
The achievable spatial resolution is a function of scatter angle, incident beam thickness 
and collimator – detector pixel area. Further work is needed to select the optimum 
scatter angle. This will involve: 
(i) Consideration of voxel size (which reduces with angle). 
(ii) Reduction of the Compton background beneath the XRF signal. XRF is 
isotropic whereas Compton scatter is at a minimum at 90º. This is 
achieved at high scatter angles. 
(iii) Increasing the detection of coherent compared with Compton scatter. 
Coherent scatter is forward peaked whereas Compton scatter can be 
considered more uniformly distributed at low angles. This is achieved at 
low angles. 
Use of a polycapillary optic also improves the momentum transfer resolution by 
a factor of ten compared with a mechanical collimator system. The momentum transfer 
resolution of two systems has been calculated to be 0.1 nm
-1
 and 0.06 nm
-1
 for the optic 
coupled to the CDD and SDD respectively. Using breast tissue as an example, the main 
coherent scatter peaks of healthy and carcinoma are found at momentum transfer values 
of 1.1 nm
-1
 and 1.6 nm
-1
 respectively. It can be concluded that the peak position of these 
tissues can be discriminated using either proposed XRD system. Even if the actual peak 
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positions of tissue to be discriminated have a momentum transfer difference less than 
the momentum transfer resolution of the system it may still be possible to differentiate 
them providing the spectral shape differs. Spectral shape can potentially be used as a 
measured parameter in this system by virtue of the fact that it has both energy and 
position information.     
The peak positions of an artificial cancer mass (x = 1.6 nm
-1
 from [41]) and 
collagen type I gel (thought to be x = 1.68 nm
-1
 from measurement) have a peak 
separation of 0.08 nm
-1
. The CDD cannot achieve this, even when used with the 
polycapillary optic, whereas the superior energy resolution of the SDD may be able to 
achieve this. However, the spectral shape parameter could mean that differentiation is 
possible with both systems.   
The incident x-ray spectrum (considering both energy and intensity) affects the 
scatter signature in the following ways: (i) the position of the peak (energy dependence 
of scatter), (ii) peak height (intensity of scatter) and (iii) peak width (spectral shape). 
Section 2.5.5 introduced the concept of using filters to shape the beam produced by an 
x-ray tube.        
As discussed in Section 2.4.1.1 the ideal beam for XRF measurements would 
have a narrow spectral width and high intensity. The spectral width required for XRD 
measurements is different for each diffraction mode: 
1. ADXRD requires a near-monoenergetic beam, such as a synchrotron or 
molybdenum filtered bench-top source. 
2. EDXRD requires a spectral width wide enough to cover the momentum 
range of interest (i.e. the momentum range where there is a maximum 
difference in scatter intensity between gold and carcinoma). It is beneficial to 
select as narrow a spectral width as possible to (i) reduce the number of low 
energy x-rays not contributing to the useful scatter information but 
contributing to dead time losses of the detector, (ii) reduce the number of 
higher energy x-rays not providing useful scatter information but 
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contributing to the Compton scatter background that degrades the useful 
signal. 
In choosing the ideal incident spectrum for a combined system, the coherent 
scatter peak positions and intensities of tissue types to be distinguished must be 
considered, in addition to XRF excitation energies of gold. For ADXRD measurements, 
an energy giving the greatest difference in scatter angle between the materials being 
measured should be selected. For EDXRD, a fixed scatter angle should be used that 
brings about the greatest difference in scatter energy (to increase the separation of the 
scatter peaks on an energy-axis with a separation greater than the energy resolution of 
the detector). 
In order to find the mean energy giving the greatest difference in scatter angle 
between healthy breast (x=1.1 nm
-1
) and carcinoma (x=1.6 nm
-1
), calculations of energy 
and scatter angle at these values of x have been performed. The result is illustrated in 
Figure 85, and shows that the largest scatter angle distinction between healthy tissue 
and carcinoma can be found at mean energies below 30 keV. For EDXRD 
measurements, it can be seen that a fixed scatter collection angle below 5° brings about 
the greatest difference in scatter peak energy between healthy tissue and carcinoma. To 
excite the gold L-lines (requiring a beam energy above 13.7 keV) a fixed scatter angle 
of 15° and a filtered beam ranging from ~ 10 - 16 keV x-rays will produce healthy 
tissue and carcinoma peaks separated by 4.7 keV, which is easily resolvable by the 
CDD and SDD.                             
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Figure 85 Top: Calculated values of constant momentum transfer for healthy breast (x=1.1 nm
-1
) and 
breast carcinoma (x =1.6 nm
-1
): the plot illustrates that the greatest difference between healthy tissue and 
carcinoma occurs at low energies (below 30 keV). Bottom left: Calculated scatter angle difference 
between healthy breast and carcinoma over a range of energies. Bottom right: Calculated energy 
difference of healthy breast and carcinoma coherent scatter peaks over a range of scatter angles.  
 
There are two proposed possibilities for the format that a combined system 
could take: 
(i) Using two separate spectrometer arms to simultaneously measure XRF 
and XRD: One arm optimised for XRF measurement will be set at 90º 
(using one of the imaging modules demonstrated in Section 4.4 and 4.5).  
The other arm will be set at an optimum scatter angle for XRD detection, 
using either the CDD or SDD coupled to a parallel polycapillary optic. 
A 
C B 
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(ii) Using one spectrometer arm to simultaneously measure XRF and XRD: 
This will involve either the SDD or CDD coupled to a parallel 
polycapillary optic to gain both XRF and XRD signal from the same 
spectra. An optimum scatter angle should be selected to gain sufficient 
XRF and XRD signal as discussed above. Placing the spectrometer at 
angles less than 90º will act to reduce the XRF signal to background 
ratio, and use of the optic will result in signal loss due to losses in 
transmission. To demonstrate this effect, preliminary measurements were 
made of an 8 mgAu/ml sample in typical XRF (90º, no optic) and XRD 
(11º, with parallel optic) geometries. Figure 86 displays the measured 
spectra for each geometry.    
 
Figure 86 Emitted x-ray spectra of an 8 mgAu/ml sample measured in two different geometries: (i) in 
optimum XRF geometry (90º with no optic) acquired over 60 s, and (ii) in a typical XRD geometry (11º 
with a parallel optic) acquired over 240 s. Both spectra have been corrected for acquisition time and 
measured incident beam intensity to enable comparison.    
  
It can be seen that measurement in typical XRD geometries reduces the gold 
XRF signal by over two orders of magnitude. It can be inferred that the sensitivity and 
4. Towards a real system 
 
217 
 
detection limit of GNP concentration measurement will be worsened using XRD 
geometries, and so the two-arm system would be a better technique. However, further 
work is required to investigate methods to fully optimise a one-arm system in terms of 
detection angle.   
4.7.6 Summary of key ideas 
The latter half of this chapter has introduced the potential role of diffraction in a 
combined XRF/XRD system in order to image GNP concentration and distinguish 
tissue type simultaneously. Design aspects of the system have been considered, and 
capabilities of the proposed system have been estimated through preliminary 
measurements. In summary: 
 There is a strong role for XRD in tissue discrimination (in particular 
between healthy and cancerous tissue as reported in the literature), 
enabling potential application for our purpose. 
 GNP presence does not provide a strong XRD signal, and will not 
interfere with XRD measurement of tissue. If larger GNP sizes are used 
in further work, this conclusion may not apply as larger GNPs give 
stronger XRD signals. 
 Use of a parallel polycapillary optic can improve spatial resolution and 
momentum transfer resolution (both key in sensitivity to sub-clinical 
clusters of proliferating cells) by factors of 1.6 and 10 respectively 
(dependent on detection geometry). The estimated resolution capabilities 
are better than those of systems present in the literature. 
 Calculations have demonstrated that the proposed systems will be able to 
discriminate between healthy and cancerous tissue. Further work is 
needed to determine if the systems can distinguish between components 
found in the bio-phantoms produced in Chapter Three. 
 Two possible systems have been proposed consisting of (i) a one-arm 
spectrometer to simultaneously measure XRD and XRF from the same 
spectrum, and (ii) a two-arm system consisting of two spectrometers to 
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separately measure the signals. The one arm system poses potential 
issues in reducing sensitivity to the XRF signal when in diffraction set-
ups, and further work is recommended to fully optimise the set up to be 
sensitive to both signals.     
 
4.8 Conclusions 
Just as Chapter Two demonstrated the ability of the XRF technique to quantify 
GNP concentration, this Chapter has met its aim in showing that XRF can be used to 
acquire images of GNP distribution. An XRF spectrometer coupled to a polycapillary 
lens has been developed and used to prove the feasibility of performing energy-
resolving imaging of GNP distributions at concentrations relevant for in vitro imaging 
of bio-phantoms and in vivo imaging for radiotherapy applications. Details of phantoms 
with concentrations as low as 0.025 mgAu/ml have been successfully imaged, with 
potential to image lower concentrations: Chapter Two demonstrated that the technique 
is sensitive to quantitative measurement of GNPs down to the detection limit of 0.005 
mgAu/ml (further improvements to the detection limit were made in Chapter Three to a 
limit of 0.001 mgAu/ml). The feasibility of excitation of the whole specimen with a 
wide beam and detection of XRF x-rays with a 2D pixellated energy dispersive detector 
without scanning was shown. This system avoids step and scan techniques and so 
reduces the required measurement times. Through the results of both this chapter and 
Chapter Two, it can be inferred that quantitative imaging of GNP concentration is 
feasible providing the imaging system has been calibrated for GNP concentration 
measurement.    
A novel combined XRF/XRD system was proposed to image both GNP 
concentration and discriminate tissue type (with sufficient evidence in the literature that 
XRD can discriminate between tissue types). The system proposed is a high 
performance XRD system, with excellent momentum transfer resolution (due to the 
angular resolution improvements through use of the parallel polycapillary optic 
compared with other systems reported in the literature using mechanical collimators). 
One can therefore infer its potential clinical use, but cannot quantify its ability to 
distinguish tissue without further work.                 
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5 Conclusions 
This thesis has made a contribution in terms of a research effort aimed at 
identifying suitable techniques to image bio-markers to provide a map of 
radiosensitivity in order to guide radiotherapy treatment dose prescription. In answer to 
the aims of this project, GNPs have been identified as a suitable bio-marker imaging 
contrast agent; they can be functionalised to be taken up by less radiosensitive cells, and 
then imaged using x-ray techniques. A novel L-XRF system (consisting of an SDD 
module) has been conceived and developed that is capable of quantitative detection of 
GNPs, with a linear relationship between GNP concentration and L-XRF signal found. 
Concentrations can be measured up to an accuracy of ± 0.005 mgAu/ml for systems 
using either synchrotron radiation or a bench-top x-ray tube as the exciting source. The 
linearity extends down to the detection limit of 0.001 mgAu/ml; a concentration that is 
an order of magnitude lower than concentrations found in vivo as presented in the 
literature (~ 0.01 mgAu/ml) [25]. Our novel L-XRF system therefore meets the 
requirements set out at the design stage. Our system has a detection limit that surpasses 
the sensitivity of other x-ray based techniques found in the literature [24], [38], and 
could be used in the future to answer the clinical need for radiotherapy imaging of 
clusters of infiltrating cells. The measured DL was found to be the same for both the 
synchrotron and bench-top sources, showing potential for this technique to be used in 
the clinic.  
A K-XRF technique was also assessed, and its performance was found to be 
worse than for the L-XRF system, having 6.5 times less sensitivity than the L-XRF 
bench-top system, and a detection limit of 0.2 mgAu/ml. This can be attributed to lower 
photoelectric interaction probabilities at higher K-edge energies, and a higher spectral 
background contribution. The K-XRF technique is however less affected by overlying 
thickness, and so may have a future application in measuring thick samples containing 
high GNP concentrations.     
Translation from 1D spectroscopic measurement to 2D imaging was achieved. 
An L-XRF spectrometer coupled to a polycapillary lens has been developed, and 
demonstrated feasibility in performing energy-resolving imaging of GNP distributions 
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at concentrations relevant for in vitro imaging of bio-phantoms and in vivo imaging for 
radiotherapy applications. Details of phantoms with concentrations as low as 0.025 
mgAu/ml have been successfully imaged, with potential to image lower concentrations 
(the L-XRF technique having a DL of 0.001 mgAu/ml). The feasibility of excitation of 
the whole specimen with a wide beam and detection of XRF x-rays with a 2D pixellated 
energy dispersive detector without scanning was shown. This system avoids step and 
scan techniques and so reduces the required measurement times. Both systems can 
achieve spatial resolution capabilities better than 1 mm (thus meeting the requirements 
for use in radiotherapy). It can be inferred that quantitative imaging of GNP 
concentration is feasible providing the imaging system has been calibrated for GNP 
concentration measurement. Further work is required to investigate methods to perform 
absolute quantitative imaging. This is not an easily solved problem, and will involve 
development of correction procedures for sample attenuation, consideration of partial 
volume effect and calibration techniques to gain absolute concentration information. 
Novel bio-phantoms were engineered with GNP inclusions at concentrations that 
represent the clinical situation in order to demonstrate the XRF measurement technique 
in a more realistic case. GNP uptake in 3T3 and HT29 cells was demonstrated; it was 
found that using 1.9 nm GNPs and an incubation time of 24 hours gave sufficient GNP 
uptake. A second size GNP of nominal size 15 nm was found to barely be taken up by 
cells. TEM analysis confirmed that GNP uptake was achieved in both cell lines, through 
the mechanism of endocytosis. The L-XRF technique was then used to measure GNP 
concentration in the cells. The cells were embedded in a 3D scaffold (collagen type I 
matrix) using a standard technique [73]. Each sample contained a GNP concentration 
above the DL of the XRF system (> 0.001 mgAu/ml). GNP uptake was shown to be 
repeatable within measurement error. The XRF technique (a technique that doesn‘t 
destroy samples) successfully measured GNP concentration in the cellular samples; it 
was found that GNP uptake increases with incubation dose. The percentage uptake of 
initial incubation GNP dose per million cells measured by the XRF system was found to 
range between 0.3 – 0.5% and 0.1 – 0.3% for the 3T3 and HT29 cell samples 
respectively. In an in vivo situation tumour cells will take up more GNPs than healthy 
cells due to leaky tumour vasculature and poor lymphatic drainage at tumour sites. TEM 
images qualitatively corroborated the XRF technique‘s findings that uptake was 
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proportional to initial GNP dose. The passive GNP uptake demonstrated here may be 
extended through functionalisation to meet the overall eventual aim of this project in 
using GNPs as a contrast agent to image the distribution of bio-parameters of a tumour. 
Uptake efficiency could be increased in the future by coating the GNPs in a protein 
taken up by the specific target cells. It was estimated that a 4 mgAu/ml incubation dose 
resulted in ~ 5 x 10
7
 GNPs taken up per 3T3 cell. It was also estimated that the 
measured detection limit of the XRF system (0.001 mgAu/ml) enables ~ 1.4 x 10
13
 
GNPs to be detected per cm
3
. The number of cells that this corresponds to is dependent 
on incubation dose, and other factors that affect NP uptake such as surface properties 
and size of GNPs.  
  A set of artificial cancer mass phantoms were successfully constructed, 
building on the work previously undertaken [99]. This work was extended to produce a 
set of novel phantoms with GNP inclusions for XRF imaging. The samples will be 
imaged at the Diamond Synchrotron in the near future. The 3D cellular phantoms with 
GNP inclusions are planned to be used in future work investigating the dose 
enhancement effect of GNPs. Radiobiological studies will be performed on GNP-filled 
cells to determine the extent of the dose enhancement effect. 
An extension study aimed at developing a novel combined XRF/XRD system to 
perform quantitative measurement of GNP concentrations and enable tissue 
discrimination will be undertaken in the near future. There is sufficient evidence in the 
literature that XRD can discriminate between tissue types. The system proposed is a 
high performance XRD system, with excellent momentum transfer resolution (due to 
the angular resolution improvements through use of the parallel polycapillary optic 
compared with other systems reported in the literature using mechanical collimators). 
One can therefore infer its potential clinical use, but cannot quantify its ability to 
distinguish tissue without further work. 
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